data_2lg7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lg7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 120.826 0.126 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG21 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.459 ' H ' HG21 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 121.519 0.511 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.475 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 121.639 0.577 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.52 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.52 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG13 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' H ' HG13 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 CA-C-O 121.131 0.295 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.791 0.662 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.499 ' CG1' ' CD2' ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.499 ' CD2' ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.408 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.25 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 52' ' ' VAL . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.412 ' H ' HG13 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.538 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.54 ' H ' ' CD ' ' A' ' 107' ' ' GLU . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 52' ' ' VAL . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG13 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 114.237 0.455 . . . . 0.0 114.237 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.347 0.594 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.464 ' H ' HG13 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.467 0.651 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 108' ' ' LYS . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-O 122.821 1.234 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' H ' HG21 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.432 ' HG1' ' HG2' ' A' ' 46' ' ' GLU . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG2' ' HG1' ' A' ' 44' ' ' THR . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 121.328 0.585 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 112.651 -0.18 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 52' ' ' VAL . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt . . . . . 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.448 ' H ' HD21 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.463 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.861 0.145 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.419 HG22 ' HG1' ' A' ' 65' ' ' THR . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.419 ' HG1' HG22 ' A' ' 16' ' ' THR . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.479 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 CA--C 1.506 -0.518 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 174.23 85.66 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 2 C-N-CA 131.997 4.119 . . . . 0.0 100.141 -155.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 3.3 m-20 -137.85 100.25 4.13 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -151.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.84 169.64 22.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.521 1.528 . . . . 0.0 108.742 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -130.53 70.62 82.43 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 109.015 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.65 93.13 1.09 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.244 2.629 . . . . 0.0 112.056 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.86 -114.07 1.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.51 152.49 16.81 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.798 1.19 . . . . 0.0 110.88 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -141.01 107.86 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.536 1.134 . . . . 0.0 108.922 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.06 154.9 0.41 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 127.485 2.469 . . . . 0.0 112.87 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG21 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.459 ' H ' HG21 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.39 173.81 14.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.81 162.14 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 122.866 0.466 . . . . 0.0 110.651 164.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.06 89.13 7.26 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.291 1.836 . . . . 0.0 110.491 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.14 101.69 2.38 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 124.233 0.921 . . . . 0.0 112.311 -166.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.05 -164.56 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.914 1.286 . . . . 0.0 110.603 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -74.96 165.06 25.86 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.663 -1.273 . . . . 0.0 108.896 168.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -20.32 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.317 -0.864 . . . . 0.0 113.471 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t 75.66 -63.86 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 127.282 2.233 . . . . 0.0 110.925 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p 52.0 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 130.622 3.569 . . . . 0.0 112.734 -166.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -150.28 -68.4 0.19 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.034 -1.041 . . . . 0.0 110.163 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.93 154.68 88.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 124.808 1.243 . . . . 0.0 112.014 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 170.98 13.47 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.864 3.709 . . . . 0.0 113.69 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp -118.78 147.51 43.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -114.64 135.54 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -163.04 110.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.85 0.75 . . . . 0.0 109.262 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -134.74 178.11 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.374 0.669 . . . . 0.0 111.158 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.078 1.751 . . . . 0.0 111.179 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 t0 44.21 84.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.668 2.387 . . . . 0.0 113.389 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.05 42.65 0.02 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 124.22 0.914 . . . . 0.0 111.413 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.46 131.06 12.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.398 1.099 . . . . 0.0 108.081 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.73 117.14 21.15 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 tp -142.8 138.82 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.396 1.878 . . . . 0.0 106.332 164.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 1.76 7.09 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -176.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.21 164.57 29.89 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.672 1.123 . . . . 0.0 111.606 -172.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.47 -2.49 0.67 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.643 1.214 . . . . 0.0 113.8 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -149.2 168.27 23.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.01 146.12 42.7 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 128.106 2.563 . . . . 0.0 110.956 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -143.52 137.91 28.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.52 1.528 . . . . 0.0 108.536 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 75.1 163.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 127.371 2.454 . . . . 0.0 111.036 152.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -170.64 179.67 3.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.696 1.599 . . . . 0.0 107.171 -158.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -125.76 158.79 34.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.83 1.252 . . . . 0.0 110.067 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 54.08 1.49 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.327 0.651 . . . . 0.0 112.746 171.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.39 1.1 9.11 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.527 2.818 . . . . 0.0 113.774 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 -61.02 7.08 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.72 178.56 9.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.39 1.948 . . . . 0.0 114.925 168.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.96 142.31 54.02 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 155.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.4 120.77 4.29 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.057 0.837 . . . . 0.0 113.102 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.94 -172.33 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.49 162.28 4.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.569 0.699 . . . . 0.0 110.622 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -65.56 140.97 58.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.911 1.284 . . . . 0.0 108.262 165.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.51 -179.42 16.28 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.142 0.877 . . . . 0.0 112.333 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 56.59 18.45 3.62 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.077 2.551 . . . . 0.0 114.328 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.84 112.72 0.03 OUTLIER 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.179 2.192 . . . . 0.0 111.204 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.47 171.27 25.27 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 121.092 -1.005 . . . . 0.0 110.741 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 m -97.28 -29.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 118.301 -0.856 . . . . 0.0 113.276 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.7 p -172.49 -36.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.187 1.395 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 57.57 163.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.599 2.359 . . . . 0.0 112.254 -165.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.52 164.78 49.98 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 121.03 -1.044 . . . . 0.0 110.664 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.99 86.71 1.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.149 2.566 . . . . 0.0 111.815 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.1 104.92 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.473 1.909 . . . . 0.0 108.416 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 pp -135.58 146.46 48.0 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -155.13 122.07 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.982 2.113 . . . . 0.0 106.15 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -148.15 139.65 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.405 1.457 . . . . 0.0 110.389 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.64 120.37 4.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.558 1.543 . . . . 0.0 107.461 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 t0 44.92 57.65 4.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.179 2.192 . . . . 0.0 111.905 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.88 163.64 39.01 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.401 1.477 . . . . 0.0 112.6 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -140.62 174.37 10.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -75.01 -45.46 41.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.735 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -71.85 173.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.088 0.955 . . . . 0.0 111.336 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.07 69.21 0.77 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 125.13 1.372 . . . . 0.0 110.625 173.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.48 158.32 42.41 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.458 1.903 . . . . 0.0 108.396 164.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -171.77 62.68 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -139.1 158.04 44.9 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.171 -1.581 . . . . 0.0 109.46 167.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -154.71 128.56 8.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.707 1.139 . . . . 0.0 111.183 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.22 132.89 23.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.422 0.689 . . . . 0.0 110.934 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.45 169.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 126.877 2.163 . . . . 0.0 111.695 139.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -160.16 175.5 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -158.31 66.9 0.46 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.283 0.0 OUTLIER -110.37 71.43 0.65 Allowed Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 113.243 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.45 0.32 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.708 1.606 . . . . 0.0 113.935 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.92 11.43 83.72 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.94 1.245 . . . . 0.0 114.201 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.54 151.75 8.89 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 120.707 -1.466 . . . . 0.0 109.536 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -145.4 162.13 38.02 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.871 1.668 . . . . 0.0 109.577 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.75 -179.1 41.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 128.181 2.8 . . . . 0.0 112.257 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.52 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -120.84 165.2 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -122.83 157.74 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -73.64 96.92 2.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.7 0.12 62.16 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 117.551 -1.694 . . . . 0.0 113.916 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.76 -171.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.927 1.691 . . . . 0.0 111.271 -168.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 51.32 94.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.8 2.84 . . . . 0.0 111.244 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.55 99.06 0.44 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.893 1.235 . . . . 0.0 110.298 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.94 133.38 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.422 1.489 . . . . 0.0 108.134 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.58 167.73 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.989 1.316 . . . . 0.0 109.628 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.43 -61.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.534 -0.728 . . . . 0.0 111.682 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -140.05 160.98 58.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 109.608 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.19 108.71 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.283 2.655 . . . . 0.0 110.657 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.23 114.45 12.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 159.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.455 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp -130.38 151.72 50.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -150.48 119.83 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.119 0.967 . . . . 0.0 110.038 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -149.76 178.82 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.546 1.138 . . . . 0.0 111.445 165.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 126.94 3.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.3 21.0 t0 43.6 25.43 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.847 3.259 . . . . 0.0 115.829 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.94 79.79 0.1 OUTLIER Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.453 -1.405 . . . . 0.0 112.128 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 42.8 0.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.471 -1.017 . . . . 0.0 113.534 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 66.27 1.5 2.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.784 2.434 . . . . 0.0 114.025 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.25 174.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.217 1.407 . . . . 0.0 111.8 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.69 123.05 23.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.598 2.359 . . . . 0.0 110.975 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.1 174.18 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.548 1.139 . . . . 0.0 109.334 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.34 171.41 4.01 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.818 -1.176 . . . . 0.0 109.56 165.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 173.71 2.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.499 1.119 . . . . 0.0 110.899 166.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.8 mt -113.98 166.12 11.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.073 0.949 . . . . 0.0 109.353 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -176.05 97.42 0.06 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.807 1.643 . . . . 0.0 108.033 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.18 150.44 10.9 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 133.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -144.7 108.54 4.71 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.377 0.99 . . . . 0.0 109.082 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -74.25 125.46 28.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.835 . . . . 0.0 109.947 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.2 84.81 1.8 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.315 0.646 . . . . 0.0 110.908 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.67 82.23 1.73 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.827 3.018 . . . . 0.0 110.476 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.33 -148.01 3.61 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 156.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.47 152.24 5.62 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 127.734 2.587 . . . . 0.0 110.047 -171.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.73 131.24 57.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.392 1.096 . . . . 0.0 111.719 -158.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.32 164.57 21.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.243 0.925 . . . . 0.0 114.938 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG13 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' H ' HG13 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -124.91 169.87 15.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.22 -168.45 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.115 0.566 . . . . 0.0 109.608 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -109.67 80.36 1.31 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 120.831 -1.168 . . . . 0.0 108.589 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.86 -0.39 66.4 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.498 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 45.24 68.72 0.53 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.443 2.697 . . . . 0.0 113.426 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.61 -62.25 2.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.858 1.263 . . . . 0.0 111.042 166.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.51 -163.57 37.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -165.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.79 158.14 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.976 1.71 . . . . 0.0 107.891 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 t 60.92 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.032 1.733 . . . . 0.0 109.558 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -134.0 174.62 10.28 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 109.663 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -72.25 159.32 85.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.276 -0.89 . . . . 0.0 111.121 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -66.17 85.12 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.525 3.483 . . . . 0.0 111.175 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.94 141.88 48.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.54 139.6 39.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.65 112.29 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 111.19 11.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.241 1.016 . . . . 0.0 109.395 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 147.33 24.81 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.676 1.991 . . . . 0.0 107.777 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 52.52 -173.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.233 2.213 . . . . 0.0 112.713 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.77 112.19 4.45 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 162.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -134.7 30.31 3.45 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 111.633 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 74.79 171.19 0.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.726 2.81 . . . . 0.0 110.33 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.15 140.04 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 120.694 -1.254 . . . . 0.0 108.764 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.32 -172.76 4.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 110.202 169.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.09 164.94 21.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.011 0.924 . . . . 0.0 109.779 174.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.86 1.68 0.68 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -99.87 167.47 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.843 1.656 . . . . 0.0 111.757 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.45 116.92 31.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.669 2.388 . . . . 0.0 107.452 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.7 64.3 1.49 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.291 0.636 . . . . 0.0 109.836 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.639 0 N-CA-C 105.205 -3.158 . . . . 0.0 105.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.42 147.19 25.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -141.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -155.34 175.82 13.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.062 1.745 . . . . 0.0 107.713 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -138.34 164.42 29.33 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.248 1.385 . . . . 0.0 112.533 -170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -125.11 79.74 65.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.102 2.161 . . . . 0.0 105.862 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.47 64.63 7.32 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.356 2.704 . . . . 0.0 109.806 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 89.91 1.2 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.3 24.99 4.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 123.913 0.768 . . . . 0.0 114.959 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt -127.35 156.33 42.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 117.945 0.872 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.58 153.77 30.4 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.357 1.932 . . . . 0.0 112.855 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.71 -177.2 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.95 155.1 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 161.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.7 127.97 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.15 1.78 . . . . 0.0 108.891 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.79 52.2 0.69 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 124.838 1.209 . . . . 0.0 110.314 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 48.57 70.84 0.41 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.956 2.102 . . . . 0.0 110.729 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.04 172.64 2.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.412 161.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.97 -82.44 1.28 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.88 136.57 42.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.19 101.0 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.055 1.742 . . . . 0.0 107.396 -170.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.0 -42.93 97.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.258 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -143.61 162.57 41.12 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -64.25 112.52 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.067 3.178 . . . . 0.0 112.014 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -81.56 96.11 7.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.989 0.916 . . . . 0.0 111.36 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.9 46.18 2.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.75 120.79 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 120.596 -1.315 . . . . 0.0 110.029 -172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -144.61 135.4 24.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.75 1.62 . . . . 0.0 108.109 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 105.15 2.7 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 170.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 61.95 -170.81 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.873 1.269 . . . . 0.0 110.581 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.16 114.54 6.9 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 163.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 61.53 1.6 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.732 1.613 . . . . 0.0 108.624 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 60.76 158.56 0.04 OUTLIER 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.92 2.088 . . . . 0.0 112.467 -169.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.67 125.46 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.403 -1.272 . . . . 0.0 107.819 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.3 t -146.93 169.61 18.81 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.747 -0.596 . . . . 0.0 110.915 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.07 154.3 41.87 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 169.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -14.26 4.21 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -114.16 144.79 42.61 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.845 0.858 . . . . 0.0 109.748 -171.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.9 142.21 51.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 126.293 1.837 . . . . 0.0 107.599 171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.68 67.34 1.45 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 75.15 83.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -137.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.57 131.73 5.64 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.739 2.016 . . . . 0.0 106.426 -159.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -160.15 159.46 31.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.318 1.847 . . . . 0.0 107.296 -161.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -133.44 61.72 55.76 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.835 0.743 . . . . 0.0 112.97 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.01 103.15 1.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.152 2.568 . . . . 0.0 110.057 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.5 33.45 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 CA-C-O 117.205 -1.886 . . . . 0.0 115.901 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.3 -106.29 1.22 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 120.332 2.066 . . . . 0.0 111.111 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -72.42 144.6 48.08 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 118.567 1.183 . . . . 0.0 109.788 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.8 165.02 40.67 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.507 1.051 . . . . 0.0 113.148 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.499 ' CG1' ' CD2' ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.2 174.09 12.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -132.81 164.95 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.16 -0.42 51.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.509 1.924 . . . . 0.0 111.569 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.09 -71.53 2.53 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 125.179 1.371 . . . . 0.0 111.664 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.313 0.1 OUTLIER -132.49 -163.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.46 1.13 . . . . 0.0 111.297 -174.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.73 77.75 2.06 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.9 1.28 . . . . 0.0 110.495 -170.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.96 -164.97 11.51 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.207 2.337 . . . . 0.0 111.616 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.79 171.23 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.687 1.995 . . . . 0.0 108.701 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.1 m -101.85 160.8 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.643 1.177 . . . . 0.0 111.147 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -111.01 -67.54 0.99 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -171.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.41 162.93 18.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 119.913 -1.742 . . . . 0.0 111.408 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.35 104.99 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.322 2.014 . . . . 0.0 111.164 168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.36 142.71 55.39 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.522 163.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.59 118.6 35.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -144.4 112.09 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . 33.3 p90 -138.11 158.28 44.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.713 1.605 . . . . 0.0 111.539 166.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 160.14 19.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.432 1.493 . . . . 0.0 109.089 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -32.18 22.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.207 2.203 . . . . 0.0 115.048 -171.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.3 -3.84 58.48 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.632 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 113' ' ' PHE . 4.4 pttp -126.56 159.31 33.85 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.783 1.791 . . . . 0.0 109.622 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -58.59 129.32 41.54 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.38 154.04 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 123.197 1.475 . . . . 0.0 110.447 -171.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 51.2 m -146.2 119.71 9.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 C-N-CA 127.092 2.157 . . . . 0.0 105.434 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.39 163.4 8.64 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.375 1.47 . . . . 0.0 109.425 171.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.98 158.73 33.82 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 166.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.61 82.38 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.712 1.205 . . . . 0.0 109.536 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.21 133.63 55.22 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -139.18 112.89 8.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.753 1.621 . . . . 0.0 107.512 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.499 ' CD2' ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.46 -165.54 1.64 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 -154.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -77.55 52.58 0.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.336 1.455 . . . . 0.0 110.559 172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.42 107.66 9.92 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.719 0.808 . . . . 0.0 112.941 -156.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -114.12 80.42 5.57 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 152.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 113.91 3.7 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.822 2.348 . . . . 0.0 108.951 168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.02 -67.42 0.22 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.21 0.909 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.22 12.58 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.845 1.212 . . . . 0.0 111.106 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.65 158.4 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.175 1.39 . . . . 0.0 108.27 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 166.74 16.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.24 0.927 . . . . 0.0 111.688 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -153.22 151.38 11.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.36 161.19 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.514 1.126 . . . . 0.0 108.177 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 126.22 29.05 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.3 -98.45 2.51 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.03 -177.85 3.6 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.036 0.935 . . . . 0.0 110.104 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.45 151.49 0.77 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.654 1.981 . . . . 0.0 112.017 174.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.09 103.01 0.26 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -66.49 142.73 16.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 117.994 0.897 . . . . 0.0 109.574 167.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.2 102.55 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -108.78 -38.07 5.72 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.657 -1.277 . . . . 0.0 112.754 -168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -112.12 165.22 13.39 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 119.244 0.929 . . . . 0.0 109.973 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 75.83 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.92 2.413 . . . . 0.0 110.043 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.19 78.74 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.231 1.412 . . . . 0.0 109.866 171.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HZ1' ' CD2' ' A' ' 124' ' ' LEU . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -104.98 81.19 1.71 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.4 p -82.11 139.28 18.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.88 175.65 13.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.435 2.294 . . . . 0.0 106.76 162.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -161.36 175.69 11.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.609 1.964 . . . . 0.0 107.181 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.1 74.87 1.75 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.813 1.245 . . . . 0.0 110.49 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.68 67.91 0.78 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -159.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -87.89 -164.62 1.13 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 147.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.457 ' HG3' ' H ' ' A' ' 119' ' ' ILE . 1.4 pt-20 -90.61 -56.83 3.04 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.597 1.159 . . . . 0.0 108.323 166.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.457 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 2.0 pp -74.93 172.91 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 127.997 2.519 . . . . 0.0 111.81 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -150.17 165.75 31.91 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.021 1.328 . . . . 0.0 107.818 155.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.01 156.19 3.23 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 127.843 2.457 . . . . 0.0 109.899 170.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.12 -19.32 0.49 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 168.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.37 132.78 47.66 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.136 1.789 . . . . 0.0 111.744 -173.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.445 ' CD2' ' HZ1' ' A' ' 109' ' ' LYS . 47.0 mt -144.86 105.22 4.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.888 1.275 . . . . 0.0 110.427 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -135.87 109.73 8.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 111.66 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.36 167.36 28.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -139.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -149.06 169.57 20.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.0 1.32 . . . . 0.0 108.917 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -142.59 86.21 1.94 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.06 1.344 . . . . 0.0 110.803 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -64.88 143.1 98.77 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.65 72.19 3.12 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 124.322 3.348 . . . . 0.0 112.006 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.49 -107.02 0.24 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.741 1.639 . . . . 0.0 112.7 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.42 54.6 4.18 Favored Glycine 0 C--N 1.331 0.288 0 O-C-N 121.248 -1.148 . . . . 0.0 111.24 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -125.33 142.89 51.24 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.822 0.849 . . . . 0.0 110.814 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.44 167.99 4.69 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.173 1.844 . . . . 0.0 111.579 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.408 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.468 ' H ' HG12 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p -158.86 172.08 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.89 171.45 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 157.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.82 14.8 20.24 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.39 1.476 . . . . 0.0 110.904 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.23 -102.71 0.76 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 -160.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.75 5.4 3.13 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.329 -168.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.02 134.65 14.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.804 1.184 . . . . 0.0 110.277 170.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.22 51.69 4.52 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.587 1.565 . . . . 0.0 114.375 -162.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.63 107.25 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.278 1.039 . . . . 0.0 110.588 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.51 -42.53 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.115 0.966 . . . . 0.0 111.729 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 53.65 -85.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.315 2.246 . . . . 0.0 113.103 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.9 159.87 24.13 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 124.969 1.308 . . . . 0.0 110.034 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.52 156.48 32.28 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.396 2.064 . . . . 0.0 110.907 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm -119.3 165.21 14.56 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.882 1.673 . . . . 0.0 108.053 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.06 146.3 27.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -145.13 109.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.669 1.988 . . . . 0.0 105.718 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -125.97 160.4 30.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.776 1.23 . . . . 0.0 108.744 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -165.94 -177.53 4.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.022 2.529 . . . . 0.0 108.349 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.47 101.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.891 0.876 . . . . 0.0 109.206 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.1 114.32 0.28 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -150.59 109.43 3.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.439 -1.036 . . . . 0.0 110.369 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.22 69.58 1.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.491 2.316 . . . . 0.0 107.776 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 tp -133.63 165.25 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.682 1.593 . . . . 0.0 108.04 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -108.8 122.55 47.4 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 163.57 36.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 124.111 0.882 . . . . 0.0 111.848 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -143.81 176.09 9.51 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.219 1.808 . . . . 0.0 108.755 165.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.4 -176.7 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.84 1.656 . . . . 0.0 110.713 167.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.57 146.21 46.57 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.474 1.91 . . . . 0.0 107.964 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -137.04 88.03 2.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.354 1.462 . . . . 0.0 109.416 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.694 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.75 -160.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.64 169.61 21.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 121.3 1.864 . . . . 0.0 109.723 157.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -173.05 171.38 4.19 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.943 1.297 . . . . 0.0 107.765 -153.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.55 78.93 0.58 Allowed Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 158.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.86 81.04 1.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.805 2.336 . . . . 0.0 107.477 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.75 66.37 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.289 -0.728 . . . . 0.0 111.63 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.54 142.41 0.78 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.201 1.382 . . . . 0.0 110.598 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -134.69 140.31 45.9 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.15 162.95 26.89 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.6 169.19 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 m -133.21 173.28 15.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.589 0.755 . . . . 0.0 110.09 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.55 154.59 28.33 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.069 1.347 . . . . 0.0 111.308 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.81 92.68 0.23 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 45.01 61.96 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 111.262 -163.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 53.3 37.49 25.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.851 1.26 . . . . 0.0 113.242 164.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.7 125.51 30.92 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.177 1.37 . . . . 0.0 113.547 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.19 -41.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.94 1.696 . . . . 0.0 109.33 168.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t 68.06 -71.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 126.503 1.921 . . . . 0.0 110.125 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -164.37 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.673 1.124 . . . . 0.0 110.198 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 156.51 85.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.25 129.05 26.94 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.616 2.211 . . . . 0.0 109.54 163.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.59 157.51 29.64 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 164.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' HE3' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.83 151.53 47.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 p -166.44 138.6 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 157.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -139.86 155.71 47.08 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.216 1.406 . . . . 0.0 107.249 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.62 133.55 3.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 158.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 44.21 39.78 3.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.405 2.282 . . . . 0.0 113.559 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.81 52.02 41.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.406 -0.809 . . . . 0.0 112.933 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -56.45 170.62 0.35 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.235 1.017 . . . . 0.0 111.698 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.11 86.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.419 2.287 . . . . 0.0 110.914 170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.27 147.0 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 127.286 2.234 . . . . 0.0 106.414 169.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.33 82.91 1.48 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.062 1.301 . . . . 0.0 112.101 166.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 167.03 23.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.596 1.959 . . . . 0.0 107.186 164.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -166.56 88.87 0.36 Allowed 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 124.767 1.227 . . . . 0.0 109.078 168.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -166.35 152.13 8.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.017 1.727 . . . . 0.0 106.618 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 ' CD1' ' HE3' ' A' ' 109' ' ' LYS . 15.8 tp -159.4 126.57 4.69 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.47 113.24 8.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.455 0.57 . . . . 0.0 110.065 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' HA2' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.477 1.377 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 t70 76.29 108.3 0.08 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -114.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 17.3 m-20 -126.52 156.68 40.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.995 0.918 . . . . 0.0 108.82 -141.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.01 131.56 47.41 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.183 0.993 . . . . 0.0 110.84 -164.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 76.11 65.86 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 125.597 1.559 . . . . 0.0 107.437 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.2 111.73 1.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.363 2.709 . . . . 0.0 108.695 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.74 89.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.96 -179.81 21.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.514 1.054 . . . . 0.0 110.58 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -138.96 107.26 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 121.586 -0.949 . . . . 0.0 109.477 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.54 167.66 44.03 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.137 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 52' ' ' VAL . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.412 ' H ' HG13 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.19 172.29 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.96 178.35 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.078 1.351 . . . . 0.0 108.339 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.72 58.74 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.878 -1.139 . . . . 0.0 108.934 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.01 133.02 28.85 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.99 88.85 0.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -66.35 148.02 52.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.4 152.15 24.25 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.287 15.3 m 58.16 -4.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 128.57 2.748 . . . . 0.0 116.081 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.38 164.6 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.515 1.526 . . . . 0.0 111.893 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -166.7 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.686 1.194 . . . . 0.0 112.594 149.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.28 165.02 45.13 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.621 -0.674 . . . . 0.0 111.859 -153.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.39 91.06 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.154 2.57 . . . . 0.0 111.123 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.55 122.42 19.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.538 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 108' ' ' LYS . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.54 ' H ' ' CD ' ' A' ' 107' ' ' GLU . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.96 156.42 44.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.19 130.29 2.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 159.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.56 155.05 49.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.983 0.913 . . . . 0.0 110.431 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.53 68.41 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.247 2.619 . . . . 0.0 109.811 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 52.44 69.78 0.64 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.558 1.171 . . . . 0.0 111.876 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.0 141.22 4.11 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 122.528 1.071 . . . . 0.0 112.543 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.49 19.81 1.19 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.731 -1.452 . . . . 0.0 111.369 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 75.09 14.11 3.16 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.965 2.106 . . . . 0.0 112.369 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.05 146.1 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.695 1.198 . . . . 0.0 110.048 -159.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -82.48 105.77 13.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.512 0.725 . . . . 0.0 110.929 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 157.7 1.81 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.442 1.097 . . . . 0.0 109.851 163.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -158.66 172.66 17.87 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.12 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -79.0 -179.75 6.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.962 1.305 . . . . 0.0 111.753 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -124.54 151.52 44.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.33 67.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.642 1.177 . . . . 0.0 108.156 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 74.1 7.45 4.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.235 1.414 . . . . 0.0 110.289 168.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.52 119.35 13.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 129.985 3.314 . . . . 0.0 107.634 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -154.46 162.31 41.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.657 0.783 . . . . 0.0 109.179 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.46 86.63 0.43 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 125.406 1.483 . . . . 0.0 108.737 162.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -63.63 73.11 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.735 2.29 . . . . 0.0 110.276 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 -11.86 79.37 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.974 -1.079 . . . . 0.0 111.749 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.42 160.56 53.18 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.189 0.995 . . . . 0.0 111.101 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -139.91 154.25 47.19 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.1 1.36 . . . . 0.0 109.28 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.98 172.6 20.46 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG13 ' H ' ' A' ' 52' ' ' VAL . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG13 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.43 178.8 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.38 161.42 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 148.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.26 83.18 7.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.814 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.63 -46.49 92.08 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.99 -25.66 0.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 117.262 -1.351 . . . . 0.0 113.964 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.79 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.16 1.784 . . . . 0.0 111.555 -160.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.0 -95.01 0.47 Allowed Glycine 0 C--N 1.333 0.363 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.75 -173.09 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.339 1.856 . . . . 0.0 107.048 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.71 104.03 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 111.209 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -81.63 -169.03 2.12 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.817 1.647 . . . . 0.0 111.358 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 162.52 43.6 Favored Pre-proline 0 CA--C 1.538 0.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.682 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.68 89.6 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.751 2.301 . . . . 0.0 111.184 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm -52.36 114.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 157.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt -148.77 143.55 26.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.51 121.5 4.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 166.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.2 156.97 47.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.039 1.336 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -165.77 155.72 12.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.259 1.823 . . . . 0.0 107.692 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.92 108.76 4.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.18 -4.0 7.28 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.58 1.562 . . . . 0.0 112.839 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -122.17 47.19 1.95 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.877 1.838 . . . . 0.0 108.121 160.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.306 6.4 pm0 48.03 -163.57 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.61 1.564 . . . . 0.0 111.906 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.46 136.91 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.0 1.32 . . . . 0.0 108.137 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.1 t -147.14 138.19 23.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 161.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.95 163.8 25.25 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.232 1.015 . . . . 0.0 108.906 160.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -156.04 139.45 15.79 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 167.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -148.88 167.83 24.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.08 144.72 48.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.61 83.79 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.653 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.4 169.1 3.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.218 0.607 . . . . 0.0 110.164 141.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -158.11 -179.62 8.29 Favored 'General case' 0 CA--C 1.548 0.891 1 C-N-CA 132.076 4.151 . . . . 0.0 104.238 167.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.6 103.22 5.37 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.228 -1.545 . . . . 0.0 109.075 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -130.08 85.0 58.61 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.636 1.574 . . . . 0.0 107.842 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.2 110.48 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.462 2.108 . . . . 0.0 110.936 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.75 -109.53 2.24 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.169 1.366 . . . . 0.0 112.122 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.14 141.8 3.3 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 125.125 1.345 . . . . 0.0 111.424 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 -169.99 2.44 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.565 1.546 . . . . 0.0 110.314 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.21 -179.37 18.12 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.007 1.289 . . . . 0.0 114.237 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.525 ' H ' HG23 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.34 147.96 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.92 165.58 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 99.21 6.42 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.17 -75.84 0.51 Allowed Glycine 0 C--O 1.227 -0.343 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -139.53 104.55 4.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.599 1.16 . . . . 0.0 108.441 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 88' ' ' VAL . 77.5 m-20 60.12 -31.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.439 3.495 . . . . 0.0 118.021 172.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.49 -24.9 0.47 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 127.192 2.33 . . . . 0.0 114.052 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 86' ' ' ASP . 33.8 m 44.75 22.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 130.844 3.658 . . . . 0.0 115.069 175.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.93 120.11 3.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 118.787 0.721 . . . . 0.0 110.256 -165.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.32 -85.28 0.41 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -76.41 161.61 74.04 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.26 157.26 57.53 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.553 2.835 . . . . 0.0 110.642 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.79 150.21 42.2 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.489 1.916 . . . . 0.0 106.956 164.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -79.65 143.33 34.76 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.58 132.48 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -98.41 27.53 4.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.201 1.001 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -153.4 -163.97 1.8 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.515 1.926 . . . . 0.0 107.909 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 65.63 70.88 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.872 1.269 . . . . 0.0 110.906 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.6 56.78 9.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 115.26 1.98 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.392 1.077 . . . . 0.0 112.198 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.16 160.33 27.08 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 110.914 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -91.32 4.8 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 113.263 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -147.07 62.38 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.638 -1.289 . . . . 0.0 108.958 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.5 p -139.86 154.56 47.33 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.093 0.957 . . . . 0.0 110.595 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -155.61 -169.36 3.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 161.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.78 168.79 10.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.062 1.345 . . . . 0.0 113.23 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.97 128.97 38.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.894 2.078 . . . . 0.0 111.375 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.42 46.37 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.281 0.633 . . . . 0.0 111.858 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.46 ' CD2' ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.63 121.15 4.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 101.691 -3.448 . . . . 0.0 101.691 -148.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.0 170.97 20.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.636 1.574 . . . . 0.0 107.263 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.49 118.12 8.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.538 1.063 . . . . 0.0 110.564 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -110.66 76.79 1.2 Allowed Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 124.825 1.25 . . . . 0.0 108.807 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 81.37 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.593 2.862 . . . . 0.0 111.363 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.34 -66.43 1.79 Allowed Glycine 0 CA--C 1.523 0.535 0 O-C-N 121.605 -0.684 . . . . 0.0 112.615 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.03 147.96 18.8 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -147.44 163.77 35.47 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.791 1.636 . . . . 0.0 109.407 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.47 179.91 28.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.26 1.409 . . . . 0.0 114.299 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.431 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 HG13 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.464 ' H ' HG13 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.3 174.91 12.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.47 140.95 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 C-N-CA 126.114 1.765 . . . . 0.0 106.278 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.87 109.99 21.43 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.63 -31.72 5.08 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.634 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -170.99 162.96 7.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.707 2.403 . . . . 0.0 104.579 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -144.9 179.87 7.05 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.196 -0.94 . . . . 0.0 109.994 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.54 -91.48 0.08 OUTLIER Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.214 0.916 . . . . 0.0 112.268 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -78.8 127.32 38.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.966 0.889 . . . . 0.0 109.674 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.83 8.84 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.861 1.664 . . . . 0.0 112.508 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -70.15 -49.16 53.39 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.875 -1.141 . . . . 0.0 112.521 -174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.37 146.49 58.1 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 126.21 1.804 . . . . 0.0 107.412 -171.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.69 145.2 36.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.24 1.96 . . . . 0.0 111.237 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm -73.19 74.02 1.27 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.14 139.93 30.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.29 141.01 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -99.02 1.6 45.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.271 1.028 . . . . 0.0 111.554 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.56 -175.09 4.01 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.709 2.003 . . . . 0.0 110.351 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.7 t0 73.42 114.15 0.06 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.231 2.612 . . . . 0.0 110.792 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.8 30.83 63.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.376 0.512 . . . . 0.0 113.608 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.65 60.89 3.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 123.714 1.721 . . . . 0.0 109.825 -166.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.56 -12.71 18.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.341 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.36 167.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.6 1.96 . . . . 0.0 111.845 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -178.51 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.667 1.587 . . . . 0.0 112.096 161.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.68 171.93 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.614 1.166 . . . . 0.0 108.499 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.58 169.39 24.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.149 0.58 . . . . 0.0 109.739 171.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.0 154.45 34.99 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.879 0.872 . . . . 0.0 111.838 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.82 150.13 36.15 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 125.857 1.663 . . . . 0.0 111.452 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -150.29 85.93 1.4 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.76 162.58 36.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -153.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -152.38 178.33 9.64 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 160.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -165.36 176.74 8.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.212 2.205 . . . . 0.0 107.304 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -109.43 54.17 0.26 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.632 1.173 . . . . 0.0 112.784 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.26 108.76 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.799 2.333 . . . . 0.0 111.51 -170.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.76 18.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.463 1.506 . . . . 0.0 112.269 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.81 84.7 1.51 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.949 1.262 . . . . 0.0 110.399 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -70.28 120.39 15.88 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.32 175.98 52.32 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -162.55 168.04 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.22 158.72 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 164.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.92 119.91 25.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.02 1.728 . . . . 0.0 107.554 170.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.36 -72.63 0.95 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -126.46 159.73 32.51 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.282 1.833 . . . . 0.0 107.249 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -147.41 125.51 12.13 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.157 -0.964 . . . . 0.0 110.337 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.88 0.9 87.98 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.265 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 59.37 71.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.914 1.686 . . . . 0.0 110.483 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -105.44 -22.94 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.84 0.856 . . . . 0.0 111.574 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.52 28.25 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.71 2.004 . . . . 0.0 113.758 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -106.63 87.18 2.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.61 1.964 . . . . 0.0 110.306 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -63.12 94.91 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 1 C-N-CA 126.745 4.963 . . . . 0.0 111.922 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp -51.53 118.92 3.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.024 0.93 . . . . 0.0 109.702 170.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 108' ' ' LYS . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -137.15 93.73 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.419 ' O ' ' HE3' ' A' ' 117' ' ' LYS . 7.3 p -151.42 138.64 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -150.06 134.69 17.52 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -169.84 -167.61 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.503 1.521 . . . . 0.0 108.838 -168.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.58 -161.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.853 1.661 . . . . 0.0 111.676 156.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -47.94 108.07 0.31 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.979 1.752 . . . . 0.0 113.741 -171.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 112' ' ' VAL . 7.6 mtpm? -93.88 134.63 36.05 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 123.877 0.871 . . . . 0.0 109.391 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -69.35 17.06 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.948 1.299 . . . . 0.0 112.641 163.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.43 138.21 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 120.851 1.659 . . . . 0.0 110.266 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -70.64 107.97 4.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.977 1.711 . . . . 0.0 112.095 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.63 150.83 6.61 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.457 1.903 . . . . 0.0 110.102 170.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.98 176.23 11.31 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.08 154.53 19.72 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.446 2.298 . . . . 0.0 110.16 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.5 mt -141.8 92.44 2.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.929 0.891 . . . . 0.0 110.854 -163.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.1 118.27 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 163.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.21 154.18 41.17 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 160.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -140.23 169.36 17.82 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.305 1.042 . . . . 0.0 108.66 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.59 158.92 28.35 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.222 1.009 . . . . 0.0 110.12 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -140.56 148.37 53.01 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.41 75.17 4.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.51 2.807 . . . . 0.0 109.857 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.84 -32.42 4.43 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 123.837 0.732 . . . . 0.0 112.746 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.28 162.5 14.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.724 1.631 . . . . 0.0 110.857 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -133.26 100.02 4.72 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.77 167.3 0.32 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 128.551 2.976 . . . . 0.0 112.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG21 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' H ' HG21 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -128.19 144.45 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.1 155.01 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.85 92.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.36 2.264 . . . . 0.0 107.653 168.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.56 -82.6 0.7 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -134.63 61.92 1.66 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.866 1.266 . . . . 0.0 107.771 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.23 -172.89 4.33 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.765 -1.209 . . . . 0.0 108.368 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.35 1.54 0.03 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.141 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.32 -169.02 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.845 1.822 . . . . 0.0 110.692 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.96 157.15 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.728 2.011 . . . . 0.0 108.47 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -147.37 170.83 16.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.168 0.894 . . . . 0.0 112.708 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.66 161.53 20.23 Favored Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 121.94 -0.475 . . . . 0.0 111.495 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.92 92.59 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.804 2.336 . . . . 0.0 110.833 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -60.18 107.28 0.62 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 168.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp -124.87 135.54 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.42 102.55 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -143.07 149.23 37.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.715 0.806 . . . . 0.0 110.319 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -175.73 -175.6 0.78 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.489 1.916 . . . . 0.0 109.08 -168.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -45.95 -59.29 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.541 2.336 . . . . 0.0 113.135 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.76 55.92 4.9 Favored Glycine 0 CA--C 1.523 0.566 0 O-C-N 120.571 -1.331 . . . . 0.0 110.83 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -153.03 16.85 0.56 Allowed 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 75.13 -43.6 0.51 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.787 1.631 . . . . 0.0 112.128 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 120' ' ' SER . 5.9 tp -147.11 164.17 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.663 1.985 . . . . 0.0 108.758 164.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' H ' HD11 ' A' ' 119' ' ' ILE . 7.4 m -115.9 9.13 14.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.028 1.731 . . . . 0.0 113.341 -168.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.2 p -125.57 155.6 40.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.194 0.998 . . . . 0.0 110.387 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.92 143.33 5.5 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.978 1.311 . . . . 0.0 108.288 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -139.71 143.92 37.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.917 2.087 . . . . 0.0 106.663 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -118.37 144.52 45.84 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.778 1.631 . . . . 0.0 109.727 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -139.27 134.66 32.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.98 152.32 34.75 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -138.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -137.71 -169.4 2.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.01 1.324 . . . . 0.0 110.123 -173.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.66 131.36 5.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.249 1.02 . . . . 0.0 108.671 -163.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.5 72.2 66.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.418 1.087 . . . . 0.0 109.234 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.27 68.22 8.35 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.628 2.885 . . . . 0.0 113.197 -167.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.36 102.83 0.38 Allowed Glycine 0 C--N 1.336 0.538 0 O-C-N 120.716 -1.24 . . . . 0.0 113.608 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.32 -103.52 0.17 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.522 -0.987 . . . . 0.0 113.632 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.92 146.28 22.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.922 1.289 . . . . 0.0 110.387 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.32 -176.92 47.1 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.432 ' HG1' ' HG2' ' A' ' 46' ' ' GLU . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.432 ' HG2' ' HG1' ' A' ' 44' ' ' THR . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t -140.19 169.89 15.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.88 154.62 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.69 84.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 110.589 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.58 -69.79 1.35 Allowed Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.769 -0.582 . . . . 0.0 112.301 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.97 155.2 11.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.368 1.067 . . . . 0.0 108.806 -165.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -57.92 152.39 16.25 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.041 1.736 . . . . 0.0 112.767 -165.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.22 178.64 25.67 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.909 1.719 . . . . 0.0 112.059 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.48 -13.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t 44.32 59.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.872 1.669 . . . . 0.0 114.229 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -60.2 -42.19 94.57 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.928 -1.107 . . . . 0.0 111.962 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.74 158.28 68.22 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 124.056 0.942 . . . . 0.0 111.373 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 112.51 3.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.978 3.119 . . . . 0.0 112.047 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 154.75 34.08 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.861 1.264 . . . . 0.0 110.222 167.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp -72.25 31.55 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.06 120.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 120.671 -1.268 . . . . 0.0 108.614 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -142.91 130.86 21.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.737 2.015 . . . . 0.0 109.034 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.61 158.33 23.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 167.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 44.5 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.817 2.847 . . . . 0.0 113.802 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.87 126.95 1.38 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -143.92 26.47 1.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.208 1.003 . . . . 0.0 110.307 -170.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.254 7.9 pm0 50.71 26.19 2.41 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.004 2.122 . . . . 0.0 115.977 173.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.415 HD11 ' H ' ' A' ' 121' ' ' THR . 2.2 pp -77.09 176.86 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.223 -1.548 . . . . 0.0 114.085 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -153.81 59.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.107 1.363 . . . . 0.0 110.323 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' H ' HD11 ' A' ' 119' ' ' ILE . 0.7 OUTLIER -159.62 162.09 35.16 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.245 -1.534 . . . . 0.0 110.97 170.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.87 -11.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -128.66 152.83 47.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.058 1.753 . . . . 0.0 108.712 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -134.77 142.95 46.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.1 1.36 . . . . 0.0 107.602 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -134.17 91.74 2.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.65 160.76 38.29 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.142 0.977 . . . . 0.0 109.241 -168.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.72 153.32 18.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.52 1.528 . . . . 0.0 106.994 156.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.08 145.54 7.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.807 0.843 . . . . 0.0 108.733 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -118.19 78.69 13.93 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.514 1.526 . . . . 0.0 109.462 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.22 89.23 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.165 3.243 . . . . 0.0 112.369 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.12 -66.38 2.11 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 122.012 -0.43 . . . . 0.0 112.087 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.14 19.51 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.722 1.153 . . . . 0.0 112.351 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -142.04 117.5 10.25 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -175.1 4.75 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 128.335 2.874 . . . . 0.0 112.004 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.66 155.27 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 162.04 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 158.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -84.02 131.3 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.14 -158.95 11.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.957 1.741 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.75 92.07 3.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.382 1.073 . . . . 0.0 109.254 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.15 -86.04 0.65 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.249 1.82 . . . . 0.0 106.431 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.98 -152.62 6.97 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 127.712 2.577 . . . . 0.0 109.995 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.7 t -133.97 -8.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 111.102 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 90' ' ' ASN 0.341 7.7 p 46.51 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 127.26 2.224 . . . . 0.0 111.709 -175.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.449 ' H ' HG23 ' A' ' 89' ' ' VAL . 55.0 t30 -162.0 -75.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.159 -1.588 . . . . 0.0 110.385 162.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 163.77 25.8 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.177 1.791 . . . . 0.0 111.514 -171.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.67 155.05 71.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.099 1.866 . . . . 0.0 113.959 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.82 99.21 5.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.31 160.3 29.63 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.81 81.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.078 0.942 . . . . 0.0 109.5 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -91.0 174.3 7.49 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.127 -0.983 . . . . 0.0 110.733 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.33 2.652 . . . . 0.0 106.113 165.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.31 144.91 37.74 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 161.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.66 47.28 69.29 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -170.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -98.92 171.78 7.84 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 150.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.05 -58.47 7.17 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 tp -148.24 99.16 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.976 -168.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -44.63 120.7 2.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 127.286 2.234 . . . . 0.0 111.167 166.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.17 151.02 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.58 1.952 . . . . 0.0 108.475 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.0 156.39 43.0 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.07 51.9 0.26 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 111.588 -162.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mp -138.29 146.9 43.03 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.486 -1.384 . . . . 0.0 112.56 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.46 56.43 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -139.96 163.6 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -155.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.62 77.97 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.404 1.481 . . . . 0.0 110.446 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -123.2 109.1 13.57 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.901 2.08 . . . . 0.0 107.734 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.66 62.2 63.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.72 1.608 . . . . 0.0 110.565 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.66 102.56 1.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.97 2.446 . . . . 0.0 110.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.21 -77.32 0.18 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.116 0.865 . . . . 0.0 113.177 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 51.65 54.35 25.15 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.091 0.853 . . . . 0.0 112.118 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -95.76 143.11 27.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 164.43 54.92 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.648 1.118 . . . . 0.0 112.651 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG13 ' H ' ' A' ' 52' ' ' VAL . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.454 ' H ' HG13 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.57 175.35 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.13 162.51 3.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -80.77 79.75 7.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -55.28 -47.73 73.24 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.279 0.466 . . . . 0.0 112.273 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.93 32.66 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.097 1.359 . . . . 0.0 109.188 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 49.57 -87.04 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.384 2.274 . . . . 0.0 109.737 -156.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.52 170.21 16.62 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.293 1.901 . . . . 0.0 110.613 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.06 157.99 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 108.239 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t 58.09 85.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.863 2.065 . . . . 0.0 112.215 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -153.03 175.81 12.57 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.145 -0.972 . . . . 0.0 111.027 169.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -85.61 165.87 33.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.555 1.542 . . . . 0.0 111.21 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.54 101.94 1.44 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.963 3.109 . . . . 0.0 112.96 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -69.15 97.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.617 1.967 . . . . 0.0 109.131 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt -145.28 142.23 29.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.8 p -167.66 139.08 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.936 1.694 . . . . 0.0 107.111 164.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -135.48 164.98 26.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.091 0.956 . . . . 0.0 108.431 166.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.23 165.12 13.2 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.889 1.676 . . . . 0.0 107.617 171.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -49.12 -44.11 42.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.136 1.774 . . . . 0.0 112.794 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.5 47.48 3.62 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 123.799 0.714 . . . . 0.0 112.615 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.38 -177.87 6.53 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.137 1.375 . . . . 0.0 107.959 165.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.73 137.12 57.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.7 tp -96.7 136.67 26.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 161.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.0 t -154.75 130.9 10.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.64 174.15 11.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.998 0.817 . . . . 0.0 111.605 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -152.33 -175.44 5.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 109.889 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -164.37 140.06 5.99 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.013 1.725 . . . . 0.0 109.295 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.94 159.57 37.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.391 1.876 . . . . 0.0 109.466 -169.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -164.42 68.98 0.17 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.967 0.907 . . . . 0.0 110.671 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.472 ' H1 ' ' CG ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -50.82 123.69 9.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 122.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.472 ' CG ' ' H1 ' ' A' ' 1' ' ' GLY . 58.3 m-20 -143.96 170.34 16.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.943 2.497 . . . . 0.0 105.555 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.29 176.65 8.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.308 0.958 . . . . 0.0 111.518 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -125.46 73.33 67.97 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.037 1.335 . . . . 0.0 111.085 -174.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.23 64.33 7.08 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.025 3.15 . . . . 0.0 112.061 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 -71.53 1.13 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.222 1.391 . . . . 0.0 110.416 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.47 76.95 0.17 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.479 1.038 . . . . 0.0 113.477 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -133.65 176.22 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.693 1.197 . . . . 0.0 112.908 -166.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.99 42.28 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' H ' HD21 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.463 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 HG21 ' H ' ' A' ' 82' ' ' VAL . 2.7 p -148.97 -172.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.522 ' H ' HG21 ' A' ' 81' ' ' VAL . 1.4 p -130.22 165.95 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 149.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -72.67 95.37 1.86 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.216 1.406 . . . . 0.0 109.42 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.66 5.78 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.887 -0.508 . . . . 0.0 112.282 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -163.44 148.52 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.42 1.888 . . . . 0.0 107.162 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -44.57 -53.11 7.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.266 2.627 . . . . 0.0 113.594 -163.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.82 2.79 47.53 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.693 -1.615 . . . . 0.0 115.821 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.253 32.6 m 49.55 -177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.43 1.892 . . . . 0.0 112.312 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.1 t -71.23 139.82 19.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -120.43 -177.07 3.36 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.6 156.44 78.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 120.685 -1.259 . . . . 0.0 109.992 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.06 85.76 1.78 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.209 2.606 . . . . 0.0 112.593 -166.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.57 127.22 15.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.964 1.705 . . . . 0.0 110.948 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -78.65 127.95 32.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 t -155.08 117.98 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -148.48 123.12 9.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.589 1.54 . . . . 0.0 109.695 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.38 71.23 0.13 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.43 1.892 . . . . 0.0 110.558 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 54.62 -172.03 0.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.096 0.959 . . . . 0.0 110.029 -169.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.28 23.8 60.42 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.535 -1.353 . . . . 0.0 114.288 167.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -142.84 119.49 11.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.69 97.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 tp -170.97 165.45 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.004 2.122 . . . . 0.0 107.173 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.4 t -152.88 58.29 0.79 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.83 153.39 18.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.907 1.683 . . . . 0.0 107.1 174.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -146.9 12.47 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 168.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.88 171.95 13.53 Favored 'General case' 0 C--O 1.242 0.679 0 O-C-N 120.607 -1.308 . . . . 0.0 110.607 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 tp -143.83 151.4 39.86 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.674 -0.641 . . . . 0.0 112.065 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.42 105.41 3.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.524 1.529 . . . . 0.0 108.047 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 107.001 -2.44 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.2 t0 56.53 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -112.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.24 177.41 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.607 1.563 . . . . 0.0 108.865 -160.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -105.81 75.8 1.15 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.677 0.751 . . . . 0.0 112.311 -159.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.98 59.31 10.52 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.151 1.38 . . . . 0.0 113.588 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.21 109.49 1.16 Allowed 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 112.07 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.03 50.3 3.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 126.548 2.023 . . . . 0.0 112.345 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.49 123.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -141.19 146.05 36.43 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.442 1.121 . . . . 0.0 110.399 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.08 161.06 44.86 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 124.491 1.119 . . . . 0.0 112.999 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.419 HG22 ' HG1' ' A' ' 65' ' ' THR . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.407 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' H ' ' A' ' 34' ' ' ALA . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' H ' ' CG2' ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.419 ' HG1' HG22 ' A' ' 16' ' ' THR . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.6 173.25 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.04 162.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 122.303 1.049 . . . . 0.0 110.477 161.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.85 105.62 0.33 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.796 2.039 . . . . 0.0 107.049 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.17 -95.34 2.39 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -135.84 170.74 15.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.954 1.702 . . . . 0.0 107.928 171.202 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.9 t70 70.47 -179.59 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.096 2.158 . . . . 0.0 110.816 174.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.64 -176.46 28.33 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.385 6.4 p 61.83 -0.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 127.602 2.361 . . . . 0.0 113.569 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.56 -9.89 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 127.827 2.451 . . . . 0.0 113.877 -175.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 44.4 t30 64.99 11.3 6.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.449 1.499 . . . . 0.0 112.967 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.8 89.48 1.25 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 128.092 2.557 . . . . 0.0 112.207 -159.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.38 64.59 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.985 1 C-N-CA 126.012 4.475 . . . . 0.0 112.814 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt -69.63 99.47 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.973 1.309 . . . . 0.0 108.919 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.479 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.91 138.75 25.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.62 97.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -132.6 161.76 33.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.716 0.806 . . . . 0.0 109.087 170.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -154.99 30.45 0.41 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.022 1.329 . . . . 0.0 111.504 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.1 30.41 16.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.2 1.8 . . . . 0.0 111.469 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.63 115.76 0.41 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -141.91 -177.78 5.37 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.345 1.072 . . . . 0.0 108.753 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -71.6 -15.96 62.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.548 1.539 . . . . 0.0 112.579 -170.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 tp -164.99 170.48 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.992 3.717 . . . . 0.0 106.135 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 143.29 33.0 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.652 1.181 . . . . 0.0 108.433 169.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.17 168.45 9.71 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.876 1.27 . . . . 0.0 109.702 -174.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.5 98.09 1.93 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.446 -0.784 . . . . 0.0 110.22 166.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.7 94.79 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.2 mt -144.3 100.07 3.48 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.211 1.005 . . . . 0.0 109.043 171.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.38 115.46 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 120.826 0.126 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 59' ' ' LEU . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 121.519 0.511 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.901 HG23 HG22 ' A' ' 99' ' ' VAL . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB2' HG11 ' A' ' 81' ' ' VAL . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 37' ' ' THR . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 34' ' ' ALA . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 99' ' ' VAL . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 28' ' ' LYS . 18.8 m . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.901 HG22 HG23 ' A' ' 15' ' ' VAL . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 1.7 pp . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 121.639 0.577 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 99' ' ' VAL . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 51' ' ' PRO . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HA ' HG21 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' VAL . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 54' ' ' LEU . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 99' ' ' VAL . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.48 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 77' ' ' VAL . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.5 p30 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 125' ' ' ASN . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 32' ' ' VAL . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CH2' ' A' ' 95' ' ' TRP . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 54' ' ' LEU . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 15' ' ' VAL . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' H ' HD23 ' A' ' 39' ' ' LEU . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 39' ' ' LEU . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CH2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 CA-C-O 121.131 0.295 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 59' ' ' LEU . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ALA . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 72' ' ' ALA . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 99' ' ' VAL . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 109' ' ' LYS . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.791 0.662 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 77' ' ' VAL . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' CG ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.595 HG23 HD11 ' A' ' 59' ' ' LEU . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 30' ' ' VAL . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 ' CG1' HD22 ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.647 HD22 ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 99' ' ' VAL . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 77' ' ' VAL . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.436 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.583 HG11 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.419 HG22 ' HB1' ' A' ' 34' ' ' ALA . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HA ' HG21 ' A' ' 33' ' ' VAL . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.583 ' H ' HG11 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 99' ' ' VAL . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 77' ' ' VAL . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.25 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 99' ' ' VAL . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.582 ' CG2' HD21 ' A' ' 59' ' ' LEU . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 51' ' ' PRO . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 33' ' ' VAL . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 99' ' ' VAL . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 77' ' ' VAL . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 32' ' ' VAL . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 15' ' ' VAL . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ASP . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.437 ' H ' HG11 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 99' ' ' VAL . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.519 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 114.237 0.455 . . . . 0.0 114.237 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 77' ' ' VAL 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 97' ' ' VAL . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.412 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.52 HG22 ' CG ' ' A' ' 46' ' ' GLU . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' HG22 ' A' ' 44' ' ' THR . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 41' ' ' ASP . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.822 ' CG1' HD22 ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.443 ' CZ3' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 17' ' ' ILE . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 126' ' ' LEU . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.347 0.594 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.822 HD22 ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 99' ' ' VAL . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 74' ' ' GLU . 1.1 t30 -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 44' ' ' THR . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' H ' HG11 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.598 HD13 ' CE1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 35' ' ' ASN . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 99' ' ' VAL . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 77' ' ' VAL . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 51' ' ' PRO . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 48' ' ' LEU . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 72' ' ' ALA . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.467 0.651 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' HG3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-O 122.821 1.234 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 32' ' ' VAL . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.464 ' CG1' HG12 ' A' ' 32' ' ' VAL . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 15' ' ' VAL . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' OE1' ' A' ' 105' ' ' GLU . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' A' ' 98' ' ' THR . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HB2' HD21 ' A' ' 48' ' ' LEU . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.449 ' H ' HG11 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 72' ' ' ALA . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 99' ' ' VAL . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 121.328 0.585 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 77' ' ' VAL . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HD1' ' HB2' ' A' ' 76' ' ' ALA . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 HD21 ' A' ' 59' ' ' LEU . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 48' ' ' LEU . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.449 HD12 ' HE3' ' A' ' 28' ' ' LYS . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.514 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 112.651 -0.18 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 32' ' ' VAL . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 34' ' ' ALA . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG11 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB2' HG12 ' A' ' 30' ' ' VAL . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 66' ' ' LEU . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.404 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt . . . . . 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 65' ' ' THR . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.559 ' H ' HD23 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 16' ' ' THR . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 72' ' ' ALA . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.861 0.145 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 51' ' ' PRO . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 34' ' ' ALA . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' HB2' HD21 ' A' ' 48' ' ' LEU . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' VAL . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 99' ' ' VAL . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.518 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 174.23 85.66 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 2 C-N-CA 131.997 4.119 . . . . 0.0 100.141 -155.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.85 100.25 4.13 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -151.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.84 169.64 22.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.521 1.528 . . . . 0.0 108.742 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -130.53 70.62 82.43 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 109.015 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.65 93.13 1.09 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.244 2.629 . . . . 0.0 112.056 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.86 -114.07 1.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.51 152.49 16.81 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.798 1.19 . . . . 0.0 110.88 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -141.01 107.86 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.536 1.134 . . . . 0.0 108.922 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.06 154.9 0.41 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 127.485 2.469 . . . . 0.0 112.87 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 59' ' ' LEU . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.39 173.81 14.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.81 162.14 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 122.866 0.466 . . . . 0.0 110.651 164.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.06 89.13 7.26 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.291 1.836 . . . . 0.0 110.491 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.14 101.69 2.38 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 124.233 0.921 . . . . 0.0 112.311 -166.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.05 -164.56 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.914 1.286 . . . . 0.0 110.603 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -74.96 165.06 25.86 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.663 -1.273 . . . . 0.0 108.896 168.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -20.32 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.317 -0.864 . . . . 0.0 113.471 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t 75.66 -63.86 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 127.282 2.233 . . . . 0.0 110.925 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p 52.0 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 130.622 3.569 . . . . 0.0 112.734 -166.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -150.28 -68.4 0.19 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.034 -1.041 . . . . 0.0 110.163 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.93 154.68 88.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 124.808 1.243 . . . . 0.0 112.014 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 170.98 13.47 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.864 3.709 . . . . 0.0 113.69 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp -118.78 147.51 43.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -114.64 135.54 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -163.04 110.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.85 0.75 . . . . 0.0 109.262 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -134.74 178.11 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.374 0.669 . . . . 0.0 111.158 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.078 1.751 . . . . 0.0 111.179 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 t0 44.21 84.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.668 2.387 . . . . 0.0 113.389 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.05 42.65 0.02 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 124.22 0.914 . . . . 0.0 111.413 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.46 131.06 12.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.398 1.099 . . . . 0.0 108.081 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.73 117.14 21.15 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 tp -142.8 138.82 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.396 1.878 . . . . 0.0 106.332 164.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 1.76 7.09 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.21 164.57 29.89 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.672 1.123 . . . . 0.0 111.606 -172.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.47 -2.49 0.67 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.643 1.214 . . . . 0.0 113.8 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -149.2 168.27 23.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.01 146.12 42.7 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 128.106 2.563 . . . . 0.0 110.956 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -143.52 137.91 28.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.52 1.528 . . . . 0.0 108.536 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 75.1 163.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 127.371 2.454 . . . . 0.0 111.036 152.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -170.64 179.67 3.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.696 1.599 . . . . 0.0 107.171 -158.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -125.76 158.79 34.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.83 1.252 . . . . 0.0 110.067 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 54.08 1.49 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.327 0.651 . . . . 0.0 112.746 171.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.39 1.1 9.11 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.527 2.818 . . . . 0.0 113.774 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 -61.02 7.08 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.72 178.56 9.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.39 1.948 . . . . 0.0 114.925 168.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.96 142.31 54.02 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 155.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.4 120.77 4.29 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.057 0.837 . . . . 0.0 113.102 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.901 HG23 HG22 ' A' ' 99' ' ' VAL . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.421 HD11 ' HA3' ' A' ' 84' ' ' GLY . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB2' HG11 ' A' ' 81' ' ' VAL . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 37' ' ' THR . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 34' ' ' ALA . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 99' ' ' VAL . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 28' ' ' LYS . 18.8 m -141.94 -172.33 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.49 162.28 4.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.569 0.699 . . . . 0.0 110.622 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -65.56 140.97 58.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.911 1.284 . . . . 0.0 108.262 165.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 27' ' ' ILE . . . -120.51 -179.42 16.28 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.142 0.877 . . . . 0.0 112.333 177.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 56.59 18.45 3.62 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.077 2.551 . . . . 0.0 114.328 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.84 112.72 0.03 OUTLIER 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.179 2.192 . . . . 0.0 111.204 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.47 171.27 25.27 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 121.092 -1.005 . . . . 0.0 110.741 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 m -97.28 -29.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 118.301 -0.856 . . . . 0.0 113.276 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.7 p -172.49 -36.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.187 1.395 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 57.57 163.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.599 2.359 . . . . 0.0 112.254 -165.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.52 164.78 49.98 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 121.03 -1.044 . . . . 0.0 110.664 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HB3' ' HB3' ' A' ' 114' ' ' ARG . 64.0 Cg_endo -79.99 86.71 1.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.149 2.566 . . . . 0.0 111.815 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.1 104.92 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.473 1.909 . . . . 0.0 108.416 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.901 HG22 HG23 ' A' ' 15' ' ' VAL . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 1.7 pp -135.58 146.46 48.0 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -155.13 122.07 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.982 2.113 . . . . 0.0 106.15 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -148.15 139.65 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.405 1.457 . . . . 0.0 110.389 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -156.64 120.37 4.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.558 1.543 . . . . 0.0 107.461 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 t0 44.92 57.65 4.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.179 2.192 . . . . 0.0 111.905 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.88 163.64 39.01 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.401 1.477 . . . . 0.0 112.6 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -140.62 174.37 10.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -75.01 -45.46 41.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.735 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -71.85 173.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.088 0.955 . . . . 0.0 111.336 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.07 69.21 0.77 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 125.13 1.372 . . . . 0.0 110.625 173.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.48 158.32 42.41 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.458 1.903 . . . . 0.0 108.396 164.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -171.77 62.68 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -139.1 158.04 44.9 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.171 -1.581 . . . . 0.0 109.46 167.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -154.71 128.56 8.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.707 1.139 . . . . 0.0 111.183 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.22 132.89 23.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.422 0.689 . . . . 0.0 110.934 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.45 169.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 126.877 2.163 . . . . 0.0 111.695 139.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -160.16 175.5 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -158.31 66.9 0.46 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.283 0.0 OUTLIER -110.37 71.43 0.65 Allowed Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 113.243 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.45 0.32 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.708 1.606 . . . . 0.0 113.935 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.92 11.43 83.72 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.94 1.245 . . . . 0.0 114.201 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.54 151.75 8.89 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 120.707 -1.466 . . . . 0.0 109.536 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -145.4 162.13 38.02 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.871 1.668 . . . . 0.0 109.577 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.75 -179.1 41.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 128.181 2.8 . . . . 0.0 112.257 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 99' ' ' VAL . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 51' ' ' PRO . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HA ' HG21 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' VAL . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.415 HD22 ' H ' ' A' ' 54' ' ' LEU . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 99' ' ' VAL . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -120.84 165.2 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -122.83 157.74 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -73.64 96.92 2.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.7 0.12 62.16 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 117.551 -1.694 . . . . 0.0 113.916 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.76 -171.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.927 1.691 . . . . 0.0 111.271 -168.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 51.32 94.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.8 2.84 . . . . 0.0 111.244 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.55 99.06 0.44 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.893 1.235 . . . . 0.0 110.298 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.94 133.38 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.422 1.489 . . . . 0.0 108.134 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.58 167.73 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.989 1.316 . . . . 0.0 109.628 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.43 -61.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.534 -0.728 . . . . 0.0 111.682 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -140.05 160.98 58.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 109.608 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.19 108.71 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.283 2.655 . . . . 0.0 110.657 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.23 114.45 12.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 159.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.48 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 77' ' ' VAL . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp -130.38 151.72 50.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -150.48 119.83 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.119 0.967 . . . . 0.0 110.038 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -149.76 178.82 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.546 1.138 . . . . 0.0 111.445 165.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 126.94 3.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.3 21.0 t0 43.6 25.43 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.847 3.259 . . . . 0.0 115.829 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.94 79.79 0.1 OUTLIER Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.453 -1.405 . . . . 0.0 112.128 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 42.8 0.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.471 -1.017 . . . . 0.0 113.534 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 66.27 1.5 2.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.784 2.434 . . . . 0.0 114.025 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.25 174.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.217 1.407 . . . . 0.0 111.8 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.69 123.05 23.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.598 2.359 . . . . 0.0 110.975 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.1 174.18 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.548 1.139 . . . . 0.0 109.334 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.34 171.41 4.01 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.818 -1.176 . . . . 0.0 109.56 165.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 173.71 2.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.499 1.119 . . . . 0.0 110.899 166.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.8 mt -113.98 166.12 11.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.073 0.949 . . . . 0.0 109.353 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.5 p30 -176.05 97.42 0.06 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.807 1.643 . . . . 0.0 108.033 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 125' ' ' ASN . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.18 150.44 10.9 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 133.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -144.7 108.54 4.71 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.377 0.99 . . . . 0.0 109.082 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -74.25 125.46 28.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.835 . . . . 0.0 109.947 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.2 84.81 1.8 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.315 0.646 . . . . 0.0 110.908 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.67 82.23 1.73 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.827 3.018 . . . . 0.0 110.476 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.33 -148.01 3.61 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 156.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.47 152.24 5.62 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 127.734 2.587 . . . . 0.0 110.047 -171.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.73 131.24 57.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.392 1.096 . . . . 0.0 111.719 -158.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.32 164.57 21.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.243 0.925 . . . . 0.0 114.938 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 32' ' ' VAL . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CH2' ' A' ' 95' ' ' TRP . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 54' ' ' LEU . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 15' ' ' VAL . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' H ' HD23 ' A' ' 39' ' ' LEU . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 39' ' ' LEU . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -124.91 169.87 15.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.22 -168.45 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.115 0.566 . . . . 0.0 109.608 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -109.67 80.36 1.31 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 120.831 -1.168 . . . . 0.0 108.589 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.86 -0.39 66.4 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.498 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 45.24 68.72 0.53 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.443 2.697 . . . . 0.0 113.426 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.61 -62.25 2.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.858 1.263 . . . . 0.0 111.042 166.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.51 -163.57 37.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -165.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.79 158.14 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.976 1.71 . . . . 0.0 107.891 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 t 60.92 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.032 1.733 . . . . 0.0 109.558 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -134.0 174.62 10.28 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 109.663 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -72.25 159.32 85.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.276 -0.89 . . . . 0.0 111.121 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -66.17 85.12 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.525 3.483 . . . . 0.0 111.175 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.94 141.88 48.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CH2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.54 139.6 39.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.65 112.29 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 111.19 11.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.241 1.016 . . . . 0.0 109.395 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 147.33 24.81 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.676 1.991 . . . . 0.0 107.777 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 52.52 -173.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.233 2.213 . . . . 0.0 112.713 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.77 112.19 4.45 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 162.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -134.7 30.31 3.45 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 111.633 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 74.79 171.19 0.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.726 2.81 . . . . 0.0 110.33 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.15 140.04 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 120.694 -1.254 . . . . 0.0 108.764 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.32 -172.76 4.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 110.202 169.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.09 164.94 21.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.011 0.924 . . . . 0.0 109.779 174.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.86 1.68 0.68 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -99.87 167.47 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.843 1.656 . . . . 0.0 111.757 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.45 116.92 31.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.669 2.388 . . . . 0.0 107.452 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.7 64.3 1.49 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.291 0.636 . . . . 0.0 109.836 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.639 0 N-CA-C 105.205 -3.158 . . . . 0.0 105.205 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.42 147.19 25.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -141.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -155.34 175.82 13.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.062 1.745 . . . . 0.0 107.713 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -138.34 164.42 29.33 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.248 1.385 . . . . 0.0 112.533 -170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -125.11 79.74 65.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.102 2.161 . . . . 0.0 105.862 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.47 64.63 7.32 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.356 2.704 . . . . 0.0 109.806 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 89.91 1.2 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.3 24.99 4.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 123.913 0.768 . . . . 0.0 114.959 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt -127.35 156.33 42.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 117.945 0.872 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.58 153.77 30.4 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.357 1.932 . . . . 0.0 112.855 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 59' ' ' LEU . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ALA . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 72' ' ' ALA . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 99' ' ' VAL . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.71 -177.2 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.95 155.1 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 161.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.7 127.97 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.15 1.78 . . . . 0.0 108.891 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.79 52.2 0.69 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 124.838 1.209 . . . . 0.0 110.314 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 48.57 70.84 0.41 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.956 2.102 . . . . 0.0 110.729 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.04 172.64 2.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.412 161.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.97 -82.44 1.28 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.88 136.57 42.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.19 101.0 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.055 1.742 . . . . 0.0 107.396 -170.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.0 -42.93 97.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.258 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -143.61 162.57 41.12 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -64.25 112.52 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.067 3.178 . . . . 0.0 112.014 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -81.56 96.11 7.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.989 0.916 . . . . 0.0 111.36 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.9 46.18 2.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.75 120.79 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 120.596 -1.315 . . . . 0.0 110.029 -172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -144.61 135.4 24.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.75 1.62 . . . . 0.0 108.109 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 105.15 2.7 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 170.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 61.95 -170.81 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.873 1.269 . . . . 0.0 110.581 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.16 114.54 6.9 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 163.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 61.53 1.6 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.732 1.613 . . . . 0.0 108.624 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 60.76 158.56 0.04 OUTLIER 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.92 2.088 . . . . 0.0 112.467 -169.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.67 125.46 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.403 -1.272 . . . . 0.0 107.819 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.3 t -146.93 169.61 18.81 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.747 -0.596 . . . . 0.0 110.915 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.07 154.3 41.87 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -14.26 4.21 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -114.16 144.79 42.61 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.845 0.858 . . . . 0.0 109.748 -171.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.9 142.21 51.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 126.293 1.837 . . . . 0.0 107.599 171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.68 67.34 1.45 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 109' ' ' LYS . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 75.15 83.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -137.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.57 131.73 5.64 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.739 2.016 . . . . 0.0 106.426 -159.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -160.15 159.46 31.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.318 1.847 . . . . 0.0 107.296 -161.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -133.44 61.72 55.76 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.835 0.743 . . . . 0.0 112.97 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.01 103.15 1.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.152 2.568 . . . . 0.0 110.057 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.5 33.45 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 CA-C-O 117.205 -1.886 . . . . 0.0 115.901 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.3 -106.29 1.22 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 120.332 2.066 . . . . 0.0 111.111 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -72.42 144.6 48.08 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 118.567 1.183 . . . . 0.0 109.788 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.8 165.02 40.67 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.507 1.051 . . . . 0.0 113.148 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 77' ' ' VAL . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' CG ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.595 HG23 HD11 ' A' ' 59' ' ' LEU . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 30' ' ' VAL . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 ' CG1' HD22 ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.2 174.09 12.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -132.81 164.95 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.16 -0.42 51.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.509 1.924 . . . . 0.0 111.569 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.09 -71.53 2.53 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 125.179 1.371 . . . . 0.0 111.664 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.313 0.1 OUTLIER -132.49 -163.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.46 1.13 . . . . 0.0 111.297 -174.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.73 77.75 2.06 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.9 1.28 . . . . 0.0 110.495 -170.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.96 -164.97 11.51 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.207 2.337 . . . . 0.0 111.616 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.79 171.23 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.687 1.995 . . . . 0.0 108.701 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.1 m -101.85 160.8 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.643 1.177 . . . . 0.0 111.147 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -111.01 -67.54 0.99 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -171.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.41 162.93 18.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 119.913 -1.742 . . . . 0.0 111.408 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.35 104.99 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.322 2.014 . . . . 0.0 111.164 168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.36 142.71 55.39 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.522 163.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.59 118.6 35.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -144.4 112.09 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . 33.3 p90 -138.11 158.28 44.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.713 1.605 . . . . 0.0 111.539 166.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 160.14 19.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.432 1.493 . . . . 0.0 109.089 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -32.18 22.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.207 2.203 . . . . 0.0 115.048 -171.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.3 -3.84 58.48 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.632 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 113' ' ' PHE . 4.4 pttp -126.56 159.31 33.85 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.783 1.791 . . . . 0.0 109.622 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -58.59 129.32 41.54 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.38 154.04 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 123.197 1.475 . . . . 0.0 110.447 -171.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 51.2 m -146.2 119.71 9.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 C-N-CA 127.092 2.157 . . . . 0.0 105.434 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.39 163.4 8.64 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.375 1.47 . . . . 0.0 109.425 171.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.98 158.73 33.82 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 166.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.61 82.38 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.712 1.205 . . . . 0.0 109.536 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.21 133.63 55.22 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -139.18 112.89 8.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.753 1.621 . . . . 0.0 107.512 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.647 HD22 ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.46 -165.54 1.64 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 -154.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -77.55 52.58 0.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.336 1.455 . . . . 0.0 110.559 172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.42 107.66 9.92 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.719 0.808 . . . . 0.0 112.941 -156.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -114.12 80.42 5.57 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 152.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 113.91 3.7 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.822 2.348 . . . . 0.0 108.951 168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.02 -67.42 0.22 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.21 0.909 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.22 12.58 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.845 1.212 . . . . 0.0 111.106 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.65 158.4 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.175 1.39 . . . . 0.0 108.27 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 166.74 16.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.24 0.927 . . . . 0.0 111.688 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 99' ' ' VAL . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -153.22 151.38 11.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.36 161.19 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.514 1.126 . . . . 0.0 108.177 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 126.22 29.05 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.3 -98.45 2.51 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.03 -177.85 3.6 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.036 0.935 . . . . 0.0 110.104 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.45 151.49 0.77 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.654 1.981 . . . . 0.0 112.017 174.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.09 103.01 0.26 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -66.49 142.73 16.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 117.994 0.897 . . . . 0.0 109.574 167.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.2 102.55 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -108.78 -38.07 5.72 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.657 -1.277 . . . . 0.0 112.754 -168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -112.12 165.22 13.39 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 119.244 0.929 . . . . 0.0 109.973 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 75.83 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.92 2.413 . . . . 0.0 110.043 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.19 78.74 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.231 1.412 . . . . 0.0 109.866 171.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 77' ' ' VAL . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -104.98 81.19 1.71 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.4 p -82.11 139.28 18.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.88 175.65 13.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.435 2.294 . . . . 0.0 106.76 162.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -161.36 175.69 11.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.609 1.964 . . . . 0.0 107.181 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.1 74.87 1.75 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.813 1.245 . . . . 0.0 110.49 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.68 67.91 0.78 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -159.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -87.89 -164.62 1.13 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 147.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 119' ' ' ILE . 1.4 pt-20 -90.61 -56.83 3.04 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.597 1.159 . . . . 0.0 108.323 166.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 2.0 pp -74.93 172.91 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 127.997 2.519 . . . . 0.0 111.81 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -150.17 165.75 31.91 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.021 1.328 . . . . 0.0 107.818 155.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.01 156.19 3.23 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 127.843 2.457 . . . . 0.0 109.899 170.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.12 -19.32 0.49 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 168.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.37 132.78 47.66 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.136 1.789 . . . . 0.0 111.744 -173.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.0 mt -144.86 105.22 4.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.888 1.275 . . . . 0.0 110.427 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -135.87 109.73 8.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 111.66 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.36 167.36 28.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -139.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -149.06 169.57 20.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.0 1.32 . . . . 0.0 108.917 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -142.59 86.21 1.94 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.06 1.344 . . . . 0.0 110.803 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -64.88 143.1 98.77 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.65 72.19 3.12 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 124.322 3.348 . . . . 0.0 112.006 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.49 -107.02 0.24 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.741 1.639 . . . . 0.0 112.7 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.42 54.6 4.18 Favored Glycine 0 C--N 1.331 0.288 0 O-C-N 121.248 -1.148 . . . . 0.0 111.24 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -125.33 142.89 51.24 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.822 0.849 . . . . 0.0 110.814 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.44 167.99 4.69 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.173 1.844 . . . . 0.0 111.579 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.436 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.583 HG11 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.419 HG22 ' HB1' ' A' ' 34' ' ' ALA . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HA ' HG21 ' A' ' 33' ' ' VAL . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.583 ' H ' HG11 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 99' ' ' VAL . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p -158.86 172.08 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.89 171.45 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 157.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.82 14.8 20.24 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.39 1.476 . . . . 0.0 110.904 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.23 -102.71 0.76 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 -160.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.75 5.4 3.13 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.329 -168.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.02 134.65 14.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.804 1.184 . . . . 0.0 110.277 170.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.22 51.69 4.52 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.587 1.565 . . . . 0.0 114.375 -162.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.63 107.25 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.278 1.039 . . . . 0.0 110.588 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.51 -42.53 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.115 0.966 . . . . 0.0 111.729 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 53.65 -85.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.315 2.246 . . . . 0.0 113.103 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.9 159.87 24.13 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 124.969 1.308 . . . . 0.0 110.034 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.52 156.48 32.28 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.396 2.064 . . . . 0.0 110.907 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm -119.3 165.21 14.56 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.882 1.673 . . . . 0.0 108.053 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 77' ' ' VAL . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.06 146.3 27.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -145.13 109.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.669 1.988 . . . . 0.0 105.718 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -125.97 160.4 30.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.776 1.23 . . . . 0.0 108.744 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -165.94 -177.53 4.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.022 2.529 . . . . 0.0 108.349 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.47 101.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.891 0.876 . . . . 0.0 109.206 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.1 114.32 0.28 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -150.59 109.43 3.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.439 -1.036 . . . . 0.0 110.369 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.22 69.58 1.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.491 2.316 . . . . 0.0 107.776 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 tp -133.63 165.25 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.682 1.593 . . . . 0.0 108.04 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -108.8 122.55 47.4 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 163.57 36.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 124.111 0.882 . . . . 0.0 111.848 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -143.81 176.09 9.51 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.219 1.808 . . . . 0.0 108.755 165.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.4 -176.7 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.84 1.656 . . . . 0.0 110.713 167.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.57 146.21 46.57 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.474 1.91 . . . . 0.0 107.964 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -137.04 88.03 2.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.354 1.462 . . . . 0.0 109.416 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.694 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.75 -160.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.64 169.61 21.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 121.3 1.864 . . . . 0.0 109.723 157.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -173.05 171.38 4.19 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.943 1.297 . . . . 0.0 107.765 -153.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.55 78.93 0.58 Allowed Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 158.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.86 81.04 1.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.805 2.336 . . . . 0.0 107.477 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.75 66.37 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.289 -0.728 . . . . 0.0 111.63 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.54 142.41 0.78 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.201 1.382 . . . . 0.0 110.598 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -134.69 140.31 45.9 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.15 162.95 26.89 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.6 169.19 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 m -133.21 173.28 15.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.589 0.755 . . . . 0.0 110.09 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.55 154.59 28.33 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.069 1.347 . . . . 0.0 111.308 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.81 92.68 0.23 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 45.01 61.96 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 111.262 -163.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 53.3 37.49 25.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.851 1.26 . . . . 0.0 113.242 164.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.7 125.51 30.92 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.177 1.37 . . . . 0.0 113.547 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.19 -41.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.94 1.696 . . . . 0.0 109.33 168.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t 68.06 -71.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 126.503 1.921 . . . . 0.0 110.125 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -164.37 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.673 1.124 . . . . 0.0 110.198 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 156.51 85.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.25 129.05 26.94 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.616 2.211 . . . . 0.0 109.54 163.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.59 157.51 29.64 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 164.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.707 ' HE3' HD13 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.83 151.53 47.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 p -166.44 138.6 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 157.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -139.86 155.71 47.08 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.216 1.406 . . . . 0.0 107.249 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.62 133.55 3.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 158.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 44.21 39.78 3.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.405 2.282 . . . . 0.0 113.559 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.81 52.02 41.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.406 -0.809 . . . . 0.0 112.933 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -56.45 170.62 0.35 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.235 1.017 . . . . 0.0 111.698 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 118' ' ' GLU . 1.7 pm0 -62.11 86.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.419 2.287 . . . . 0.0 110.914 170.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -159.27 147.0 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 127.286 2.234 . . . . 0.0 106.414 169.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.33 82.91 1.48 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.062 1.301 . . . . 0.0 112.101 166.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.452 ' H ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -162.74 167.03 23.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.596 1.959 . . . . 0.0 107.186 164.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -166.56 88.87 0.36 Allowed 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 124.767 1.227 . . . . 0.0 109.078 168.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -166.35 152.13 8.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.017 1.727 . . . . 0.0 106.618 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.707 HD13 ' HE3' ' A' ' 109' ' ' LYS . 15.8 tp -159.4 126.57 4.69 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.47 113.24 8.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.455 0.57 . . . . 0.0 110.065 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.477 1.377 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 t70 76.29 108.3 0.08 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -114.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 17.3 m-20 -126.52 156.68 40.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.995 0.918 . . . . 0.0 108.82 -141.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.01 131.56 47.41 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.183 0.993 . . . . 0.0 110.84 -164.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 76.11 65.86 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 125.597 1.559 . . . . 0.0 107.437 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.2 111.73 1.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.363 2.709 . . . . 0.0 108.695 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.74 89.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.96 -179.81 21.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.514 1.054 . . . . 0.0 110.58 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -138.96 107.26 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 121.586 -0.949 . . . . 0.0 109.477 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.54 167.66 44.03 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.137 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 99' ' ' VAL . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.415 HD12 ' HA2' ' A' ' 84' ' ' GLY . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.582 ' CG2' HD21 ' A' ' 59' ' ' LEU . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 51' ' ' PRO . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 33' ' ' VAL . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 99' ' ' VAL . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.19 172.29 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.96 178.35 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.078 1.351 . . . . 0.0 108.339 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.72 58.74 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.878 -1.139 . . . . 0.0 108.934 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 27' ' ' ILE . . . -68.01 133.02 28.85 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.99 88.85 0.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -66.35 148.02 52.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.4 152.15 24.25 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.287 15.3 m 58.16 -4.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 128.57 2.748 . . . . 0.0 116.081 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.38 164.6 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.515 1.526 . . . . 0.0 111.893 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -166.7 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.686 1.194 . . . . 0.0 112.594 149.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.28 165.02 45.13 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.621 -0.674 . . . . 0.0 111.859 -153.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.39 91.06 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.154 2.57 . . . . 0.0 111.123 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.55 122.42 19.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 77' ' ' VAL . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.96 156.42 44.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.19 130.29 2.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 159.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.56 155.05 49.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.983 0.913 . . . . 0.0 110.431 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.53 68.41 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.247 2.619 . . . . 0.0 109.811 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 52.44 69.78 0.64 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.558 1.171 . . . . 0.0 111.876 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.0 141.22 4.11 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 122.528 1.071 . . . . 0.0 112.543 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.49 19.81 1.19 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.731 -1.452 . . . . 0.0 111.369 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 75.09 14.11 3.16 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.965 2.106 . . . . 0.0 112.369 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.05 146.1 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.695 1.198 . . . . 0.0 110.048 -159.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -82.48 105.77 13.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.512 0.725 . . . . 0.0 110.929 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 157.7 1.81 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.442 1.097 . . . . 0.0 109.851 163.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -158.66 172.66 17.87 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.12 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -79.0 -179.75 6.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.962 1.305 . . . . 0.0 111.753 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -124.54 151.52 44.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.33 67.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.642 1.177 . . . . 0.0 108.156 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 74.1 7.45 4.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.235 1.414 . . . . 0.0 110.289 168.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.52 119.35 13.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 129.985 3.314 . . . . 0.0 107.634 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -154.46 162.31 41.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.657 0.783 . . . . 0.0 109.179 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.46 86.63 0.43 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 125.406 1.483 . . . . 0.0 108.737 162.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -63.63 73.11 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.735 2.29 . . . . 0.0 110.276 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 -11.86 79.37 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.974 -1.079 . . . . 0.0 111.749 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.42 160.56 53.18 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.189 0.995 . . . . 0.0 111.101 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -139.91 154.25 47.19 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.1 1.36 . . . . 0.0 109.28 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.98 172.6 20.46 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 32' ' ' VAL . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 15' ' ' VAL . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ASP . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.437 ' H ' HG11 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 99' ' ' VAL . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.43 178.8 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.38 161.42 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 148.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.26 83.18 7.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.814 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.63 -46.49 92.08 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.99 -25.66 0.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 117.262 -1.351 . . . . 0.0 113.964 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.79 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.16 1.784 . . . . 0.0 111.555 -160.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.0 -95.01 0.47 Allowed Glycine 0 C--N 1.333 0.363 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.75 -173.09 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.339 1.856 . . . . 0.0 107.048 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.71 104.03 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 111.209 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -81.63 -169.03 2.12 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.817 1.647 . . . . 0.0 111.358 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 162.52 43.6 Favored Pre-proline 0 CA--C 1.538 0.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.682 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.68 89.6 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.751 2.301 . . . . 0.0 111.184 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm -52.36 114.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 157.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.519 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt -148.77 143.55 26.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.51 121.5 4.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 166.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.2 156.97 47.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.039 1.336 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -165.77 155.72 12.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.259 1.823 . . . . 0.0 107.692 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.92 108.76 4.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.18 -4.0 7.28 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.58 1.562 . . . . 0.0 112.839 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -122.17 47.19 1.95 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.877 1.838 . . . . 0.0 108.121 160.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.306 6.4 pm0 48.03 -163.57 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.61 1.564 . . . . 0.0 111.906 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.46 136.91 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.0 1.32 . . . . 0.0 108.137 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.1 t -147.14 138.19 23.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 161.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.95 163.8 25.25 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.232 1.015 . . . . 0.0 108.906 160.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -156.04 139.45 15.79 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 167.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -148.88 167.83 24.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.08 144.72 48.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.61 83.79 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.653 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.4 169.1 3.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.218 0.607 . . . . 0.0 110.164 141.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -158.11 -179.62 8.29 Favored 'General case' 0 CA--C 1.548 0.891 1 C-N-CA 132.076 4.151 . . . . 0.0 104.238 167.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.6 103.22 5.37 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.228 -1.545 . . . . 0.0 109.075 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -130.08 85.0 58.61 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.636 1.574 . . . . 0.0 107.842 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.2 110.48 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.462 2.108 . . . . 0.0 110.936 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.75 -109.53 2.24 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.169 1.366 . . . . 0.0 112.122 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.14 141.8 3.3 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 125.125 1.345 . . . . 0.0 111.424 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 -169.99 2.44 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.565 1.546 . . . . 0.0 110.314 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.21 -179.37 18.12 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.007 1.289 . . . . 0.0 114.237 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 77' ' ' VAL 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 97' ' ' VAL . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.412 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.52 HG22 ' CG ' ' A' ' 46' ' ' GLU . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' HG22 ' A' ' 44' ' ' THR . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 41' ' ' ASP . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.822 ' CG1' HD22 ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.34 147.96 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.92 165.58 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 99.21 6.42 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.17 -75.84 0.51 Allowed Glycine 0 C--O 1.227 -0.343 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -139.53 104.55 4.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.599 1.16 . . . . 0.0 108.441 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 60.12 -31.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.439 3.495 . . . . 0.0 118.021 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.49 -24.9 0.47 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 127.192 2.33 . . . . 0.0 114.052 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m 44.75 22.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 130.844 3.658 . . . . 0.0 115.069 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.93 120.11 3.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 118.787 0.721 . . . . 0.0 110.256 -165.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.32 -85.28 0.41 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -76.41 161.61 74.04 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.26 157.26 57.53 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.553 2.835 . . . . 0.0 110.642 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.79 150.21 42.2 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.489 1.916 . . . . 0.0 106.956 164.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.443 ' CZ3' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 17' ' ' ILE . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 126' ' ' LEU . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -79.65 143.33 34.76 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 114' ' ' ARG . 7.2 p -155.58 132.48 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -98.41 27.53 4.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.201 1.001 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 112' ' ' VAL . 1.3 tpt180 -153.4 -163.97 1.8 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.515 1.926 . . . . 0.0 107.909 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 65.63 70.88 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.872 1.269 . . . . 0.0 110.906 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.6 56.78 9.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 115.26 1.98 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.392 1.077 . . . . 0.0 112.198 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.16 160.33 27.08 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 110.914 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -91.32 4.8 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 113.263 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -147.07 62.38 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.638 -1.289 . . . . 0.0 108.958 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.5 p -139.86 154.56 47.33 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.093 0.957 . . . . 0.0 110.595 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -155.61 -169.36 3.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 161.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.78 168.79 10.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.062 1.345 . . . . 0.0 113.23 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.97 128.97 38.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.894 2.078 . . . . 0.0 111.375 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.42 46.37 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.281 0.633 . . . . 0.0 111.858 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.822 HD22 ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.63 121.15 4.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 101.691 -3.448 . . . . 0.0 101.691 -148.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.0 170.97 20.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.636 1.574 . . . . 0.0 107.263 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.49 118.12 8.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.538 1.063 . . . . 0.0 110.564 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -110.66 76.79 1.2 Allowed Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 124.825 1.25 . . . . 0.0 108.807 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 81.37 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.593 2.862 . . . . 0.0 111.363 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.34 -66.43 1.79 Allowed Glycine 0 CA--C 1.523 0.535 0 O-C-N 121.605 -0.684 . . . . 0.0 112.615 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.03 147.96 18.8 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -147.44 163.77 35.47 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.791 1.636 . . . . 0.0 109.407 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.47 179.91 28.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.26 1.409 . . . . 0.0 114.299 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 99' ' ' VAL . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 74' ' ' GLU . 1.1 t30 -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 44' ' ' THR . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' H ' HG11 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.598 HD13 ' CE1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 35' ' ' ASN . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 99' ' ' VAL . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.3 174.91 12.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.47 140.95 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 C-N-CA 126.114 1.765 . . . . 0.0 106.278 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.87 109.99 21.43 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.63 -31.72 5.08 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.634 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -170.99 162.96 7.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.707 2.403 . . . . 0.0 104.579 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -144.9 179.87 7.05 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.196 -0.94 . . . . 0.0 109.994 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.54 -91.48 0.08 OUTLIER Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.214 0.916 . . . . 0.0 112.268 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -78.8 127.32 38.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.966 0.889 . . . . 0.0 109.674 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.83 8.84 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.861 1.664 . . . . 0.0 112.508 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -70.15 -49.16 53.39 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.875 -1.141 . . . . 0.0 112.521 -174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.37 146.49 58.1 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 126.21 1.804 . . . . 0.0 107.412 -171.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.69 145.2 36.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.24 1.96 . . . . 0.0 111.237 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm -73.19 74.02 1.27 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 77' ' ' VAL . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.14 139.93 30.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 114' ' ' ARG . 13.3 p -142.29 141.01 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 171.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -99.02 1.6 45.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.271 1.028 . . . . 0.0 111.554 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.447 ' H ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -138.56 -175.09 4.01 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.709 2.003 . . . . 0.0 110.351 175.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.7 t0 73.42 114.15 0.06 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.231 2.612 . . . . 0.0 110.792 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.8 30.83 63.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.376 0.512 . . . . 0.0 113.608 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.65 60.89 3.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 123.714 1.721 . . . . 0.0 109.825 -166.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.56 -12.71 18.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.341 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.36 167.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.6 1.96 . . . . 0.0 111.845 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -178.51 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.667 1.587 . . . . 0.0 112.096 161.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.68 171.93 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.614 1.166 . . . . 0.0 108.499 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.58 169.39 24.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.149 0.58 . . . . 0.0 109.739 171.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.0 154.45 34.99 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.879 0.872 . . . . 0.0 111.838 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.82 150.13 36.15 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 125.857 1.663 . . . . 0.0 111.452 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -150.29 85.93 1.4 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.76 162.58 36.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -153.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -152.38 178.33 9.64 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 160.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -165.36 176.74 8.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.212 2.205 . . . . 0.0 107.304 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -109.43 54.17 0.26 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.632 1.173 . . . . 0.0 112.784 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.26 108.76 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.799 2.333 . . . . 0.0 111.51 -170.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.76 18.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.463 1.506 . . . . 0.0 112.269 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.81 84.7 1.51 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.949 1.262 . . . . 0.0 110.399 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -70.28 120.39 15.88 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.32 175.98 52.32 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 51' ' ' PRO . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 48' ' ' LEU . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 72' ' ' ALA . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -162.55 168.04 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.22 158.72 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 164.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.92 119.91 25.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.02 1.728 . . . . 0.0 107.554 170.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.36 -72.63 0.95 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -126.46 159.73 32.51 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.282 1.833 . . . . 0.0 107.249 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -147.41 125.51 12.13 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.157 -0.964 . . . . 0.0 110.337 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.88 0.9 87.98 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.265 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 59.37 71.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.914 1.686 . . . . 0.0 110.483 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -105.44 -22.94 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.84 0.856 . . . . 0.0 111.574 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.52 28.25 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.71 2.004 . . . . 0.0 113.758 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -106.63 87.18 2.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.61 1.964 . . . . 0.0 110.306 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 114' ' ' ARG . 97.6 Cg_endo -63.12 94.91 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 1 C-N-CA 126.745 4.963 . . . . 0.0 111.922 -179.166 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp -51.53 118.92 3.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.024 0.93 . . . . 0.0 109.702 170.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' HG3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -137.15 93.73 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HE3' ' A' ' 117' ' ' LYS . 7.3 p -151.42 138.64 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -150.06 134.69 17.52 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 92' ' ' PRO . 1.3 ptm180 -169.84 -167.61 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.503 1.521 . . . . 0.0 108.838 -168.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.58 -161.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.853 1.661 . . . . 0.0 111.676 156.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -47.94 108.07 0.31 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.979 1.752 . . . . 0.0 113.741 -171.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 112' ' ' VAL . 7.6 mtpm? -93.88 134.63 36.05 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 123.877 0.871 . . . . 0.0 109.391 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -69.35 17.06 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.948 1.299 . . . . 0.0 112.641 163.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.43 138.21 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 120.851 1.659 . . . . 0.0 110.266 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -70.64 107.97 4.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.977 1.711 . . . . 0.0 112.095 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.63 150.83 6.61 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.457 1.903 . . . . 0.0 110.102 170.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.98 176.23 11.31 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.08 154.53 19.72 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.446 2.298 . . . . 0.0 110.16 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.5 mt -141.8 92.44 2.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.929 0.891 . . . . 0.0 110.854 -163.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.1 118.27 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 163.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.21 154.18 41.17 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 160.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -140.23 169.36 17.82 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.305 1.042 . . . . 0.0 108.66 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.59 158.92 28.35 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.222 1.009 . . . . 0.0 110.12 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -140.56 148.37 53.01 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.41 75.17 4.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.51 2.807 . . . . 0.0 109.857 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.84 -32.42 4.43 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 123.837 0.732 . . . . 0.0 112.746 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.28 162.5 14.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.724 1.631 . . . . 0.0 110.857 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -133.26 100.02 4.72 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.77 167.3 0.32 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 128.551 2.976 . . . . 0.0 112.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 32' ' ' VAL . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.464 ' CG1' HG12 ' A' ' 32' ' ' VAL . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 15' ' ' VAL . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -128.19 144.45 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.1 155.01 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.85 92.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.36 2.264 . . . . 0.0 107.653 168.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.56 -82.6 0.7 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -134.63 61.92 1.66 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.866 1.266 . . . . 0.0 107.771 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.23 -172.89 4.33 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.765 -1.209 . . . . 0.0 108.368 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.35 1.54 0.03 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.141 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.32 -169.02 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.845 1.822 . . . . 0.0 110.692 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.96 157.15 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.728 2.011 . . . . 0.0 108.47 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -147.37 170.83 16.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.168 0.894 . . . . 0.0 112.708 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.66 161.53 20.23 Favored Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 121.94 -0.475 . . . . 0.0 111.495 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.92 92.59 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.804 2.336 . . . . 0.0 110.833 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -60.18 107.28 0.62 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 168.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' OE1' ' A' ' 105' ' ' GLU . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' A' ' 98' ' ' THR . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp -124.87 135.54 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.42 102.55 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -143.07 149.23 37.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.715 0.806 . . . . 0.0 110.319 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -175.73 -175.6 0.78 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.489 1.916 . . . . 0.0 109.08 -168.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -45.95 -59.29 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.541 2.336 . . . . 0.0 113.135 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.76 55.92 4.9 Favored Glycine 0 CA--C 1.523 0.566 0 O-C-N 120.571 -1.331 . . . . 0.0 110.83 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -153.03 16.85 0.56 Allowed 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 75.13 -43.6 0.51 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.787 1.631 . . . . 0.0 112.128 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.9 tp -147.11 164.17 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.663 1.985 . . . . 0.0 108.758 164.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.4 m -115.9 9.13 14.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.028 1.731 . . . . 0.0 113.341 -168.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.2 p -125.57 155.6 40.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.194 0.998 . . . . 0.0 110.387 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.92 143.33 5.5 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.978 1.311 . . . . 0.0 108.288 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -139.71 143.92 37.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.917 2.087 . . . . 0.0 106.663 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -118.37 144.52 45.84 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.778 1.631 . . . . 0.0 109.727 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -139.27 134.66 32.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.98 152.32 34.75 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -138.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -137.71 -169.4 2.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.01 1.324 . . . . 0.0 110.123 -173.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.66 131.36 5.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.249 1.02 . . . . 0.0 108.671 -163.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.5 72.2 66.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.418 1.087 . . . . 0.0 109.234 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.27 68.22 8.35 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.628 2.885 . . . . 0.0 113.197 -167.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.36 102.83 0.38 Allowed Glycine 0 C--N 1.336 0.538 0 O-C-N 120.716 -1.24 . . . . 0.0 113.608 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.32 -103.52 0.17 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.522 -0.987 . . . . 0.0 113.632 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.92 146.28 22.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.922 1.289 . . . . 0.0 110.387 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.32 -176.92 47.1 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HB2' HD21 ' A' ' 48' ' ' LEU . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.449 ' H ' HG11 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 72' ' ' ALA . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 99' ' ' VAL . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t -140.19 169.89 15.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.88 154.62 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.69 84.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 110.589 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.58 -69.79 1.35 Allowed Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.769 -0.582 . . . . 0.0 112.301 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.97 155.2 11.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.368 1.067 . . . . 0.0 108.806 -165.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -57.92 152.39 16.25 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.041 1.736 . . . . 0.0 112.767 -165.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.22 178.64 25.67 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.909 1.719 . . . . 0.0 112.059 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.48 -13.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t 44.32 59.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.872 1.669 . . . . 0.0 114.229 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -60.2 -42.19 94.57 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.928 -1.107 . . . . 0.0 111.962 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.74 158.28 68.22 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 124.056 0.942 . . . . 0.0 111.373 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 112.51 3.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.978 3.119 . . . . 0.0 112.047 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 154.75 34.08 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.861 1.264 . . . . 0.0 110.222 167.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 77' ' ' VAL . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp -72.25 31.55 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.06 120.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 120.671 -1.268 . . . . 0.0 108.614 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -142.91 130.86 21.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.737 2.015 . . . . 0.0 109.034 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.61 158.33 23.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 167.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 44.5 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.817 2.847 . . . . 0.0 113.802 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.87 126.95 1.38 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -143.92 26.47 1.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.208 1.003 . . . . 0.0 110.307 -170.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.254 7.9 pm0 50.71 26.19 2.41 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.004 2.122 . . . . 0.0 115.977 173.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.09 176.86 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.223 -1.548 . . . . 0.0 114.085 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -153.81 59.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.107 1.363 . . . . 0.0 110.323 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.62 162.09 35.16 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.245 -1.534 . . . . 0.0 110.97 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.87 -11.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -128.66 152.83 47.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.058 1.753 . . . . 0.0 108.712 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -134.77 142.95 46.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.1 1.36 . . . . 0.0 107.602 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -134.17 91.74 2.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HD1' ' HB2' ' A' ' 76' ' ' ALA . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.65 160.76 38.29 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.142 0.977 . . . . 0.0 109.241 -168.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.72 153.32 18.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.52 1.528 . . . . 0.0 106.994 156.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.08 145.54 7.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.807 0.843 . . . . 0.0 108.733 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -118.19 78.69 13.93 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.514 1.526 . . . . 0.0 109.462 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.22 89.23 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.165 3.243 . . . . 0.0 112.369 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.12 -66.38 2.11 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 122.012 -0.43 . . . . 0.0 112.087 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.14 19.51 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.722 1.153 . . . . 0.0 112.351 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -142.04 117.5 10.25 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -175.1 4.75 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 128.335 2.874 . . . . 0.0 112.004 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 HD21 ' A' ' 59' ' ' LEU . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 48' ' ' LEU . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.449 HD12 ' HE3' ' A' ' 28' ' ' LYS . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.66 155.27 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 162.04 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 158.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -84.02 131.3 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.14 -158.95 11.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.957 1.741 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.75 92.07 3.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.382 1.073 . . . . 0.0 109.254 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.15 -86.04 0.65 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.249 1.82 . . . . 0.0 106.431 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.98 -152.62 6.97 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 127.712 2.577 . . . . 0.0 109.995 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.7 t -133.97 -8.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 111.102 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 90' ' ' ASN 0.341 7.7 p 46.51 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 127.26 2.224 . . . . 0.0 111.709 -175.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.518 ' H ' HG22 ' A' ' 89' ' ' VAL . 55.0 t30 -162.0 -75.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.159 -1.588 . . . . 0.0 110.385 162.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 163.77 25.8 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.177 1.791 . . . . 0.0 111.514 -171.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.67 155.05 71.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.099 1.866 . . . . 0.0 113.959 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.82 99.21 5.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.514 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.31 160.3 29.63 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.81 81.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.078 0.942 . . . . 0.0 109.5 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -91.0 174.3 7.49 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.127 -0.983 . . . . 0.0 110.733 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.33 2.652 . . . . 0.0 106.113 165.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.31 144.91 37.74 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 161.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.66 47.28 69.29 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -170.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -98.92 171.78 7.84 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 150.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.05 -58.47 7.17 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 tp -148.24 99.16 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.976 -168.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -44.63 120.7 2.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 127.286 2.234 . . . . 0.0 111.167 166.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.17 151.02 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.58 1.952 . . . . 0.0 108.475 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.0 156.39 43.0 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.07 51.9 0.26 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 111.588 -162.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mp -138.29 146.9 43.03 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.486 -1.384 . . . . 0.0 112.56 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.46 56.43 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -139.96 163.6 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -155.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.62 77.97 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.404 1.481 . . . . 0.0 110.446 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -123.2 109.1 13.57 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.901 2.08 . . . . 0.0 107.734 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.66 62.2 63.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.72 1.608 . . . . 0.0 110.565 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.66 102.56 1.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.97 2.446 . . . . 0.0 110.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.21 -77.32 0.18 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.116 0.865 . . . . 0.0 113.177 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 51.65 54.35 25.15 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.091 0.853 . . . . 0.0 112.118 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -95.76 143.11 27.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 164.43 54.92 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.648 1.118 . . . . 0.0 112.651 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 32' ' ' VAL . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 34' ' ' ALA . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG11 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB2' HG12 ' A' ' 30' ' ' VAL . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 66' ' ' LEU . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.404 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.57 175.35 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.13 162.51 3.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -80.77 79.75 7.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -55.28 -47.73 73.24 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.279 0.466 . . . . 0.0 112.273 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.93 32.66 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.097 1.359 . . . . 0.0 109.188 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 49.57 -87.04 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.384 2.274 . . . . 0.0 109.737 -156.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.52 170.21 16.62 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.293 1.901 . . . . 0.0 110.613 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.06 157.99 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 108.239 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t 58.09 85.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.863 2.065 . . . . 0.0 112.215 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -153.03 175.81 12.57 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.145 -0.972 . . . . 0.0 111.027 169.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -85.61 165.87 33.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.555 1.542 . . . . 0.0 111.21 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.54 101.94 1.44 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.963 3.109 . . . . 0.0 112.96 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -69.15 97.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.617 1.967 . . . . 0.0 109.131 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt -145.28 142.23 29.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.8 p -167.66 139.08 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.936 1.694 . . . . 0.0 107.111 164.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 69.1 m-85 -135.48 164.98 26.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.091 0.956 . . . . 0.0 108.431 166.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.23 165.12 13.2 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.889 1.676 . . . . 0.0 107.617 171.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -49.12 -44.11 42.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.136 1.774 . . . . 0.0 112.794 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.5 47.48 3.62 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 123.799 0.714 . . . . 0.0 112.615 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -160.38 -177.87 6.53 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.137 1.375 . . . . 0.0 107.959 165.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.73 137.12 57.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.7 tp -96.7 136.67 26.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 161.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.0 t -154.75 130.9 10.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.64 174.15 11.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.998 0.817 . . . . 0.0 111.605 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -152.33 -175.44 5.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 109.889 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -164.37 140.06 5.99 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.013 1.725 . . . . 0.0 109.295 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.94 159.57 37.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.391 1.876 . . . . 0.0 109.466 -169.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -164.42 68.98 0.17 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.967 0.907 . . . . 0.0 110.671 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -50.82 123.69 9.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 122.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -143.96 170.34 16.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.943 2.497 . . . . 0.0 105.555 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.29 176.65 8.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.308 0.958 . . . . 0.0 111.518 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -125.46 73.33 67.97 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.037 1.335 . . . . 0.0 111.085 -174.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.23 64.33 7.08 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.025 3.15 . . . . 0.0 112.061 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 -71.53 1.13 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.222 1.391 . . . . 0.0 110.416 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.47 76.95 0.17 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.479 1.038 . . . . 0.0 113.477 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -133.65 176.22 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.693 1.197 . . . . 0.0 112.908 -166.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.99 42.28 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 65' ' ' THR . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.559 ' H ' HD23 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 16' ' ' THR . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 72' ' ' ALA . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 -172.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.22 165.95 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 149.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -72.67 95.37 1.86 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.216 1.406 . . . . 0.0 109.42 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.66 5.78 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.887 -0.508 . . . . 0.0 112.282 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -163.44 148.52 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.42 1.888 . . . . 0.0 107.162 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -44.57 -53.11 7.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.266 2.627 . . . . 0.0 113.594 -163.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.82 2.79 47.53 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.693 -1.615 . . . . 0.0 115.821 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.253 32.6 m 49.55 -177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.43 1.892 . . . . 0.0 112.312 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.1 t -71.23 139.82 19.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -120.43 -177.07 3.36 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.6 156.44 78.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 120.685 -1.259 . . . . 0.0 109.992 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.06 85.76 1.78 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.209 2.606 . . . . 0.0 112.593 -166.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.57 127.22 15.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.964 1.705 . . . . 0.0 110.948 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -78.65 127.95 32.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 t -155.08 117.98 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -148.48 123.12 9.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.589 1.54 . . . . 0.0 109.695 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.38 71.23 0.13 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.43 1.892 . . . . 0.0 110.558 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 54.62 -172.03 0.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.096 0.959 . . . . 0.0 110.029 -169.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.28 23.8 60.42 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.535 -1.353 . . . . 0.0 114.288 167.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -142.84 119.49 11.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.69 97.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 tp -170.97 165.45 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.004 2.122 . . . . 0.0 107.173 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.4 t -152.88 58.29 0.79 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.83 153.39 18.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.907 1.683 . . . . 0.0 107.1 174.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -146.9 12.47 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 168.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.88 171.95 13.53 Favored 'General case' 0 C--O 1.242 0.679 0 O-C-N 120.607 -1.308 . . . . 0.0 110.607 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 tp -143.83 151.4 39.86 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.674 -0.641 . . . . 0.0 112.065 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.42 105.41 3.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.524 1.529 . . . . 0.0 108.047 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 107.001 -2.44 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.2 t0 56.53 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -112.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.24 177.41 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.607 1.563 . . . . 0.0 108.865 -160.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -105.81 75.8 1.15 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.677 0.751 . . . . 0.0 112.311 -159.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.98 59.31 10.52 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.151 1.38 . . . . 0.0 113.588 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.21 109.49 1.16 Allowed 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 112.07 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.03 50.3 3.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 126.548 2.023 . . . . 0.0 112.345 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.49 123.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -141.19 146.05 36.43 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.442 1.121 . . . . 0.0 110.399 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.08 161.06 44.86 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 124.491 1.119 . . . . 0.0 112.999 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 51' ' ' PRO . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 34' ' ' ALA . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' HB2' HD21 ' A' ' 48' ' ' LEU . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' VAL . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.6 173.25 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.04 162.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 122.303 1.049 . . . . 0.0 110.477 161.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.85 105.62 0.33 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.796 2.039 . . . . 0.0 107.049 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.17 -95.34 2.39 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -135.84 170.74 15.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.954 1.702 . . . . 0.0 107.928 171.202 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.9 t70 70.47 -179.59 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.096 2.158 . . . . 0.0 110.816 174.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.64 -176.46 28.33 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.385 6.4 p 61.83 -0.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 127.602 2.361 . . . . 0.0 113.569 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 89' ' ' VAL . 1.9 t -59.56 -9.89 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 127.827 2.451 . . . . 0.0 113.877 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 44.4 t30 64.99 11.3 6.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.449 1.499 . . . . 0.0 112.967 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.8 89.48 1.25 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 128.092 2.557 . . . . 0.0 112.207 -159.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.38 64.59 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.985 1 C-N-CA 126.012 4.475 . . . . 0.0 112.814 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt -69.63 99.47 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.973 1.309 . . . . 0.0 108.919 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 99' ' ' VAL . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.91 138.75 25.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.62 97.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -132.6 161.76 33.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.716 0.806 . . . . 0.0 109.087 170.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -154.99 30.45 0.41 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.022 1.329 . . . . 0.0 111.504 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.1 30.41 16.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.2 1.8 . . . . 0.0 111.469 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.63 115.76 0.41 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -141.91 -177.78 5.37 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.345 1.072 . . . . 0.0 108.753 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -71.6 -15.96 62.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.548 1.539 . . . . 0.0 112.579 -170.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 tp -164.99 170.48 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.992 3.717 . . . . 0.0 106.135 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 143.29 33.0 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.652 1.181 . . . . 0.0 108.433 169.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.17 168.45 9.71 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.876 1.27 . . . . 0.0 109.702 -174.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.5 98.09 1.93 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.446 -0.784 . . . . 0.0 110.22 166.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.7 94.79 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.2 mt -144.3 100.07 3.48 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.211 1.005 . . . . 0.0 109.043 171.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.38 115.46 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 120.826 0.126 . . . . 0.0 112.87 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 59' ' ' LEU . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp . . . . . 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 121.519 0.511 . . . . 0.0 113.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.901 HG23 HG22 ' A' ' 99' ' ' VAL . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB2' HG11 ' A' ' 81' ' ' VAL . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 37' ' ' THR . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 34' ' ' ALA . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 99' ' ' VAL . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 28' ' ' LYS . 18.8 m . . . . . 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.901 HG22 HG23 ' A' ' 15' ' ' VAL . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 1.7 pp . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.465 0.303 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 CA-C-O 121.639 0.577 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 99' ' ' VAL . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 51' ' ' PRO . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HA ' HG21 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' VAL . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 54' ' ' LEU . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 99' ' ' VAL . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.48 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 77' ' ' VAL . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.5 p30 . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 125' ' ' ASN . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.762 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 32' ' ' VAL . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CH2' ' A' ' 95' ' ' TRP . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 54' ' ' LEU . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 15' ' ' VAL . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.537 ' H ' HD23 ' A' ' 39' ' ' LEU . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 39' ' ' LEU . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CH2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.018 0 CA-C-O 121.131 0.295 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 59' ' ' LEU . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ALA . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 72' ' ' ALA . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 99' ' ' VAL . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 109' ' ' LYS . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.791 0.662 . . . . 0.0 113.148 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 77' ' ' VAL . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' CG ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.595 HG23 HD11 ' A' ' 59' ' ' LEU . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 30' ' ' VAL . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 ' CG1' HD22 ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.647 HD22 ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 99' ' ' VAL . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 77' ' ' VAL . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 111.66 0.245 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.436 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.583 HG11 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.419 HG22 ' HB1' ' A' ' 34' ' ' ALA . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HA ' HG21 ' A' ' 33' ' ' VAL . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.583 ' H ' HG11 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 99' ' ' VAL . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 77' ' ' VAL . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.413 ' H ' HD22 ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.25 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 99' ' ' VAL . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.582 ' CG2' HD21 ' A' ' 59' ' ' LEU . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 51' ' ' PRO . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.484 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 33' ' ' VAL . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 99' ' ' VAL . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 77' ' ' VAL . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 . . . . . 0 N--CA 1.455 -0.196 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.887 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 32' ' ' VAL . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 15' ' ' VAL . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ASP . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.437 ' H ' HG11 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 99' ' ' VAL . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.519 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 N-CA-C 114.237 0.455 . . . . 0.0 114.237 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 77' ' ' VAL 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 97' ' ' VAL . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.412 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.52 HG22 ' CG ' ' A' ' 46' ' ' GLU . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' HG22 ' A' ' 44' ' ' THR . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 41' ' ' ASP . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.822 ' CG1' HD22 ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.503 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.443 ' CZ3' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 17' ' ' ILE . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 126' ' ' LEU . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 121.347 0.594 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.822 HD22 ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.052 0 N-CA-C 114.299 0.48 . . . . 0.0 114.299 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 99' ' ' VAL . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 44' ' ' THR . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' H ' HG11 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.598 HD13 ' CE1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 35' ' ' ASN . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 99' ' ' VAL . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 77' ' ' VAL . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 51' ' ' PRO . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 48' ' ' LEU . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 72' ' ' ALA . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 N--CA 1.446 -0.654 0 CA-C-O 121.467 0.651 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' HG3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt . . . . . 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.07 0 CA-C-O 122.821 1.234 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 32' ' ' VAL . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.464 ' CG1' HG12 ' A' ' 32' ' ' VAL . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 15' ' ' VAL . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' OE1' ' A' ' 105' ' ' GLU . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' A' ' 98' ' ' THR . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HB2' HD21 ' A' ' 48' ' ' LEU . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.449 ' H ' HG11 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 72' ' ' ALA . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 99' ' ' VAL . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 121.328 0.585 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 77' ' ' VAL . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HD1' ' HB2' ' A' ' 76' ' ' ALA . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.729 0 N-CA-C 112.004 -0.438 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 HD21 ' A' ' 59' ' ' LEU . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 48' ' ' LEU . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.449 HD12 ' HE3' ' A' ' 28' ' ' LYS . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.514 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 112.651 -0.18 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 32' ' ' VAL . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 34' ' ' ALA . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG11 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB2' HG12 ' A' ' 30' ' ' VAL . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 66' ' ' LEU . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.404 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.234 0.275 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt . . . . . 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 CA--C 1.55 0.972 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 65' ' ' THR . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.559 ' H ' HD23 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 16' ' ' THR . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 72' ' ' ALA . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.861 0.145 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 51' ' ' PRO . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 34' ' ' ALA . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' HB2' HD21 ' A' ' 48' ' ' LEU . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' VAL . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 99' ' ' VAL . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 C--O 1.234 0.245 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.518 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 174.23 85.66 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.715 2 C-N-CA 131.997 4.119 . . . . 0.0 100.141 -155.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.85 100.25 4.13 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -151.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -152.84 169.64 22.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.521 1.528 . . . . 0.0 108.742 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -130.53 70.62 82.43 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 109.015 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.65 93.13 1.09 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.244 2.629 . . . . 0.0 112.056 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.86 -114.07 1.56 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.51 152.49 16.81 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.798 1.19 . . . . 0.0 110.88 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -141.01 107.86 5.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.536 1.134 . . . . 0.0 108.922 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.06 154.9 0.41 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 127.485 2.469 . . . . 0.0 112.87 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.17 150.83 43.26 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.587 -0.949 . . . . 0.0 111.761 -169.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 74.9 mtp -73.1 150.85 41.93 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.64 168.72 21.31 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.775 1.63 . . . . 0.0 108.024 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -135.3 154.19 51.62 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 162.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.8 p -139.59 152.26 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -143.61 111.62 6.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.2 tp -108.92 144.55 17.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -134.82 124.3 24.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.309 1.443 . . . . 0.0 107.13 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -122.34 136.04 54.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.046 1.738 . . . . 0.0 107.576 166.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.0 p -160.65 179.76 8.29 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 162.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.73 -157.47 53.49 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -157.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.1 92.59 5.04 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.53 -0.982 . . . . 0.0 109.508 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -106.7 -39.46 5.82 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -85.23 58.75 5.21 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.879 1.271 . . . . 0.0 109.205 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.3 p -151.23 2.72 0.42 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 127.907 2.483 . . . . 0.0 111.925 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -137.87 128.8 27.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.661 1.984 . . . . 0.0 106.085 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.7 mm -79.62 108.4 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 125.405 1.482 . . . . 0.0 108.523 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -133.62 -177.46 4.55 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.74 1.609 . . . . 0.0 112.777 176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.1 m -144.49 102.26 3.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.02 0.928 . . . . 0.0 110.87 -167.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG23 HD21 ' A' ' 59' ' ' LEU . 47.2 t -76.14 95.39 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.65 110.02 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 141.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.5 t -140.0 117.65 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 134.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 34' ' ' ALA . 4.1 p -156.34 -172.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 119.107 0.867 . . . . 0.0 109.082 159.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.601 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.48 148.54 41.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 127.422 2.289 . . . . 0.0 107.24 169.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.03 23.81 7.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.51 1.124 . . . . 0.0 111.719 175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.31 -68.29 0.01 OUTLIER Glycine 0 C--N 1.334 0.435 0 O-C-N 120.952 -1.092 . . . . 0.0 110.746 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -81.1 175.47 10.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.238 0.615 . . . . 0.0 111.308 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -81.15 160.19 24.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.57 1.548 . . . . 0.0 111.829 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.43 164.72 11.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.43 1.092 . . . . 0.0 108.975 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -132.2 125.54 31.41 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 108.532 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -80.56 129.3 34.43 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.656 1.182 . . . . 0.0 110.158 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.07 -18.05 56.68 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.143 -1.365 . . . . 0.0 114.272 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.38 -53.0 41.03 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 120.153 1.977 . . . . 0.0 110.615 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -132.23 -13.12 3.12 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -169.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.93 65.16 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 120.761 -1.212 . . . . 0.0 111.169 -170.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -59.9 155.83 15.67 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 159.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 m -129.17 139.13 52.03 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.64 1.176 . . . . 0.0 109.118 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.2 mt -141.95 138.1 31.71 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.779 0.832 . . . . 0.0 110.321 -150.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 175.57 1.41 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.261 1.024 . . . . 0.0 111.863 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 p -141.52 147.93 48.17 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.352 -0.832 . . . . 0.0 111.87 -159.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.36 172.72 60.68 Favored 'Cis proline' 0 CA--C 1.54 0.792 0 CA-C-N 119.693 0.926 . . . . 0.0 110.726 -15.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.0 t -147.15 111.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.54 133.1 59.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.2 mt -93.33 173.29 7.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.734 1.255 . . . . 0.0 109.503 -174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.87 179.99 6.83 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.976 1.31 . . . . 0.0 107.842 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -54.1 -41.38 68.21 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.829 1.251 . . . . 0.0 111.934 -171.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -50.45 -38.1 41.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.994 1.717 . . . . 0.0 113.001 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -98.27 15.76 23.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.867 2.067 . . . . 0.0 111.207 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -107.5 9.02 29.68 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.671 -1.268 . . . . 0.0 112.858 -174.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -72.04 10.67 0.68 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.95 1.7 . . . . 0.0 114.039 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.74 142.34 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.907 1.283 . . . . 0.0 110.012 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -64.87 -77.86 0.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.415 1.086 . . . . 0.0 110.482 173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.65 151.12 50.81 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.452 0.701 . . . . 0.0 111.672 -167.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.9 t -156.16 145.33 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 124.479 1.112 . . . . 0.0 108.926 -164.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -136.51 67.49 1.45 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-O 122.198 0.999 . . . . 0.0 110.625 -165.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -86.2 146.7 26.44 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.876 -1.14 . . . . 0.0 112.028 -167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -151.74 155.79 38.99 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.432 -0.792 . . . . 0.0 109.552 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.3 p -85.3 146.9 26.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.908 0.883 . . . . 0.0 110.576 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.1 p -78.73 -52.52 8.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.88 -125.41 4.21 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.183 1.849 . . . . 0.0 109.141 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -111.74 124.35 52.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.063 1.431 . . . . 0.0 112.684 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -64.89 170.83 3.92 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 127.45 2.3 . . . . 0.0 109.173 166.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.46 -50.08 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.799 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -128.73 139.95 51.97 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -158.67 156.56 30.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 108.716 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -148.52 162.7 39.11 Favored 'General case' 0 CA--C 1.523 -0.072 0 CA-C-N 118.869 0.759 . . . . 0.0 109.563 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.5 t -141.93 91.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -131.54 120.28 22.69 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.075 -1.016 . . . . 0.0 110.046 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.75 -11.37 80.75 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.05 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.27 155.14 6.2 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.999 1.285 . . . . 0.0 115.306 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 t -133.39 173.81 14.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 127.646 2.379 . . . . 0.0 107.915 -163.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -140.81 162.14 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 122.866 0.466 . . . . 0.0 110.651 164.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.06 89.13 7.26 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.291 1.836 . . . . 0.0 110.491 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.14 101.69 2.38 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 124.233 0.921 . . . . 0.0 112.311 -166.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.05 -164.56 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.914 1.286 . . . . 0.0 110.603 -172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -74.96 165.06 25.86 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.663 -1.273 . . . . 0.0 108.896 168.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.89 -20.32 0.03 OUTLIER Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.317 -0.864 . . . . 0.0 113.471 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 t 75.66 -63.86 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 127.282 2.233 . . . . 0.0 110.925 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p 52.0 162.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 130.622 3.569 . . . . 0.0 112.734 -166.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -150.28 -68.4 0.19 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.034 -1.041 . . . . 0.0 110.163 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.93 154.68 88.79 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 124.808 1.243 . . . . 0.0 112.014 174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.24 170.98 13.47 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.864 3.709 . . . . 0.0 113.69 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.3 ttp -118.78 147.51 43.81 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -118.9 125.12 48.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 166.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.16 46.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.85 126.9 75.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.95 102.73 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 -165.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 m -119.43 133.07 55.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.15 135.47 51.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.52 1.528 . . . . 0.0 107.709 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -112.65 153.02 28.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -169.85 2.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 168.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.443 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -61.7 76.42 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.85 1.66 . . . . 0.0 109.631 164.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.89 16.69 23.07 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 117.983 -1.454 . . . . 0.0 116.162 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -157.12 167.46 30.33 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 121.15 2.475 . . . . 0.0 111.377 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -104.35 120.42 41.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.646 1.179 . . . . 0.0 108.944 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.3 pt -118.61 -20.33 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.76 132.41 16.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 120.123 1.329 . . . . 0.0 109.244 -173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -157.58 102.35 1.88 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -156.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -135.16 137.94 43.2 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 126.074 1.749 . . . . 0.0 109.681 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.49 129.25 36.94 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.995 1.318 . . . . 0.0 110.919 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -114.64 135.54 54.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 127.504 2.322 . . . . 0.0 107.189 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -163.04 110.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 118.85 0.75 . . . . 0.0 109.262 172.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -134.74 178.11 7.27 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.374 0.669 . . . . 0.0 111.158 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 33.92 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.078 1.751 . . . . 0.0 111.179 -175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.6 t0 44.21 84.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.668 2.387 . . . . 0.0 113.389 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.05 42.65 0.02 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 124.22 0.914 . . . . 0.0 111.413 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.46 131.06 12.27 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.398 1.099 . . . . 0.0 108.081 169.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.73 117.14 21.15 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 tp -142.8 138.82 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.396 1.878 . . . . 0.0 106.332 164.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.21 1.76 7.09 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 -176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.21 164.57 29.89 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 119.672 1.123 . . . . 0.0 111.606 -172.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -146.47 -2.49 0.67 Allowed 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 124.643 1.214 . . . . 0.0 113.8 174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -149.2 168.27 23.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.01 146.12 42.7 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 128.106 2.563 . . . . 0.0 110.956 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -143.52 137.91 28.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.52 1.528 . . . . 0.0 108.536 169.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.3 mt -150.38 152.2 34.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.888 2.475 . . . . 0.0 106.72 -175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.8 t80 -147.69 136.6 22.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.12 0.873 . . . . 0.0 109.882 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.79 112.26 13.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.551 1.541 . . . . 0.0 109.403 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 p30 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.342 1.457 . . . . 0.0 108.849 166.412 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 75.1 163.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 127.371 2.454 . . . . 0.0 111.036 152.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -170.64 179.67 3.2 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.696 1.599 . . . . 0.0 107.171 -158.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -125.76 158.79 34.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.83 1.252 . . . . 0.0 110.067 171.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.64 54.08 1.49 Allowed Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.327 0.651 . . . . 0.0 112.746 171.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.39 1.1 9.11 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.527 2.818 . . . . 0.0 113.774 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 -61.02 7.08 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.72 178.56 9.69 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.39 1.948 . . . . 0.0 114.925 168.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.96 142.31 54.02 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 155.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.4 120.77 4.29 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.057 0.837 . . . . 0.0 113.102 169.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.19 174.55 7.6 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.262 1.425 . . . . 0.0 109.926 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.9 mtm -90.6 158.4 16.98 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 118.413 0.551 . . . . 0.0 109.994 163.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -144.58 167.81 21.64 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.387 1.075 . . . . 0.0 110.543 165.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.91 143.27 46.84 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.901 HG23 HG22 ' A' ' 99' ' ' VAL . 8.3 p -126.96 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.55 122.19 30.49 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -170.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -129.12 113.58 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 1.7 mp0 -96.43 91.2 5.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 169.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -76.61 161.5 28.52 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 164.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.4 p -162.8 173.97 13.08 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 119.584 -1.947 . . . . 0.0 112.74 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.56 -93.82 0.32 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.415 1.96 . . . . 0.0 110.087 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 36.47 3.54 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.196 1.398 . . . . 0.0 110.381 -170.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -44.26 -23.44 0.11 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 130.419 3.488 . . . . 0.0 115.969 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -58.37 6.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -124.4 59.35 1.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 121.032 1.742 . . . . 0.0 111.368 171.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -118.22 100.23 7.37 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.651 1.18 . . . . 0.0 110.6 168.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.421 HD11 ' HA3' ' A' ' 84' ' ' GLY . 10.5 mm -76.88 78.68 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 124.878 1.271 . . . . 0.0 111.993 -172.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB2' HG11 ' A' ' 81' ' ' VAL . 1.8 tptm -156.45 168.2 28.08 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 165.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.0 m -87.94 119.67 28.53 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.389 1.876 . . . . 0.0 108.797 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.1 t -76.88 100.51 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 162.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -47.21 112.34 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 O-C-N 121.697 -0.627 . . . . 0.0 111.414 140.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.67 108.03 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 124.475 1.109 . . . . 0.0 110.81 149.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 34' ' ' ALA . 1.3 p -151.22 -171.46 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.894 -1.129 . . . . 0.0 109.352 164.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' A' ' 37' ' ' THR . . . -117.34 111.88 19.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 164.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -72.19 47.48 0.16 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.032 1.333 . . . . 0.0 112.071 171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.1 -3.12 0.03 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.246 1.879 . . . . 0.0 115.362 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' CB ' ' A' ' 34' ' ' ALA . 4.7 t -138.24 168.56 19.48 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 121.503 2.651 . . . . 0.0 109.284 170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.17 152.28 34.91 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.87 156.5 30.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.297 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -107.38 131.9 53.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 124.05 0.843 . . . . 0.0 110.028 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -85.27 123.28 30.58 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 124.405 1.066 . . . . 0.0 108.164 168.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.58 -1.68 8.99 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.094 -1.392 . . . . 0.0 114.003 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.21 -52.19 59.68 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 120.381 2.09 . . . . 0.0 109.849 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.3 p -143.15 -7.85 0.8 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.866 2.066 . . . . 0.0 111.331 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.3 55.46 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.83 1.205 . . . . 0.0 111.674 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.77 147.09 52.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.964 1.382 . . . . 0.0 107.764 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.9 t -107.2 140.63 39.77 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 125.621 1.568 . . . . 0.0 107.118 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 49.6 mt -138.07 139.7 39.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.225 1.41 . . . . 0.0 108.428 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.43 168.86 6.63 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.054 1.342 . . . . 0.0 110.46 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 p -144.19 159.02 53.93 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 123.815 0.846 . . . . 0.0 111.067 -166.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -69.89 168.93 66.26 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 CA-C-N 119.076 0.706 . . . . 0.0 112.669 -4.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.1 t -144.09 139.01 24.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 175.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.5 mt -140.6 112.56 4.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.18 168.69 11.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.072 0.949 . . . . 0.0 109.636 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 95.2 p -134.8 -177.81 4.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.598 1.159 . . . . 0.0 110.493 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.16 -41.89 65.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.741 1.217 . . . . 0.0 111.564 174.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -61.05 -24.54 66.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.578 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -90.94 -11.75 38.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.888 0.767 . . . . 0.0 111.012 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.02 49.32 1.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.099 0.959 . . . . 0.0 111.063 174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.82 9.81 17.67 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.578 1.551 . . . . 0.0 111.712 163.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 m -79.03 169.61 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 120.545 -1.347 . . . . 0.0 108.985 166.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.33 -42.17 3.97 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.868 -1.145 . . . . 0.0 110.34 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.431 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -146.97 134.63 21.06 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -165.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.26 128.29 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 O-C-N 124.402 1.064 . . . . 0.0 108.307 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.7 m -124.98 89.61 3.09 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.999 1.719 . . . . 0.0 107.367 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.1 mt -95.1 145.15 25.19 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.9 t -155.02 145.18 21.85 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.967 0.889 . . . . 0.0 112.517 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 40.5 p -71.87 132.49 44.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.498 1.519 . . . . 0.0 110.464 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 59.8 p -69.92 -51.7 30.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.611 0.719 . . . . 0.0 109.156 172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.38 -145.53 8.61 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 127.118 2.294 . . . . 0.0 110.096 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -84.82 126.09 33.15 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.662 -1.493 . . . . 0.0 112.776 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -77.41 137.48 38.73 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 162.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.7 mm -93.86 -54.74 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.764 1.226 . . . . 0.0 107.789 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -126.09 138.26 53.68 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 126.155 1.782 . . . . 0.0 106.87 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -158.04 155.26 29.0 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.65 1.58 . . . . 0.0 108.055 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.31 165.25 30.71 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 109.758 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 99' ' ' VAL . 30.8 t -138.4 143.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.86 175.33 11.34 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.46 -179.21 42.14 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.58 93.8 0.29 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -171.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 28' ' ' LYS . 18.8 m -141.94 -172.33 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.051 1.34 . . . . 0.0 110.239 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.1 p -104.49 162.28 4.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.569 0.699 . . . . 0.0 110.622 -169.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -65.56 140.97 58.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.911 1.284 . . . . 0.0 108.262 165.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA3' HD11 ' A' ' 27' ' ' ILE . . . -120.51 -179.42 16.28 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.142 0.877 . . . . 0.0 112.333 177.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 56.59 18.45 3.62 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.077 2.551 . . . . 0.0 114.328 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.8 t70 65.84 112.72 0.03 OUTLIER 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.179 2.192 . . . . 0.0 111.204 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -143.47 171.27 25.27 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 121.092 -1.005 . . . . 0.0 110.741 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.8 m -97.28 -29.05 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 118.301 -0.856 . . . . 0.0 113.276 -168.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.7 p -172.49 -36.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.187 1.395 . . . . 0.0 110.141 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 57.57 163.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.599 2.359 . . . . 0.0 112.254 -165.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.52 164.78 49.98 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 121.03 -1.044 . . . . 0.0 110.664 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HB3' ' HB3' ' A' ' 114' ' ' ARG . 64.0 Cg_endo -79.99 86.71 1.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.149 2.566 . . . . 0.0 111.815 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.3 mtt -66.1 104.92 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.473 1.909 . . . . 0.0 108.416 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.17 143.87 53.94 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.46 137.05 46.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.162 1.785 . . . . 0.0 107.262 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.09 137.7 55.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.8 m -141.34 111.56 6.8 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.901 HG22 HG23 ' A' ' 15' ' ' VAL . 13.9 t -97.51 112.26 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -86.64 143.66 27.52 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.627 1.171 . . . . 0.0 108.704 174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 102' ' ' ASN . 11.4 tptt -97.87 176.94 5.61 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 167.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -45.3 88.96 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.516 1.926 . . . . 0.0 112.225 173.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.7 35.52 66.82 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.139 -1.923 . . . . 0.0 114.617 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.62 169.4 22.96 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.963 2.381 . . . . 0.0 111.956 160.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -77.62 149.03 34.82 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 159.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.12 -9.31 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 119.213 0.915 . . . . 0.0 112.574 166.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -166.63 156.26 11.34 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.46 1.104 . . . . 0.0 109.43 -173.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -160.46 142.63 12.82 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.073 2.149 . . . . 0.0 107.813 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -141.85 163.82 31.86 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.197 1.399 . . . . 0.0 108.97 167.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.99 162.05 34.35 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.222 1.409 . . . . 0.0 110.204 161.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 1.7 pp -135.58 146.46 48.0 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 122.835 0.454 . . . . 0.0 111.676 167.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -155.13 122.07 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.982 2.113 . . . . 0.0 106.15 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -148.15 139.65 23.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.405 1.457 . . . . 0.0 110.389 167.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -156.64 120.37 4.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.558 1.543 . . . . 0.0 107.461 176.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.2 t0 44.92 57.65 4.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.179 2.192 . . . . 0.0 111.905 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.88 163.64 39.01 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.401 1.477 . . . . 0.0 112.6 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.2 mmmp? -140.62 174.37 10.58 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.497 1.119 . . . . 0.0 108.592 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -75.01 -45.46 41.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.63 -0.7 . . . . 0.0 109.735 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -71.85 173.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.088 0.955 . . . . 0.0 111.336 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.07 69.21 0.77 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 125.13 1.372 . . . . 0.0 110.625 173.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.48 158.32 42.41 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.458 1.903 . . . . 0.0 108.396 164.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -171.77 62.68 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -139.1 158.04 44.9 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.171 -1.581 . . . . 0.0 109.46 167.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -154.71 128.56 8.75 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.707 1.139 . . . . 0.0 111.183 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.22 132.89 23.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.422 0.689 . . . . 0.0 110.934 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.1 mp -138.81 156.07 47.63 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.28 1.832 . . . . 0.0 108.775 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.31 147.85 26.1 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.916 1.234 . . . . 0.0 111.849 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -142.94 114.21 7.84 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.836 1.254 . . . . 0.0 109.709 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.3 p30 . . . . . 0 C--O 1.248 0.985 0 O-C-N 120.485 -1.385 . . . . 0.0 110.29 166.076 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.423 -3.071 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.45 169.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 126.877 2.163 . . . . 0.0 111.695 139.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -160.16 175.5 12.84 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -158.31 66.9 0.46 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.283 0.0 OUTLIER -110.37 71.43 0.65 Allowed Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.531 1.132 . . . . 0.0 113.243 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.45 0.32 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.708 1.606 . . . . 0.0 113.935 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.92 11.43 83.72 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.94 1.245 . . . . 0.0 114.201 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.54 151.75 8.89 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 120.707 -1.466 . . . . 0.0 109.536 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -145.4 162.13 38.02 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.871 1.668 . . . . 0.0 109.577 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.75 -179.1 41.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 128.181 2.8 . . . . 0.0 112.257 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.09 164.97 25.08 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.792 1.237 . . . . 0.0 110.265 -176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -84.94 160.89 20.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.551 0.691 . . . . 0.0 109.593 163.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -153.88 170.58 20.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.764 1.626 . . . . 0.0 106.861 162.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.22 134.19 24.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.706 HG23 HG22 ' A' ' 99' ' ' VAL . 10.8 p -118.57 159.7 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 114.31 7.71 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 tp -123.94 133.19 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -174.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -130.93 94.98 3.71 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -83.89 134.98 34.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 166.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 p -139.84 179.02 6.83 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.258 1.423 . . . . 0.0 109.55 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.28 -146.43 43.39 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 118.898 0.772 . . . . 0.0 111.464 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.48 54.8 3.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 123.035 1.398 . . . . 0.0 109.075 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -60.14 -24.25 64.56 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.303 1.041 . . . . 0.0 113.143 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -76.54 -23.23 53.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.646 1.578 . . . . 0.0 111.731 -172.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 m -59.43 -34.37 72.42 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.844 0.747 . . . . 0.0 111.492 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -80.43 110.8 16.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.706 1.602 . . . . 0.0 108.834 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.05 105.87 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.96 174.94 12.14 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 121.284 -0.885 . . . . 0.0 111.744 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.8 m -132.67 173.75 11.02 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.398 1.879 . . . . 0.0 109.132 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -141.14 134.6 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.897 1.279 . . . . 0.0 108.36 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.19 89.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.3 t -138.92 90.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 51' ' ' PRO . 9.7 p -155.89 164.99 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 121.013 -1.054 . . . . 0.0 112.071 173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -92.46 140.41 29.6 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -93.57 18.68 9.58 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.01 -60.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 O-C-N 120.922 -1.111 . . . . 0.0 114.457 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t -82.46 170.2 15.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.041 0.92 . . . . 0.0 109.892 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -74.21 160.01 31.74 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 122.646 1.212 . . . . 0.0 111.221 171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.99 168.28 10.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.553 168.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -133.12 131.02 40.01 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -76.17 147.66 38.3 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 123.582 0.551 . . . . 0.0 110.151 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.67 -10.13 85.55 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 118.342 -1.255 . . . . 0.0 113.655 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.52 -65.74 0.64 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.841 1.321 . . . . 0.0 109.853 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.0 p -130.39 0.53 4.54 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.775 1.23 . . . . 0.0 111.398 -156.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.39 36.3 92.49 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -77.36 149.82 35.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 p -94.84 127.48 40.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.888 1.275 . . . . 0.0 107.844 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.66 151.68 40.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.611 1.164 . . . . 0.0 108.708 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.48 -177.91 1.02 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.449 1.1 . . . . 0.0 110.849 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 2.1 p -161.05 122.44 1.67 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 117.437 -1.268 . . . . 0.0 110.505 -159.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HA ' HG21 ' A' ' 33' ' ' VAL . 11.0 Cg_endo -105.7 161.15 2.99 Favored 'Cis proline' 0 C--N 1.354 0.833 0 N-CA-C 116.304 1.617 . . . . 0.0 116.304 14.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' VAL . 5.7 m -158.41 62.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.014 -2.812 . . . . 0.0 104.497 -151.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.1 mt -78.75 105.99 8.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 C-N-CA 131.589 3.955 . . . . 0.0 107.545 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 54' ' ' LEU . 2.1 mm? -70.28 150.05 46.78 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -121.1 -177.72 3.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.806 1.243 . . . . 0.0 109.739 162.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -52.68 -40.95 63.4 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 127.763 2.425 . . . . 0.0 113.527 -162.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -50.6 -55.45 16.25 Favored 'General case' 0 N--CA 1.427 -1.602 0 C-N-CA 128.778 2.831 . . . . 0.0 110.439 173.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -74.58 -28.69 61.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.166 0.986 . . . . 0.0 110.428 -168.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.84 12.99 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.556 1.942 . . . . 0.0 113.843 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.96 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 131.603 3.961 . . . . 0.0 115.387 171.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 m -123.05 153.85 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 125.633 1.573 . . . . 0.0 111.099 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -70.4 -80.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.829 0.823 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -149.67 151.49 33.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 -161.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.1 p -170.92 163.53 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.767 0.827 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.2 m -120.54 84.3 2.2 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.422 1.489 . . . . 0.0 109.724 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -80.47 145.23 32.01 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.626 -0.671 . . . . 0.0 109.935 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -153.04 156.87 39.59 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.304 -0.873 . . . . 0.0 110.266 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -76.38 143.73 40.51 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 110.1 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.1 p -72.28 -57.07 4.52 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -111.3 -103.77 2.74 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.195 1.855 . . . . 0.0 111.445 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -130.0 133.65 46.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.9 1.85 . . . . 0.0 111.955 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.9 131.94 37.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.234 1.414 . . . . 0.0 109.24 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.18 -58.94 3.93 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 125.181 1.393 . . . . 0.0 108.742 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -121.08 161.48 21.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.649 2.379 . . . . 0.0 105.772 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.82 -178.9 5.76 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.811 2.044 . . . . 0.0 107.513 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -165.19 175.57 9.19 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.349 1.059 . . . . 0.0 109.336 155.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 99' ' ' VAL . 58.8 t -152.97 95.81 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.34 146.38 32.53 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.146 -1.596 . . . . 0.0 110.39 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.77 72.95 0.22 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -75.23 161.11 52.89 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 160.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.7 t -120.84 165.2 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -122.83 157.74 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -73.64 96.92 2.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.7 0.12 62.16 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 117.551 -1.694 . . . . 0.0 113.916 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 54.76 -171.31 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.927 1.691 . . . . 0.0 111.271 -168.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 51.32 94.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.8 2.84 . . . . 0.0 111.244 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.55 99.06 0.44 Allowed Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.893 1.235 . . . . 0.0 110.298 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.94 133.38 61.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.422 1.489 . . . . 0.0 108.134 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.3 m -149.58 167.73 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.989 1.316 . . . . 0.0 109.628 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.43 -61.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.534 -0.728 . . . . 0.0 111.682 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -140.05 160.98 58.23 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 109.608 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.19 108.71 2.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.283 2.655 . . . . 0.0 110.657 173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.23 114.45 12.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 159.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.41 151.45 44.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 164.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.48 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -127.04 142.31 51.57 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.4 t -131.16 144.14 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 163.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.46 122.53 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -139.94 126.24 20.06 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.743 HG21 HG21 ' A' ' 77' ' ' VAL . 33.5 t -113.82 125.27 71.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.027 0.918 . . . . 0.0 109.249 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -102.47 119.64 39.16 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.383 1.473 . . . . 0.0 107.574 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -69.21 172.97 6.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 165.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.48 89.2 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.498 1.519 . . . . 0.0 111.895 162.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.61 43.68 11.74 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.597 1.57 . . . . 0.0 112.57 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.95 164.59 2.32 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 128.087 2.555 . . . . 0.0 110.777 162.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -83.9 146.77 27.87 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 166.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.1 pt -138.73 -4.78 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.97 147.19 24.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 172.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.37 117.1 2.42 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.617 1.167 . . . . 0.0 107.883 175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -139.57 152.26 46.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.326 1.05 . . . . 0.0 109.446 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 p -149.24 138.77 21.68 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HG ' ' HB2' ' A' ' 95' ' ' TRP . 3.2 pp -130.38 151.72 50.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.834 1.253 . . . . 0.0 108.533 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.8 t -150.48 119.83 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 124.119 0.967 . . . . 0.0 110.038 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -149.76 178.82 8.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.546 1.138 . . . . 0.0 111.445 165.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 126.94 3.51 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.3 21.0 t0 43.6 25.43 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 129.847 3.259 . . . . 0.0 115.829 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 58.94 79.79 0.1 OUTLIER Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.453 -1.405 . . . . 0.0 112.128 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 42.8 0.18 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.471 -1.017 . . . . 0.0 113.534 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 66.27 1.5 2.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.784 2.434 . . . . 0.0 114.025 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.25 174.26 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 C-N-CA 125.217 1.407 . . . . 0.0 111.8 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.69 123.05 23.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.598 2.359 . . . . 0.0 110.975 174.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.1 174.18 9.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.548 1.139 . . . . 0.0 109.334 171.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.34 171.41 4.01 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.818 -1.176 . . . . 0.0 109.56 165.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -65.93 173.71 2.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.499 1.119 . . . . 0.0 110.899 166.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.8 mt -113.98 166.12 11.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 124.073 0.949 . . . . 0.0 109.353 165.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.5 p30 -176.05 97.42 0.06 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.807 1.643 . . . . 0.0 108.033 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 125' ' ' ASN . 1.5 mt -127.98 151.9 48.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.67 156.68 48.21 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 127.996 2.518 . . . . 0.0 104.394 170.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 75' ' ' PHE . 75.4 m-85 -147.53 149.05 31.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 C--O 1.258 1.524 0 C-N-CA 129.185 2.994 . . . . 0.0 106.581 171.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.974 0 N-CA-C 106.63 -2.588 . . . . 0.0 106.63 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.18 150.44 10.9 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 133.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -144.7 108.54 4.71 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.377 0.99 . . . . 0.0 109.082 172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -74.25 125.46 28.47 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.835 . . . . 0.0 109.947 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -107.2 84.81 1.8 Allowed Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 123.315 0.646 . . . . 0.0 110.908 171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.67 82.23 1.73 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.827 3.018 . . . . 0.0 110.476 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.33 -148.01 3.61 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 156.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.47 152.24 5.62 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 127.734 2.587 . . . . 0.0 110.047 -171.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.299 0.0 OUTLIER -116.73 131.24 57.0 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.392 1.096 . . . . 0.0 111.719 -158.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.32 164.57 21.29 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.243 0.925 . . . . 0.0 114.938 -170.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -149.21 172.85 14.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.222 2.209 . . . . 0.0 111.062 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 77.7 mtp -85.86 146.81 26.57 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 124.445 1.098 . . . . 0.0 109.433 169.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -155.22 162.29 40.96 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.953 0.901 . . . . 0.0 110.989 165.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -132.19 134.48 45.41 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 32' ' ' VAL . 3.9 p -117.33 143.56 27.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 112.86 20.54 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.404 HD11 ' CH2' ' A' ' 95' ' ' TRP . 2.0 tp -120.19 138.31 51.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 39.3 mt-10 -149.19 67.68 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -153.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.12 150.02 25.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.818 1.247 . . . . 0.0 109.133 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 t -156.36 -174.18 4.83 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.68 -152.7 50.16 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 124.982 1.277 . . . . 0.0 112.04 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.09 53.24 1.68 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.75 1.262 . . . . 0.0 110.715 -173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -64.95 -35.2 80.39 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.608 -1.307 . . . . 0.0 112.0 -168.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -84.48 32.56 0.51 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.833 0.853 . . . . 0.0 111.914 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 m -140.75 37.75 1.81 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.86 1.264 . . . . 0.0 110.707 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -143.69 125.51 15.15 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.757 1.223 . . . . 0.0 109.029 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.17 87.23 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.36 -166.58 1.79 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.592 1.157 . . . . 0.0 109.012 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -153.24 169.99 21.69 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 54' ' ' LEU . 9.4 p -100.59 170.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 170.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.23 105.27 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 150.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.576 HG11 HG11 ' A' ' 15' ' ' VAL . 11.6 t -148.49 123.17 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 153.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 52' ' ' VAL . 11.6 p -162.83 168.02 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.732 1.213 . . . . 0.0 109.437 160.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.537 ' H ' HD23 ' A' ' 39' ' ' LEU . . . -76.87 133.13 39.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.6 -0.688 . . . . 0.0 109.207 165.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.81 7.53 26.61 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.28 -60.41 0.03 OUTLIER Glycine 0 C--N 1.334 0.418 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.872 -167.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 t -96.44 -179.25 4.56 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.413 0.685 . . . . 0.0 109.789 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.03 163.0 26.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 123.026 1.393 . . . . 0.0 111.11 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -94.79 153.37 17.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.232 -1.349 . . . . 0.0 108.916 169.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.0 135.68 54.0 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.137 1.375 . . . . 0.0 107.524 174.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.83 174.67 4.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.84 -6.48 22.88 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.533 1.54 . . . . 0.0 114.833 169.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.29 -61.45 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 121.187 2.494 . . . . 0.0 109.347 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -135.07 11.55 3.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.368 1.867 . . . . 0.0 110.324 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.46 31.16 79.36 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 124.785 1.183 . . . . 0.0 112.315 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.64 163.4 21.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.711 0.755 . . . . 0.0 110.287 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 p -101.15 122.13 43.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.206 1.802 . . . . 0.0 108.928 -174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.32 175.83 5.73 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.953 1.301 . . . . 0.0 108.993 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.0 -178.19 7.03 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.549 0.74 . . . . 0.0 110.265 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.2 p -155.63 158.33 31.78 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.515 1.126 . . . . 0.0 109.425 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -67.42 174.36 32.02 Favored 'Cis proline' 0 CA--C 1.546 1.118 0 CA-C-N 119.595 0.891 . . . . 0.0 112.127 -13.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' H ' HG11 ' A' ' 33' ' ' VAL . 56.5 t -151.4 110.33 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 129.597 3.159 . . . . 0.0 103.88 -172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.9 mt -128.1 105.32 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -81.02 127.1 32.21 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -172.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 m -88.36 -177.66 5.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.108 0.963 . . . . 0.0 110.642 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -49.74 -44.49 48.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.542 1.537 . . . . 0.0 112.44 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.57 -36.86 60.28 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.586 0.554 . . . . 0.0 110.348 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -67.61 -32.9 73.94 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.675 1.19 . . . . 0.0 110.614 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.52 2.74 0.84 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.895 1.678 . . . . 0.0 113.671 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.29 66.37 6.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.503 1.521 . . . . 0.0 109.125 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.7 m -135.65 161.17 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.318 2.247 . . . . 0.0 109.322 165.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -88.56 -80.39 0.28 Allowed 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.241 1.017 . . . . 0.0 109.052 174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 141.73 31.96 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 120.349 -1.47 . . . . 0.0 112.719 -169.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.9 t -156.12 155.21 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 126.209 1.804 . . . . 0.0 107.842 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -137.76 121.64 17.67 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.307 1.843 . . . . 0.0 107.733 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' HB3' HD12 ' A' ' 39' ' ' LEU . 32.8 mt -136.97 153.64 50.64 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.516 0.598 . . . . 0.0 111.077 -172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.8 145.59 25.08 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.966 0.412 . . . . 0.0 112.096 -159.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 p -67.08 144.75 55.94 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.736 -0.602 . . . . 0.0 111.221 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -71.36 -54.05 12.07 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.44 -87.31 0.8 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.861 1.219 . . . . 0.0 112.613 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -132.47 120.94 22.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.822 1.811 . . . . 0.0 108.884 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.03 172.41 12.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 159.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.2 mm -108.98 -38.02 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.474 1.51 . . . . 0.0 108.671 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -128.46 162.31 27.48 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.285 1.834 . . . . 0.0 108.204 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' CE ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -159.41 63.71 0.38 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.805 1.288 . . . . 0.0 110.521 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.03 152.0 25.06 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.532 1.533 . . . . 0.0 111.271 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.1 t -144.7 67.17 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 -175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -138.12 167.14 22.42 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.395 -0.816 . . . . 0.0 112.688 -172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -125.54 -94.47 0.98 Allowed Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.41 125.76 4.09 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 107.28 -2.328 . . . . 0.0 107.28 -160.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.9 p -124.91 169.87 15.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 125.598 1.559 . . . . 0.0 107.819 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.22 -168.45 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.115 0.566 . . . . 0.0 109.608 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -109.67 80.36 1.31 Allowed 'General case' 0 C--O 1.239 0.533 0 O-C-N 120.831 -1.168 . . . . 0.0 108.589 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -93.86 -0.39 66.4 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 118.531 -1.149 . . . . 0.0 114.498 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 45.24 68.72 0.53 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.443 2.697 . . . . 0.0 113.426 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -59.61 -62.25 2.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.858 1.263 . . . . 0.0 111.042 166.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 168.51 -163.57 37.29 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -165.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.79 158.14 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.976 1.71 . . . . 0.0 107.891 -174.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 t 60.92 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.032 1.733 . . . . 0.0 109.558 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -134.0 174.62 10.28 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.936 1.294 . . . . 0.0 109.663 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -72.25 159.32 85.72 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.276 -0.89 . . . . 0.0 111.121 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -66.17 85.12 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 124.525 3.483 . . . . 0.0 111.175 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.94 141.88 48.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 163.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -111.77 163.48 14.11 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 164.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.404 ' CH2' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -153.92 90.84 1.4 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 18' ' ' GLU . 21.3 t -89.98 142.37 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -140.26 104.49 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.13 113.79 17.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.38 116.31 51.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 109.611 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.9 134.21 34.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' CE ' ' CE2' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -76.46 -175.08 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 164.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -45.64 12.8 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 130.973 3.709 . . . . 0.0 117.624 162.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.53 36.43 0.07 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-N 121.023 1.738 . . . . 0.0 113.043 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.3 pttm -169.09 174.82 6.04 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 126.467 1.907 . . . . 0.0 109.089 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -100.29 142.54 31.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.178 1.791 . . . . 0.0 107.245 168.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.11 -5.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -151.72 153.73 34.92 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 119.641 1.109 . . . . 0.0 108.17 169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.65 63.53 0.26 Allowed 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 124.238 0.961 . . . . 0.0 110.768 -173.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -76.56 157.3 32.14 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 120.897 -1.127 . . . . 0.0 109.879 172.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 t -147.21 126.12 12.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 166.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.0 mp -104.54 139.6 39.19 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.782 1.233 . . . . 0.0 108.196 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.65 112.29 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 170.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -130.99 111.19 11.81 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.241 1.016 . . . . 0.0 109.395 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 147.33 24.81 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 126.676 1.991 . . . . 0.0 107.777 177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 52.52 -173.6 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.233 2.213 . . . . 0.0 112.713 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.77 112.19 4.45 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 107.794 -2.122 . . . . 0.0 107.794 162.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -134.7 30.31 3.45 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 111.633 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 74.79 171.19 0.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.726 2.81 . . . . 0.0 110.33 -167.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.15 140.04 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 120.694 -1.254 . . . . 0.0 108.764 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.32 -172.76 4.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.922 1.289 . . . . 0.0 110.202 169.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.09 164.94 21.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.011 0.924 . . . . 0.0 109.779 174.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -147.86 1.68 0.68 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 118.901 2.926 . . . . 0.0 118.901 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -99.87 167.47 10.5 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.843 1.656 . . . . 0.0 111.757 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.45 116.92 31.05 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 127.669 2.388 . . . . 0.0 107.452 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -138.7 64.3 1.49 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.291 0.636 . . . . 0.0 109.836 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.06 150.05 25.3 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 170.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -148.01 143.36 27.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -144.73 148.84 34.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.877 2.071 . . . . 0.0 107.771 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.259 1.572 0 C-N-CA 128.678 2.791 . . . . 0.0 107.119 166.554 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.639 0 N-CA-C 105.205 -3.158 . . . . 0.0 105.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.42 147.19 25.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 -141.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -155.34 175.82 13.38 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.062 1.745 . . . . 0.0 107.713 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -138.34 164.42 29.33 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 120.248 1.385 . . . . 0.0 112.533 -170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -125.11 79.74 65.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 127.102 2.161 . . . . 0.0 105.862 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.47 64.63 7.32 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.356 2.704 . . . . 0.0 109.806 176.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.53 89.91 1.2 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.3 24.99 4.92 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 123.913 0.768 . . . . 0.0 114.959 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt -127.35 156.33 42.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 117.945 0.872 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.58 153.77 30.4 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.357 1.932 . . . . 0.0 112.855 173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.36 155.54 42.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.604 1.961 . . . . 0.0 108.684 173.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 mtt -73.28 164.02 27.26 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.152 -1.019 . . . . 0.0 109.663 167.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -145.65 173.73 11.81 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.605 1.193 . . . . 0.0 109.122 157.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -148.16 146.24 28.65 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 103.803 -2.666 . . . . 0.0 103.803 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p -143.86 154.31 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 120.66 -1.275 . . . . 0.0 108.084 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 m -145.98 87.89 1.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.411 -1.699 . . . . 0.0 106.411 -173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -78.9 144.92 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -132.46 108.73 9.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 159.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.8 176.16 9.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 158.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p -171.54 174.33 4.43 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.832 2.053 . . . . 0.0 107.561 171.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.42 -101.05 0.29 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.579 1.562 . . . . 0.0 113.438 169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.04 54.79 0.95 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 123.952 1.834 . . . . 0.0 109.021 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.91 -21.17 60.73 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.821 1.249 . . . . 0.0 112.999 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.85 26.48 2.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 111.786 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.1 m -121.13 44.44 2.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.52 1.153 . . . . 0.0 108.999 166.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -141.82 158.77 43.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 128.952 2.901 . . . . 0.0 106.329 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -129.25 97.44 3.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.074 1.35 . . . . 0.0 108.104 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 80' ' ' GLY . 9.0 mmtt -159.05 -164.88 1.49 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.004 0.922 . . . . 0.0 110.302 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 p -146.13 154.29 41.64 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.202 1.801 . . . . 0.0 108.094 173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.543 HG23 HD21 ' A' ' 59' ' ' LEU . 43.6 t -90.0 93.61 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 173.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.0 t -84.37 78.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 162.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.0 t -135.89 100.63 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.6 p -149.78 -178.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' A' ' 72' ' ' ALA . . . -97.2 144.43 27.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.68 32.47 0.73 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.537 1.135 . . . . 0.0 111.054 170.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -168.12 -63.67 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.264 -0.898 . . . . 0.0 111.548 171.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -74.16 168.62 19.21 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.414 1.107 . . . . 0.0 111.758 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -77.11 156.26 31.81 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.948 0.88 . . . . 0.0 109.609 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -103.2 137.06 41.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -89.83 120.94 31.5 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 166.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -74.34 121.58 21.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' H ' HD23 ' A' ' 66' ' ' LEU . . . -63.68 -24.9 68.46 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-O 118.007 -1.44 . . . . 0.0 112.629 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.47 -48.52 71.7 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 125.245 1.418 . . . . 0.0 111.006 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.02 -26.62 5.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.467 1.107 . . . . 0.0 110.526 -173.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.84 7.17 78.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.677 1.132 . . . . 0.0 111.955 -168.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.65 155.51 37.73 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.723 1.262 . . . . 0.0 108.847 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.0 p -113.43 128.82 56.58 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -128.15 152.39 48.08 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.373 0.669 . . . . 0.0 109.633 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.65 163.02 17.19 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.189 1.396 . . . . 0.0 110.267 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 p -148.45 154.3 41.39 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -167.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.92 157.68 96.97 Favored 'Cis proline' 0 CA--C 1.535 0.571 0 CA-C-O 121.643 0.601 . . . . 0.0 111.167 0.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -148.95 125.21 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.42 122.75 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 127.341 2.256 . . . . 0.0 105.328 -170.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -81.94 129.06 34.66 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 76.4 p -78.31 173.51 12.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -55.67 -30.68 61.46 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.052 1.341 . . . . 0.0 112.165 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -69.06 -44.86 71.74 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.278 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -71.29 -20.99 62.14 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.257 -0.902 . . . . 0.0 111.579 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.543 HD21 HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -68.14 -1.59 6.32 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.48 2.312 . . . . 0.0 114.62 -177.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.25 45.42 0.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.154 1.782 . . . . 0.0 111.877 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.86 167.21 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 126.056 1.742 . . . . 0.0 110.956 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -90.44 -59.23 2.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.089 0.555 . . . . 0.0 112.334 -169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 163.78 38.71 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.071 -1.018 . . . . 0.0 113.639 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.9 p -160.17 160.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 118.363 0.529 . . . . 0.0 110.807 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -116.03 89.04 3.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.749 1.62 . . . . 0.0 109.221 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 42' ' ' GLY . 94.9 mt -80.83 146.16 31.04 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.395 -0.816 . . . . 0.0 109.683 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -154.3 161.6 41.68 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.53 0.681 . . . . 0.0 110.215 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.414 HG21 ' HB2' ' A' ' 72' ' ' ALA . 23.6 p -88.46 149.37 23.71 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.988 1.315 . . . . 0.0 111.128 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -84.51 -38.89 19.51 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.078 -0.388 . . . . 0.0 111.421 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -123.79 -96.96 1.23 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.87 1.7 . . . . 0.0 110.834 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -137.29 125.11 22.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.664 2.232 . . . . 0.0 110.827 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.52 141.37 44.87 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.678 -0.639 . . . . 0.0 110.702 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mt -89.13 -55.94 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.26 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -123.98 160.7 27.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.607 1.963 . . . . 0.0 107.641 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -167.01 157.71 11.76 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.783 2.833 . . . . 0.0 107.479 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.23 151.27 35.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.21 1.368 . . . . 0.0 112.182 170.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' A' ' 99' ' ' VAL . 28.0 t -137.49 51.17 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 126.782 2.033 . . . . 0.0 108.022 -172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.5 m -73.19 169.96 15.97 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.601 -1.312 . . . . 0.0 108.797 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -158.82 97.62 0.16 Allowed Glycine 0 C--O 1.222 -0.603 0 N-CA-C 105.804 -2.919 . . . . 0.0 105.804 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 28' ' ' LYS . . . 179.56 159.36 23.4 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 -177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.71 -177.2 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.5 0 C-N-CA 123.554 0.742 . . . . 0.0 109.298 -166.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.95 155.1 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 161.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -70.7 127.97 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.15 1.78 . . . . 0.0 108.891 168.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.79 52.2 0.69 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 124.838 1.209 . . . . 0.0 110.314 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 48.57 70.84 0.41 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.956 2.102 . . . . 0.0 110.729 -170.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.04 172.64 2.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.412 161.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.97 -82.44 1.28 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.88 136.57 42.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.19 101.0 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.055 1.742 . . . . 0.0 107.396 -170.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.0 -42.93 97.02 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.258 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -143.61 162.57 41.12 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -64.25 112.52 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.067 3.178 . . . . 0.0 112.014 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -81.56 96.11 7.35 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.989 0.916 . . . . 0.0 111.36 172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -68.13 128.58 37.06 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.477 0.656 . . . . 0.0 110.265 171.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -110.85 150.36 29.27 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.198 1.399 . . . . 0.0 107.753 154.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.4 t -136.19 132.48 49.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.79 92.95 1.86 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.669 1.188 . . . . 0.0 110.757 -168.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.6 m -114.16 136.31 53.08 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.249 1.82 . . . . 0.0 108.973 -173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.0 t -128.8 145.23 35.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.964 -173.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -125.22 142.01 51.75 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.393 1.877 . . . . 0.0 108.442 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -83.13 -166.33 1.32 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -63.07 88.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 154.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.86 59.23 3.51 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.619 1.104 . . . . 0.0 114.422 166.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.7 pttt 174.77 164.93 0.25 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 131.369 3.867 . . . . 0.0 108.8 164.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -92.3 143.82 26.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 165.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.5 pt -126.49 -9.03 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 123.816 0.698 . . . . 0.0 112.347 172.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -148.29 141.71 25.29 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.983 -1.073 . . . . 0.0 110.478 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -157.72 126.66 5.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.67 1.188 . . . . 0.0 108.707 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.453 ' CE ' HD11 ' A' ' 126' ' ' LEU . 0.1 OUTLIER -155.98 164.5 38.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.108 -0.995 . . . . 0.0 112.472 167.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.36 157.66 19.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.694 2.397 . . . . 0.0 109.942 175.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.9 46.18 2.15 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.286 2.634 . . . . 0.0 106.591 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -96.75 120.79 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 O-C-N 120.596 -1.315 . . . . 0.0 110.029 -172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -144.61 135.4 24.82 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.75 1.62 . . . . 0.0 108.109 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.06 105.15 2.7 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 170.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 61.95 -170.81 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.873 1.269 . . . . 0.0 110.581 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.16 114.54 6.9 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 163.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 61.53 1.6 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.732 1.613 . . . . 0.0 108.624 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 60.76 158.56 0.04 OUTLIER 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.92 2.088 . . . . 0.0 112.467 -169.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.67 125.46 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 114.403 -1.272 . . . . 0.0 107.819 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.3 t -146.93 169.61 18.81 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.747 -0.596 . . . . 0.0 110.915 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.07 154.3 41.87 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -14.26 4.21 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 169.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -114.16 144.79 42.61 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.845 0.858 . . . . 0.0 109.748 -171.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -127.9 142.21 51.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 126.293 1.837 . . . . 0.0 107.599 171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.68 67.34 1.45 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD11 ' CE ' ' A' ' 109' ' ' LYS . 24.3 mt -96.82 132.59 42.39 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -131.48 142.84 50.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -136.41 103.05 5.15 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.671 0.748 . . . . 0.0 109.434 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.258 1.823 . . . . 0.0 107.758 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 75.15 83.83 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 102.931 -2.988 . . . . 0.0 102.931 -137.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -160.57 131.73 5.64 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.739 2.016 . . . . 0.0 106.426 -159.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -160.15 159.46 31.73 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.318 1.847 . . . . 0.0 107.296 -161.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -133.44 61.72 55.76 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 118.835 0.743 . . . . 0.0 112.97 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.01 103.15 1.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.152 2.568 . . . . 0.0 110.057 -174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.5 33.45 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 CA-C-O 117.205 -1.886 . . . . 0.0 115.901 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.3 -106.29 1.22 Allowed Glycine 0 CA--C 1.529 0.923 0 CA-C-N 120.332 2.066 . . . . 0.0 111.111 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -72.42 144.6 48.08 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 118.567 1.183 . . . . 0.0 109.788 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.8 165.02 40.67 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.507 1.051 . . . . 0.0 113.148 172.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.82 166.52 23.09 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.062 0.945 . . . . 0.0 111.633 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.0 mtm -84.34 148.16 26.79 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 157.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -153.74 158.39 40.9 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.815 1.246 . . . . 0.0 109.609 168.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -133.6 126.03 30.05 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.886 2.475 . . . . 0.0 104.705 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 77' ' ' VAL . 1.7 p -124.02 123.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.2 m -99.13 137.67 37.33 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 tp -129.43 140.07 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.9 tt0 -134.43 129.43 35.29 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 169.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -127.51 115.87 19.52 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 p -131.75 160.01 36.78 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.176 1.391 . . . . 0.0 109.278 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.89 -165.46 45.67 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -166.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.17 40.99 0.79 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.82 1.248 . . . . 0.0 114.099 -166.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -52.71 -16.29 0.93 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 127.536 2.334 . . . . 0.0 115.406 -167.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -65.8 -24.89 67.02 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.249 -0.907 . . . . 0.0 110.826 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -76.37 31.71 0.12 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.863 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -144.36 166.62 24.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.702 1.201 . . . . 0.0 110.259 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.6 mm -105.46 83.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 126.562 1.945 . . . . 0.0 106.089 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' CG ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -90.38 164.79 14.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.516 177.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -138.45 168.69 19.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.107 1.363 . . . . 0.0 109.325 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.595 HG23 HD11 ' A' ' 59' ' ' LEU . 25.0 t -131.62 136.01 58.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.63 23.55 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 123.926 0.766 . . . . 0.0 109.851 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -88.68 96.93 6.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 171.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.1 p -152.11 167.37 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 159.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.3 157.09 20.66 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.194 1.798 . . . . 0.0 109.739 166.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -99.98 14.59 30.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.02 -70.67 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 123.35 0.5 . . . . 0.0 112.705 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 t -69.28 174.02 5.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.477 1.111 . . . . 0.0 111.095 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -79.7 159.62 26.59 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.095 0.958 . . . . 0.0 110.453 173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.0 174.37 5.89 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.967 172.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 40' ' ' LYS . 24.8 ttpt -130.87 127.89 39.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -72.51 166.94 21.66 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.602 1.561 . . . . 0.0 110.225 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.84 8.97 16.4 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.167 1.365 . . . . 0.0 113.368 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.86 -55.36 23.44 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.853 1.826 . . . . 0.0 108.583 166.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 p -136.32 -10.86 1.93 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.26 1.024 . . . . 0.0 111.627 -166.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.94 26.17 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.773 1.178 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -74.2 147.73 42.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.61 1.164 . . . . 0.0 107.947 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -90.41 134.11 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.109 1.364 . . . . 0.0 108.806 175.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.19 157.28 40.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.717 1.207 . . . . 0.0 108.634 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.59 -179.38 1.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.15 1.38 . . . . 0.0 112.035 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.1 p -141.05 157.91 65.93 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 123.856 0.863 . . . . 0.0 110.5 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.19 170.06 66.11 Favored 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 125.24 -0.733 . . . . 0.0 110.846 -13.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.6 t -145.58 120.67 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 176.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -137.43 122.23 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.6 162.42 18.42 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.409 0.623 . . . . 0.0 109.994 -168.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.86 -175.49 3.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.373 1.869 . . . . 0.0 108.591 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -35.88 70.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.913 0.885 . . . . 0.0 112.73 -167.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.8 -51.32 67.53 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.08 1.352 . . . . 0.0 111.264 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -79.5 14.85 1.45 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.518 1.927 . . . . 0.0 111.73 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 30' ' ' VAL . 1.9 mt -119.1 40.31 3.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.515 2.326 . . . . 0.0 109.225 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.97 23.2 0.57 Allowed 'General case' 0 CA--C 1.549 0.914 0 O-C-N 120.26 -1.525 . . . . 0.0 111.424 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.7 m -112.04 159.56 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.936 1.244 . . . . 0.0 112.495 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.29 -78.45 0.26 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.786 2.035 . . . . 0.0 109.299 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 162.45 34.93 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.506 1.522 . . . . 0.0 108.85 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.2 p -166.76 159.4 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -113.18 95.51 5.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.372 1.469 . . . . 0.0 107.88 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.6 mm? -83.11 155.53 23.78 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.2 t -158.35 155.54 28.91 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.3 p -61.25 158.84 13.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.228 0.611 . . . . 0.0 110.957 168.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.5 p -85.27 -58.02 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 161.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.45 -153.92 20.33 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 127.527 2.489 . . . . 0.0 113.473 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -83.34 113.18 20.54 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.53 -1.571 . . . . 0.0 110.684 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -77.12 144.19 38.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.158 0.983 . . . . 0.0 109.357 168.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mt -76.88 -49.63 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.467 1.107 . . . . 0.0 109.899 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -140.39 155.64 46.68 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 127.491 2.316 . . . . 0.0 105.761 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.44 166.77 5.7 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.978 1.311 . . . . 0.0 111.799 -171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.22 176.96 10.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.796 1.239 . . . . 0.0 112.633 -173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 ' CG1' HD22 ' A' ' 126' ' ' LEU . 7.5 p -152.98 41.86 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-O 124.885 2.278 . . . . 0.0 109.919 173.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 p -70.2 112.6 6.66 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 119.299 -2.125 . . . . 0.0 108.676 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.35 13.18 18.82 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.686 -1.063 . . . . 0.0 113.334 -168.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.42 148.68 50.44 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.531 1.666 . . . . 0.0 109.75 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -136.2 174.09 12.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.531 1.133 . . . . 0.0 107.965 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -132.81 164.95 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 170.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -84.16 -0.42 51.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.509 1.924 . . . . 0.0 111.569 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.09 -71.53 2.53 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 125.179 1.371 . . . . 0.0 111.664 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.313 0.1 OUTLIER -132.49 -163.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.46 1.13 . . . . 0.0 111.297 -174.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.73 77.75 2.06 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.9 1.28 . . . . 0.0 110.495 -170.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.96 -164.97 11.51 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.207 2.337 . . . . 0.0 111.616 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -146.79 171.23 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 126.687 1.995 . . . . 0.0 108.701 174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.1 m -101.85 160.8 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.643 1.177 . . . . 0.0 111.147 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -111.01 -67.54 0.99 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -171.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.41 162.93 18.35 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 119.913 -1.742 . . . . 0.0 111.408 -178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -63.35 104.99 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.322 2.014 . . . . 0.0 111.164 168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.36 142.71 55.39 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.522 163.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -124.89 133.9 52.89 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -142.65 157.96 44.14 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 126.246 1.818 . . . . 0.0 109.026 -176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -160.77 125.97 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.408 -2.528 0 CA-C-N 110.568 -3.014 . . . . 0.0 105.759 -174.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.3 134.88 54.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -142.32 133.2 25.69 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.89 134.92 48.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.344 1.058 . . . . 0.0 110.057 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -113.44 124.03 51.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.311 1.845 . . . . 0.0 106.546 169.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -76.85 179.3 6.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 164.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -55.0 84.48 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.664 1.986 . . . . 0.0 111.763 173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 91.59 18.36 45.26 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.821 1.677 . . . . 0.0 114.616 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -155.2 164.91 38.17 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.327 2.064 . . . . 0.0 110.718 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -97.17 142.79 28.66 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.653 1.581 . . . . 0.0 107.903 170.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.67 -17.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -148.5 144.47 27.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.432 1.015 . . . . 0.0 109.222 -173.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -166.14 111.14 0.83 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.986 0.914 . . . . 0.0 110.296 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.7 mmtt -129.52 167.5 17.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.876 0.871 . . . . 0.0 111.384 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t -143.1 133.81 25.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.738 1.615 . . . . 0.0 108.837 171.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.59 118.6 35.66 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 108.169 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -144.4 112.09 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.481 ' HA ' ' HE3' ' A' ' 117' ' ' LYS . 33.3 p90 -138.11 158.28 44.63 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.713 1.605 . . . . 0.0 111.539 166.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.88 160.14 19.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 125.432 1.493 . . . . 0.0 109.089 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -32.18 22.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.207 2.203 . . . . 0.0 115.048 -171.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.3 -3.84 58.48 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.005 -0.886 . . . . 0.0 113.632 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 113' ' ' PHE . 4.4 pttp -126.56 159.31 33.85 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.783 1.791 . . . . 0.0 109.622 171.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -58.59 129.32 41.54 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 tp -62.38 154.04 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 123.197 1.475 . . . . 0.0 110.447 -171.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 51.2 m -146.2 119.71 9.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 C-N-CA 127.092 2.157 . . . . 0.0 105.434 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.39 163.4 8.64 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 125.375 1.47 . . . . 0.0 109.425 171.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -158.98 158.73 33.82 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 166.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.61 82.38 0.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.712 1.205 . . . . 0.0 109.536 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.3 mt -57.21 133.63 55.22 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -139.18 112.89 8.43 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.753 1.621 . . . . 0.0 107.512 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.647 HD22 ' CG1' ' A' ' 77' ' ' VAL . 1.8 mp -133.69 159.24 41.14 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.031 0.832 . . . . 0.0 110.838 164.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -155.78 161.31 40.69 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.323 2.649 . . . . 0.0 106.241 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -150.83 156.57 41.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.63 1.972 . . . . 0.0 107.983 -175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.258 1.535 0 C-N-CA 125.89 1.676 . . . . 0.0 108.22 172.396 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.754 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.46 -165.54 1.64 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 -154.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -77.55 52.58 0.99 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.336 1.455 . . . . 0.0 110.559 172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.42 107.66 9.92 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.719 0.808 . . . . 0.0 112.941 -156.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -114.12 80.42 5.57 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 152.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.82 113.91 3.7 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.822 2.348 . . . . 0.0 108.951 168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -123.02 -67.42 0.22 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.21 0.909 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.26 165.22 12.58 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.845 1.212 . . . . 0.0 111.106 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.65 158.4 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.175 1.39 . . . . 0.0 108.27 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.47 166.74 16.98 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.24 0.927 . . . . 0.0 111.688 170.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.55 162.49 39.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.885 1.274 . . . . 0.0 111.123 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mtt -79.33 145.62 33.35 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.789 -0.569 . . . . 0.0 111.459 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -148.4 174.75 11.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.304 0.573 . . . . 0.0 110.587 165.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -142.55 158.0 44.13 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.331 2.252 . . . . 0.0 105.294 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.88 133.18 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 140.65 49.23 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.02 156.54 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 171.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -139.76 138.09 35.61 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 164.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 123.84 27.72 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.4 p -130.87 -169.03 2.08 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 120.894 -1.129 . . . . 0.0 109.873 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.33 -116.99 6.33 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 125.754 1.645 . . . . 0.0 109.131 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.3 69.54 0.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.556 1.645 . . . . 0.0 109.225 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -70.45 -3.1 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.561 -1.199 . . . . 0.0 113.529 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -121.61 52.34 1.25 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.516 1.507 . . . . 0.0 110.348 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 t -140.14 -2.61 1.45 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.682 0.793 . . . . 0.0 112.234 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -130.54 162.1 30.01 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.415 2.286 . . . . 0.0 106.942 175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -110.32 83.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.3 0.955 . . . . 0.0 110.452 -165.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 -164.37 0.98 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.426 -173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.24 168.66 16.79 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.472 -1.392 . . . . 0.0 109.582 -173.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.99 131.33 72.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.36 56.25 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.7 p -134.83 104.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 O-C-N 121.209 -0.932 . . . . 0.0 108.82 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.84 -171.14 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.1 129.95 55.84 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 119.717 1.144 . . . . 0.0 109.267 171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.96 12.47 1.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.43 1.492 . . . . 0.0 114.958 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.35 -53.18 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.493 1.044 . . . . 0.0 113.614 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -93.39 -169.92 2.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.894 0.878 . . . . 0.0 110.165 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -105.31 167.92 9.42 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.999 1.719 . . . . 0.0 111.694 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.01 143.56 34.93 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.88 2.072 . . . . 0.0 108.744 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -109.58 136.75 48.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.13 2.172 . . . . 0.0 107.915 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -88.17 149.31 23.96 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.784 0.434 . . . . 0.0 112.153 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.94 0.07 81.75 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 118.058 -1.412 . . . . 0.0 114.633 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.63 -37.98 40.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.729 2.264 . . . . 0.0 110.607 172.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -144.4 -5.45 0.75 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.788 1.235 . . . . 0.0 113.646 -162.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.22 72.79 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 119.692 1.133 . . . . 0.0 111.939 -172.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.51 159.24 24.91 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.94 1.37 . . . . 0.0 109.797 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -109.32 104.44 13.56 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.311 1.044 . . . . 0.0 111.092 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.45 -179.8 5.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.7 1.2 . . . . 0.0 108.105 -177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.21 176.07 10.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.288 0.566 . . . . 0.0 109.642 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.8 m -158.31 153.4 21.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.398 162.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.21 159.79 76.78 Favored 'Cis proline' 0 CA--C 1.536 0.589 0 CA-C-N 119.707 0.931 . . . . 0.0 110.805 -7.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -159.33 80.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.755 2.022 . . . . 0.0 106.185 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.2 mt -93.12 130.98 41.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.8 mt -108.77 149.46 29.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.902 0.881 . . . . 0.0 111.141 -169.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.28 176.47 5.01 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.113 1.765 . . . . 0.0 109.176 -171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.54 -38.46 81.12 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.094 0.861 . . . . 0.0 110.704 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.2 mp0 -56.74 -30.87 63.99 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.191 1.396 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -93.44 -14.23 26.99 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.027 1.331 . . . . 0.0 111.32 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.7 31.24 0.24 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.319 1.448 . . . . 0.0 110.827 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.09 30.63 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.438 2.295 . . . . 0.0 112.529 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.98 156.52 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.676 1.591 . . . . 0.0 110.614 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.03 -72.79 0.25 Allowed 'General case' 0 C--O 1.218 -0.566 0 C-N-CA 124.746 1.219 . . . . 0.0 112.202 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 ptpp? -160.06 164.42 33.14 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 121.015 -1.053 . . . . 0.0 112.459 -170.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -169.75 175.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 126.818 2.047 . . . . 0.0 109.2 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.0 m -132.24 119.76 21.26 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.798 1.639 . . . . 0.0 108.099 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -114.73 144.95 42.65 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.662 0.785 . . . . 0.0 109.002 -170.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -150.6 166.57 29.9 Favored 'General case' 0 C--O 1.225 -0.199 0 O-C-N 121.37 -0.831 . . . . 0.0 110.044 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 p -92.13 170.16 10.04 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.064 0.946 . . . . 0.0 110.811 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.5 p -104.93 -29.63 10.35 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.983 0.913 . . . . 0.0 112.603 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -132.97 -105.64 0.95 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 124.46 1.029 . . . . 0.0 112.349 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -132.77 121.51 23.13 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 118.449 1.124 . . . . 0.0 111.071 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.17 118.33 28.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.338 1.455 . . . . 0.0 107.08 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.5 -61.13 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -134.49 143.5 47.51 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 109.325 -172.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.45 177.72 8.64 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.123 2.569 . . . . 0.0 107.912 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.47 166.68 31.94 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.423 HG11 HG21 ' A' ' 99' ' ' VAL . 2.8 t -141.23 36.54 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.829 1.776 . . . . 0.0 108.954 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -64.11 -172.84 0.07 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.153 2.981 . . . . 0.0 110.199 162.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.52 -55.53 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 O-C-N 121.188 -0.945 . . . . 0.0 111.149 170.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.7 145.46 1.1 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -171.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -153.22 151.38 11.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.36 161.19 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.514 1.126 . . . . 0.0 108.177 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.19 126.22 29.05 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -104.3 -98.45 2.51 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 106.624 -2.59 . . . . 0.0 106.624 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.03 -177.85 3.6 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.036 0.935 . . . . 0.0 110.104 171.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -47.45 151.49 0.77 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.654 1.981 . . . . 0.0 112.017 174.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.09 103.01 0.26 Allowed Glycine 0 C--N 1.334 0.452 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -168.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -66.49 142.73 16.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 117.994 0.897 . . . . 0.0 109.574 167.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.2 102.55 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -108.78 -38.07 5.72 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 120.657 -1.277 . . . . 0.0 112.754 -168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -112.12 165.22 13.39 Favored Pre-proline 0 C--O 1.236 0.344 0 CA-C-N 119.244 0.929 . . . . 0.0 109.973 173.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 75.83 2.28 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.92 2.413 . . . . 0.0 110.043 168.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.19 78.74 0.05 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.231 1.412 . . . . 0.0 109.866 171.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -68.94 170.28 10.06 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.811 0.815 . . . . 0.0 110.577 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.83 98.15 3.59 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -113.64 142.07 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 124.539 1.135 . . . . 0.0 109.454 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.41 126.05 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -166.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.9 m -132.44 105.49 7.3 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.961 1.304 . . . . 0.0 108.82 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 77' ' ' VAL . 60.2 t -100.31 152.21 4.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 124.699 1.2 . . . . 0.0 109.577 -176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.48 -179.04 4.07 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.309 1.444 . . . . 0.0 109.937 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -136.75 -156.02 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 164.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.93 3.64 0.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.918 1.687 . . . . 0.0 115.187 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.7 -67.06 0.27 Allowed Glycine 0 CA--C 1.523 0.567 0 CA-C-N 120.56 1.527 . . . . 0.0 113.169 -170.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -175.02 -177.1 1.03 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.525 2.73 . . . . 0.0 107.784 -160.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.84 149.12 49.3 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.483 1.038 . . . . 0.0 109.319 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.4 pt -130.97 -16.48 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.313 . . . . 0.0 111.637 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -136.52 149.82 48.34 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -160.29 51.87 0.31 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.176 0.988 . . . . 0.0 110.36 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -89.2 150.96 22.43 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.695 1.198 . . . . 0.0 111.156 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -148.3 116.83 6.59 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 125.674 1.59 . . . . 0.0 109.137 -167.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -104.98 81.19 1.71 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.4 p -82.11 139.28 18.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -153.88 175.65 13.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.435 2.294 . . . . 0.0 106.76 162.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -161.36 175.69 11.96 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.609 1.964 . . . . 0.0 107.181 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -74.1 74.87 1.75 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.813 1.245 . . . . 0.0 110.49 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.68 67.91 0.78 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -159.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tptp -87.89 -164.62 1.13 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 147.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 119' ' ' ILE . 1.4 pt-20 -90.61 -56.83 3.04 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.597 1.159 . . . . 0.0 108.323 166.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.462 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 2.0 pp -74.93 172.91 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 127.997 2.519 . . . . 0.0 111.81 -178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.7 t -150.17 165.75 31.91 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.021 1.328 . . . . 0.0 107.818 155.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.01 156.19 3.23 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 127.843 2.457 . . . . 0.0 109.899 170.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.12 -19.32 0.49 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 168.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.37 132.78 47.66 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.136 1.789 . . . . 0.0 111.744 -173.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 47.0 mt -144.86 105.22 4.09 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.888 1.275 . . . . 0.0 110.427 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -135.87 109.73 8.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 111.66 170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.68 149.08 49.74 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 165.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -128.82 157.42 41.54 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.357 1.063 . . . . 0.0 108.969 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -147.45 121.19 9.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 121.497 0.665 . . . . 0.0 111.222 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.092 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 153.596 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.934 0 N-CA-C 106.524 -2.63 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.36 167.36 28.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 -139.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -149.06 169.57 20.34 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.0 1.32 . . . . 0.0 108.917 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -142.59 86.21 1.94 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.06 1.344 . . . . 0.0 110.803 -167.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -64.88 143.1 98.77 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -72.65 72.19 3.12 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 124.322 3.348 . . . . 0.0 112.006 174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.49 -107.02 0.24 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.741 1.639 . . . . 0.0 112.7 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.42 54.6 4.18 Favored Glycine 0 C--N 1.331 0.288 0 O-C-N 121.248 -1.148 . . . . 0.0 111.24 -171.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -125.33 142.89 51.24 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.822 0.849 . . . . 0.0 110.814 -172.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.44 167.99 4.69 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.173 1.844 . . . . 0.0 111.579 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.4 162.73 33.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.379 -1.66 . . . . 0.0 110.396 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.436 ' CG ' ' HE2' ' A' ' 71' ' ' LYS . 8.7 mmm -87.97 164.98 15.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.914 0.864 . . . . 0.0 110.212 167.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -156.85 170.32 22.76 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 163.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -124.96 158.76 32.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 151.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.35 151.9 16.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -137.04 127.46 26.61 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -171.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 tp -116.82 125.99 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -125.17 93.54 3.91 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -172.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -80.23 173.2 12.84 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.0 t -169.99 164.9 9.54 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.869 2.068 . . . . 0.0 106.794 166.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.41 -152.69 43.54 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 124.369 0.985 . . . . 0.0 114.169 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.39 60.07 1.97 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.279 1.432 . . . . 0.0 109.097 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -73.93 -21.47 60.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.317 -0.864 . . . . 0.0 112.16 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -76.62 20.66 0.22 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.552 1.524 . . . . 0.0 111.623 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -130.46 57.05 1.73 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.504 1.521 . . . . 0.0 108.725 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -153.78 168.93 24.66 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 158.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 mm -127.28 118.0 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 126.015 1.726 . . . . 0.0 109.829 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.19 144.91 6.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.295 173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.0 m -83.5 160.33 21.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.764 1.226 . . . . 0.0 110.892 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 74.4 t -134.61 105.68 6.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.85 114.59 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.017 144.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.1 t -133.28 109.32 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.751 142.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.583 HG11 ' H ' ' A' ' 52' ' ' VAL . 8.5 p -157.75 154.04 5.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 119.002 0.819 . . . . 0.0 112.75 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.419 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -81.51 117.72 22.15 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 109.994 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.04 9.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.06 -19.01 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 116.554 1.382 . . . . 0.0 116.554 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.419 HG22 ' HB1' ' A' ' 34' ' ' ALA . 12.2 t -125.01 178.13 5.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.746 1.273 . . . . 0.0 107.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.97 172.71 11.81 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.514 1.149 . . . . 0.0 110.417 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.37 173.59 6.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.098 168.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -131.4 130.08 42.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.594 1.958 . . . . 0.0 108.518 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.61 152.94 43.37 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.223 1.809 . . . . 0.0 109.546 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.99 -15.41 62.9 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.875 -0.958 . . . . 0.0 112.773 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.8 -57.56 8.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.083 1.442 . . . . 0.0 111.292 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.1 p -135.73 3.08 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.875 0.87 . . . . 0.0 112.034 -165.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.47 51.91 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.566 -1.13 . . . . 0.0 112.577 -170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.33 158.04 12.53 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 118.983 1.392 . . . . 0.0 108.53 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.32 150.46 26.68 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 125.305 1.442 . . . . 0.0 109.557 -177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -127.48 147.23 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.901 1.28 . . . . 0.0 109.299 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.39 125.01 28.14 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -81.04 164.09 52.23 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 122.986 0.515 . . . . 0.0 110.686 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HA ' HG21 ' A' ' 33' ' ' VAL . 44.5 Cg_endo -79.72 161.28 86.58 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 119.126 0.723 . . . . 0.0 110.649 -12.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.583 ' H ' HG11 ' A' ' 33' ' ' VAL . 80.2 t -139.25 109.35 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.325 2.65 . . . . 0.0 104.687 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.72 129.38 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.3 mt -96.3 150.14 20.9 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.348 1.459 . . . . 0.0 109.149 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.8 m -120.63 -176.35 3.22 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.927 1.691 . . . . 0.0 108.728 165.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -44.78 -45.39 9.99 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.092 2.157 . . . . 0.0 112.707 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.56 -27.83 68.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.272 -0.893 . . . . 0.0 111.998 -173.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -89.2 -4.58 58.18 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.769 1.227 . . . . 0.0 111.472 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.26 -1.38 57.92 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.039 -1.038 . . . . 0.0 112.3 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.87 35.67 0.25 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.385 1.474 . . . . 0.0 113.815 -171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 144.63 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 125.343 1.457 . . . . 0.0 111.201 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -67.69 -55.75 11.99 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.841 -1.162 . . . . 0.0 111.793 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 143.68 26.6 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 120.855 -1.153 . . . . 0.0 110.896 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -151.17 140.89 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 O-C-N 124.922 1.389 . . . . 0.0 107.398 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.3 m -137.1 79.72 1.77 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.68 160.49 20.34 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 110.798 176.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.2 t -161.53 160.14 28.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.882 0.873 . . . . 0.0 109.272 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 p -86.03 166.03 16.19 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.164 1.386 . . . . 0.0 113.115 -176.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.4 p -104.06 -36.14 7.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.958 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.93 -105.23 2.18 Favored Glycine 0 N--CA 1.478 1.478 0 CA-C-N 120.386 1.448 . . . . 0.0 113.239 -173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 12' ' ' MET . 1.8 mmtp -134.0 120.79 20.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.901 1.851 . . . . 0.0 111.668 167.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -71.8 127.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.277 1.431 . . . . 0.0 108.904 175.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 mt -70.2 -51.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 O-C-N 124.578 1.173 . . . . 0.0 109.423 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -122.37 154.22 37.97 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 128.238 2.615 . . . . 0.0 105.655 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -166.21 148.84 7.08 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.831 1.252 . . . . 0.0 108.58 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.85 154.24 46.11 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.917 1.235 . . . . 0.0 111.893 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 99' ' ' VAL . 40.5 t -147.34 66.72 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 128.12 2.568 . . . . 0.0 106.615 -173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -106.7 160.6 15.34 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 120.772 -1.205 . . . . 0.0 111.859 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.49 -152.3 24.16 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.38 1.467 . . . . 0.0 109.798 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.94 156.1 32.43 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 p -158.86 172.08 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.89 171.45 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 157.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.82 14.8 20.24 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.39 1.476 . . . . 0.0 110.904 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.23 -102.71 0.76 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 106.313 -2.715 . . . . 0.0 106.313 -160.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.75 5.4 3.13 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.329 -168.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.02 134.65 14.48 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.804 1.184 . . . . 0.0 110.277 170.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.22 51.69 4.52 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 125.587 1.565 . . . . 0.0 114.375 -162.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.63 107.25 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.278 1.039 . . . . 0.0 110.588 -169.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.7 m -127.51 -42.53 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.115 0.966 . . . . 0.0 111.729 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 53.65 -85.1 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.315 2.246 . . . . 0.0 113.103 -172.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -60.9 159.87 24.13 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 124.969 1.308 . . . . 0.0 110.034 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.52 156.48 32.28 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.396 2.064 . . . . 0.0 110.907 170.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.9 ptm -119.3 165.21 14.56 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 125.882 1.673 . . . . 0.0 108.053 168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -135.11 127.39 30.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -128.26 94.41 3.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.61 143.65 11.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 168.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 m -133.45 135.24 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.0 m -134.34 140.63 46.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 169.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 77' ' ' VAL . 2.8 t -123.62 134.31 66.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 124.224 1.01 . . . . 0.0 110.047 173.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -107.76 -177.49 3.35 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.051 1.74 . . . . 0.0 109.955 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.91 -161.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.218 1.807 . . . . 0.0 107.724 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.413 ' H ' HD22 ' A' ' 102' ' ' ASN . 0.5 OUTLIER -71.48 64.54 0.42 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.612 0.642 . . . . 0.0 109.673 164.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.5 48.98 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.761 -1.212 . . . . 0.0 113.694 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -170.81 176.17 4.25 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 128.012 2.525 . . . . 0.0 110.438 166.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -108.14 137.35 46.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.213 1.805 . . . . 0.0 107.578 171.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 pt -126.29 -22.05 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 113.115 0.784 . . . . 0.0 113.115 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.33 151.38 40.41 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.457 1.026 . . . . 0.0 108.439 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.42 125.24 0.06 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.697 1.599 . . . . 0.0 107.632 -172.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -151.29 159.47 44.31 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.026 1.73 . . . . 0.0 108.93 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 p -134.61 114.46 12.78 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.471 1.508 . . . . 0.0 110.437 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.06 146.3 27.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.333 1.453 . . . . 0.0 109.212 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.2 t -145.13 109.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.669 1.988 . . . . 0.0 105.718 171.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -125.97 160.4 30.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.776 1.23 . . . . 0.0 108.744 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -165.94 -177.53 4.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.022 2.529 . . . . 0.0 108.349 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -66.47 101.95 0.82 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.891 0.876 . . . . 0.0 109.206 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 80.1 114.32 0.28 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -150.59 109.43 3.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.439 -1.036 . . . . 0.0 110.369 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -74.22 69.58 1.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.491 2.316 . . . . 0.0 107.776 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 tp -133.63 165.25 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.682 1.593 . . . . 0.0 108.04 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -108.8 122.55 47.4 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 163.57 36.48 Favored 'General case' 0 N--CA 1.438 -1.029 0 O-C-N 124.111 0.882 . . . . 0.0 111.848 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -143.81 176.09 9.51 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.219 1.808 . . . . 0.0 108.755 165.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.4 -176.7 5.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.84 1.656 . . . . 0.0 110.713 167.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.57 146.21 46.57 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.474 1.91 . . . . 0.0 107.964 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -137.04 88.03 2.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.354 1.462 . . . . 0.0 109.416 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.16 150.23 52.03 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -158.29 115.38 2.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.245 1.818 . . . . 0.0 107.536 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -96.83 98.32 10.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 108.292 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 117.35 -1.31 . . . . 0.0 108.983 169.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.694 0 N-CA-C 107.913 -2.075 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.75 -160.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.64 169.61 21.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 121.3 1.864 . . . . 0.0 109.723 157.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -173.05 171.38 4.19 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.943 1.297 . . . . 0.0 107.765 -153.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.55 78.93 0.58 Allowed Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 158.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.86 81.04 1.69 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.805 2.336 . . . . 0.0 107.477 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.1 -23.75 66.37 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.289 -0.728 . . . . 0.0 111.63 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.54 142.41 0.78 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.201 1.382 . . . . 0.0 110.598 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt -134.69 140.31 45.9 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 -172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.15 162.95 26.89 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.827 1.251 . . . . 0.0 110.692 -174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.37 155.41 17.4 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 163.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -137.93 -169.86 2.65 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.265 1.426 . . . . 0.0 107.504 167.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -152.77 157.51 40.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.652 1.981 . . . . 0.0 106.537 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.58 143.0 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 m -143.36 91.3 2.25 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -166.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tp -91.87 141.89 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -136.7 93.29 2.84 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -92.54 136.84 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.1 p -153.43 172.69 16.71 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.502 -0.749 . . . . 0.0 109.719 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.05 -99.13 2.0 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -145.72 117.37 8.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -133.14 -18.09 2.32 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.537 1.535 . . . . 0.0 113.655 -169.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -71.2 -16.65 62.52 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 121.947 2.158 . . . . 0.0 113.162 -172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.9 m -70.38 0.51 6.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.241 1.016 . . . . 0.0 112.329 171.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -70.33 122.97 20.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.977 1.717 . . . . 0.0 109.359 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.34 95.12 3.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.448 1.099 . . . . 0.0 108.756 -173.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -162.1 172.95 15.02 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.05 0.54 . . . . 0.0 111.611 168.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.11 165.06 13.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 127.385 2.274 . . . . 0.0 109.221 164.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -133.75 110.67 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.582 1.553 . . . . 0.0 107.461 169.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -77.19 114.97 18.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 165.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -147.77 90.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.6 p -155.11 158.21 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 O-C-N 121.556 -0.715 . . . . 0.0 111.255 167.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.03 121.96 26.71 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -69.55 29.97 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.842 1.257 . . . . 0.0 112.77 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.42 -4.29 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 CA-C-O 117.196 -1.891 . . . . 0.0 117.661 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 t -142.63 176.94 8.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 121.034 2.417 . . . . 0.0 108.775 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -87.87 159.47 18.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.203 1.001 . . . . 0.0 110.841 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.55 173.79 6.24 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.467 174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.21 125.15 30.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.052 1.341 . . . . 0.0 110.137 -175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -69.84 151.0 46.23 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.488 1.115 . . . . 0.0 109.83 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.25 -15.33 78.78 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 118.799 -1.0 . . . . 0.0 115.052 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.14 -69.31 0.48 Allowed 'General case' 0 C--N 1.339 0.133 0 CA-C-N 119.068 1.434 . . . . 0.0 109.846 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.0 p -111.41 -5.06 14.66 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.964 0.506 . . . . 0.0 110.754 -170.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.49 28.87 74.04 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.58 154.09 25.87 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.346 1.073 . . . . 0.0 108.469 162.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 p -100.91 129.05 46.71 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.963 1.305 . . . . 0.0 108.071 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.38 140.46 41.64 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.763 0.825 . . . . 0.0 108.917 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.73 165.58 21.05 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.417 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -137.01 163.89 46.15 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 124.607 1.163 . . . . 0.0 110.304 -166.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' HG21 ' A' ' 33' ' ' VAL . 90.2 Cg_endo -66.18 168.66 47.87 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 109.671 -0.934 . . . . 0.0 109.671 -16.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 144.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 23.1 mm -129.52 158.1 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.1 mt -129.68 145.25 51.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -171.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -112.26 -173.19 2.19 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 110.855 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -54.29 -39.41 66.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.166 1.386 . . . . 0.0 110.496 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -72.78 -31.23 64.74 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.781 0.432 . . . . 0.0 111.957 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.77 -18.75 56.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.434 0.561 . . . . 0.0 110.699 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.04 -7.2 50.17 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -163.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.71 -1.57 5.51 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -167.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.21 130.58 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 124.275 1.03 . . . . 0.0 109.159 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -89.06 -54.11 4.27 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.758 -0.589 . . . . 0.0 109.534 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.04 107.64 5.88 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -138.84 163.91 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 C-N-CA 124.368 1.067 . . . . 0.0 109.963 166.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -121.27 108.49 13.79 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 163.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.2 mt -93.08 158.85 15.57 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 170.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 t -166.13 164.38 17.99 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -78.96 165.44 23.46 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.668 1.587 . . . . 0.0 112.226 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 p -105.45 -16.9 14.6 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.138 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.87 -106.14 1.04 Allowed Glycine 0 C--N 1.343 0.943 0 CA-C-N 120.393 1.451 . . . . 0.0 112.471 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -138.24 140.28 39.61 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 127.998 2.519 . . . . 0.0 108.645 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.1 131.71 53.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 127.62 2.368 . . . . 0.0 110.363 -169.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mm -78.39 -50.55 19.03 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 O-C-N 123.639 0.587 . . . . 0.0 109.856 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -146.03 144.04 29.81 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.64 162.19 40.7 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 127.779 2.432 . . . . 0.0 110.979 -173.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.6 146.08 32.12 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.876 0.37 . . . . 0.0 111.558 166.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.86 42.67 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 124.131 1.919 . . . . 0.0 107.051 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 152.95 13.26 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 129.309 3.044 . . . . 0.0 109.588 170.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.15 -171.46 19.22 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.56 144.63 14.62 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.438 1.494 . . . . 0.0 109.381 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 p -156.6 169.19 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 125.271 1.428 . . . . 0.0 108.722 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.7 m -133.21 173.28 15.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.589 0.755 . . . . 0.0 110.09 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -62.55 154.59 28.33 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.069 1.347 . . . . 0.0 111.308 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.81 92.68 0.23 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 107.098 -2.401 . . . . 0.0 107.098 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 45.01 61.96 2.31 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.337 1.455 . . . . 0.0 111.262 -163.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 53.3 37.49 25.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.851 1.26 . . . . 0.0 113.242 164.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.7 125.51 30.92 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.177 1.37 . . . . 0.0 113.547 -171.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.19 -41.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.94 1.696 . . . . 0.0 109.33 168.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t 68.06 -71.4 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 126.503 1.921 . . . . 0.0 110.125 -165.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -164.37 -53.73 0.03 OUTLIER 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.673 1.124 . . . . 0.0 110.198 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 156.51 85.3 Favored Pre-proline 0 N--CA 1.466 0.357 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.25 129.05 26.94 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.616 2.211 . . . . 0.0 109.54 163.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -65.59 157.51 29.64 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 164.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -135.39 151.9 50.9 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -141.98 95.34 2.79 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.33 110.35 27.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -109.15 145.29 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.0 m -150.88 98.96 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.245 1.818 . . . . 0.0 106.736 -174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.7 t -93.65 141.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 121.133 1.788 . . . . 0.0 110.821 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -111.34 146.27 37.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.533 1.533 . . . . 0.0 107.056 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -98.72 -177.28 3.61 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 165.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.07 82.72 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.898 0.879 . . . . 0.0 109.614 156.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 160.13 -65.45 0.28 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.713 1.149 . . . . 0.0 112.204 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -162.7 -179.41 6.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.032 1.333 . . . . 0.0 109.172 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -52.19 123.41 10.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.197 1.399 . . . . 0.0 108.468 167.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 9.9 pt -111.17 -9.75 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.905 0.882 . . . . 0.0 111.492 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.763 0.71 . . . . 0.0 111.042 -173.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.59 168.49 19.76 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.504 1.922 . . . . 0.0 108.256 160.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.707 ' HE3' HD13 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -164.27 112.73 1.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.73 2.012 . . . . 0.0 108.614 166.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.8 t -100.07 117.1 33.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.83 151.53 47.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 157.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.7 p -166.44 138.6 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 157.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -139.86 155.71 47.08 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.216 1.406 . . . . 0.0 107.249 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.62 133.55 3.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 158.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 44.21 39.78 3.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.405 2.282 . . . . 0.0 113.559 166.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.81 52.02 41.57 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.406 -0.809 . . . . 0.0 112.933 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -56.45 170.62 0.35 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.235 1.017 . . . . 0.0 111.698 176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 118' ' ' GLU . 1.7 pm0 -62.11 86.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.419 2.287 . . . . 0.0 110.914 170.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -159.27 147.0 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 127.286 2.234 . . . . 0.0 106.414 169.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.33 82.91 1.48 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.062 1.301 . . . . 0.0 112.101 166.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.452 ' H ' HD13 ' A' ' 119' ' ' ILE . 0.6 OUTLIER -162.74 167.03 23.59 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 126.596 1.959 . . . . 0.0 107.186 164.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -166.56 88.87 0.36 Allowed 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 124.767 1.227 . . . . 0.0 109.078 168.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -166.35 152.13 8.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.017 1.727 . . . . 0.0 106.618 168.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.707 HD13 ' HE3' ' A' ' 109' ' ' LYS . 15.8 tp -159.4 126.57 4.69 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.47 113.24 8.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.455 0.57 . . . . 0.0 110.065 171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.89 139.23 53.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.96 139.01 28.86 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -130.74 153.7 48.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.826 1.25 . . . . 0.0 109.7 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 p30 . . . . . 0 C--O 1.256 1.423 0 C-N-CA 130.433 3.493 . . . . 0.0 105.715 -171.305 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' HA2' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.477 1.377 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 t70 76.29 108.3 0.08 Allowed 'General case' 0 C--O 1.243 0.727 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -114.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 1' ' ' GLY . 17.3 m-20 -126.52 156.68 40.4 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.995 0.918 . . . . 0.0 108.82 -141.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.01 131.56 47.41 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.183 0.993 . . . . 0.0 110.84 -164.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.87 76.11 65.86 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 125.597 1.559 . . . . 0.0 107.437 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.2 111.73 1.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.363 2.709 . . . . 0.0 108.695 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.74 89.22 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.96 -179.81 21.83 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.514 1.054 . . . . 0.0 110.58 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -138.96 107.26 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 121.586 -0.949 . . . . 0.0 109.477 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.54 167.66 44.03 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.137 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.39 178.28 9.44 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 128.172 2.589 . . . . 0.0 108.708 171.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.4 mtp -74.13 151.78 40.01 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.543 -0.723 . . . . 0.0 109.579 165.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -145.88 169.68 18.08 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.1 0.952 . . . . 0.0 109.389 158.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -144.54 146.28 32.28 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.255 2.222 . . . . 0.0 105.129 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 99' ' ' VAL . 7.3 p -145.17 114.51 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 122.134 0.968 . . . . 0.0 110.139 -174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.21 131.13 44.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.2 tp -130.06 141.16 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -138.2 90.9 2.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -84.06 162.22 20.42 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.0 p -160.16 172.82 16.75 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.596 1.158 . . . . 0.0 108.86 168.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.4 -134.76 51.73 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 123.562 0.601 . . . . 0.0 112.235 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -75.55 91.58 2.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -116.22 -3.78 11.97 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -127.14 50.41 1.99 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.976 1.262 . . . . 0.0 108.231 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -146.61 -11.98 0.45 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.805 -1.088 . . . . 0.0 113.434 -153.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -138.36 147.09 43.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 131.586 3.954 . . . . 0.0 105.628 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.415 HD12 ' HA2' ' A' ' 84' ' ' GLY . 41.6 mt -90.43 98.28 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.237 0.471 . . . . 0.0 110.797 -166.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.15 161.79 27.64 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.395 0.998 . . . . 0.0 113.297 174.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.4 m -122.94 165.94 15.89 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.137 1.375 . . . . 0.0 110.898 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.582 ' CG2' HD21 ' A' ' 59' ' ' LEU . 31.2 t -137.14 104.71 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.503 1.521 . . . . 0.0 107.859 -175.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.92 71.0 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.37 91.47 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG21 ' HA ' ' A' ' 51' ' ' PRO . 8.0 p -149.18 -179.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 165.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.484 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -106.38 137.17 44.84 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.1 9.86 1.1 Allowed 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 174.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -152.33 -61.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.961 -1.087 . . . . 0.0 113.625 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -79.36 176.24 9.87 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 117.558 0.679 . . . . 0.0 110.682 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -87.42 159.65 18.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.464 1.126 . . . . 0.0 109.886 165.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.97 169.99 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.972 171.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.01 134.32 55.27 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.999 1.72 . . . . 0.0 107.768 171.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -77.06 165.4 24.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.844 1.658 . . . . 0.0 111.833 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 -0.87 37.04 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 117.744 -1.587 . . . . 0.0 115.895 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.2 -59.75 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.884 2.342 . . . . 0.0 109.452 173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.3 p -121.29 -24.3 5.5 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.621 1.568 . . . . 0.0 111.213 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.98 22.4 38.81 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.218 -0.768 . . . . 0.0 112.366 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -53.73 151.81 5.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.993 1.397 . . . . 0.0 108.542 163.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.4 p -103.53 145.02 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -131.78 147.45 52.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.14 0.976 . . . . 0.0 109.302 -162.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.76 170.77 1.85 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.906 2.082 . . . . 0.0 111.677 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -150.59 154.55 35.46 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 123.235 0.614 . . . . 0.0 110.841 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 33' ' ' VAL . 74.5 Cg_endo -72.36 168.77 73.67 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.401 0.822 . . . . 0.0 112.166 -7.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 ' H ' HG11 ' A' ' 33' ' ' VAL . 98.7 t -146.67 131.35 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 128.825 2.85 . . . . 0.0 103.384 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.1 mt -135.4 87.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 -166.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.3 mt -72.04 135.71 46.42 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.936 -0.554 . . . . 0.0 109.731 -163.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 p -107.71 -177.16 3.27 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.275 0.63 . . . . 0.0 110.311 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -57.06 -35.21 69.08 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.41 -53.45 36.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.586 1.955 . . . . 0.0 110.819 173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -72.68 -21.71 61.03 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.159 0.984 . . . . 0.0 113.354 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD21 ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -77.07 1.86 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.514 1.526 . . . . 0.0 113.72 -170.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.31 -5.92 4.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.4 m -66.27 169.02 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 128.662 2.785 . . . . 0.0 112.965 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -112.95 -47.73 3.03 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 156.51 40.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 126.087 1.755 . . . . 0.0 107.712 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 p -164.24 164.44 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.621 1.168 . . . . 0.0 108.385 162.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -110.27 118.25 35.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 105.816 -1.92 . . . . 0.0 105.816 153.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.0 mt -107.31 146.85 31.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -155.51 155.07 32.78 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.315 0.507 . . . . 0.0 110.312 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.4 p -75.43 143.36 42.72 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.118 0.967 . . . . 0.0 110.079 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.4 p -76.05 -54.33 7.01 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.14 -126.51 5.45 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 125.679 1.609 . . . . 0.0 109.826 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -117.35 123.42 46.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.051 1.425 . . . . 0.0 111.091 -165.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.59 124.63 28.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.48 0.712 . . . . 0.0 110.582 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -66.96 -56.7 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 124.546 1.154 . . . . 0.0 108.656 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -123.68 153.07 41.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 127.386 2.274 . . . . 0.0 106.541 -175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -164.24 161.79 22.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.74 2.416 . . . . 0.0 106.782 171.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -143.86 159.99 41.56 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.599 0.636 . . . . 0.0 110.295 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 99' ' ' VAL . 22.0 t -130.9 74.38 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -114.33 166.73 11.37 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.348 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -137.52 38.37 1.73 Allowed Glycine 0 C--O 1.227 -0.286 0 CA-C-O 119.081 -0.844 . . . . 0.0 111.476 -166.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.01 107.46 1.9 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 124.998 1.285 . . . . 0.0 112.485 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.6 t -101.19 172.29 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.6 m -133.96 178.35 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.078 1.351 . . . . 0.0 108.339 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.72 58.74 0.63 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.878 -1.139 . . . . 0.0 108.934 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' HA2' HD12 ' A' ' 27' ' ' ILE . . . -68.01 133.02 28.85 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 107.302 -2.319 . . . . 0.0 107.302 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.99 88.85 0.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -66.35 148.02 52.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.4 152.15 24.25 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.287 15.3 m 58.16 -4.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 128.57 2.748 . . . . 0.0 116.081 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.38 164.6 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 125.515 1.526 . . . . 0.0 111.893 175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -166.7 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.686 1.194 . . . . 0.0 112.594 149.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.28 165.02 45.13 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.621 -0.674 . . . . 0.0 111.859 -153.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.39 91.06 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.154 2.57 . . . . 0.0 111.123 169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.55 122.42 19.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 159.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -98.76 148.76 23.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.07 125.63 16.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.7 t -127.38 146.75 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.88 124.68 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m -131.76 107.46 8.79 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 77' ' ' VAL . 60.5 t -90.96 133.77 31.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -114.08 149.82 34.95 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 76.3 tttt -93.93 -154.96 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 18.8 p30 -57.19 73.48 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.224 1.81 . . . . 0.0 111.084 159.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 68.98 50.08 37.14 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.085 -1.01 . . . . 0.0 114.274 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 170.96 14.71 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 128.436 2.694 . . . . 0.0 107.864 158.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -88.82 138.35 31.49 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.371 1.468 . . . . 0.0 109.787 174.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 -8.53 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 117.999 -1.0 . . . . 0.0 113.399 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.76 153.77 51.46 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 121.112 1.778 . . . . 0.0 107.671 167.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -163.52 75.72 0.37 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -93.17 157.05 16.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 112.294 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.49 142.18 37.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.199 2.6 . . . . 0.0 107.878 173.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.96 156.42 44.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.33 1.852 . . . . 0.0 107.812 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.0 p -152.19 130.29 2.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 159.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.56 155.05 49.67 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.983 0.913 . . . . 0.0 110.431 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.53 68.41 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.247 2.619 . . . . 0.0 109.811 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 52.44 69.78 0.64 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 122.558 1.171 . . . . 0.0 111.876 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.0 141.22 4.11 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 122.528 1.071 . . . . 0.0 112.543 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.49 19.81 1.19 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.731 -1.452 . . . . 0.0 111.369 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 75.09 14.11 3.16 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.965 2.106 . . . . 0.0 112.369 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.05 146.1 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.695 1.198 . . . . 0.0 110.048 -159.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.3 m -82.48 105.77 13.8 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.512 0.725 . . . . 0.0 110.929 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.2 157.7 1.81 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.442 1.097 . . . . 0.0 109.851 163.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -158.66 172.66 17.87 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.12 169.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -79.0 -179.75 6.84 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.962 1.305 . . . . 0.0 111.753 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -124.54 151.52 44.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.33 67.03 1.02 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.642 1.177 . . . . 0.0 108.156 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.84 140.79 40.4 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -137.02 139.28 41.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -135.7 94.74 3.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.267 0.556 . . . . 0.0 109.662 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 125.883 1.673 . . . . 0.0 107.674 166.578 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 107.474 -2.25 . . . . 0.0 107.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 74.1 7.45 4.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.235 1.414 . . . . 0.0 110.289 168.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.52 119.35 13.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 129.985 3.314 . . . . 0.0 107.634 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -154.46 162.31 41.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.657 0.783 . . . . 0.0 109.179 171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.46 86.63 0.43 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 125.406 1.483 . . . . 0.0 108.737 162.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -63.63 73.11 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.735 2.29 . . . . 0.0 110.276 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.48 -11.86 79.37 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.974 -1.079 . . . . 0.0 111.749 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.42 160.56 53.18 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.189 0.995 . . . . 0.0 111.101 -178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -139.91 154.25 47.19 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.1 1.36 . . . . 0.0 109.28 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.98 172.6 20.46 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.9 157.3 42.64 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.772 1.629 . . . . 0.0 109.526 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.4 mtm -79.86 156.38 27.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -149.82 171.64 16.42 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.761 1.225 . . . . 0.0 109.815 166.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -137.26 131.68 32.67 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 169.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 32' ' ' VAL . 11.9 p -122.34 122.73 67.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 m -125.18 125.43 43.66 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -167.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.3 tp -132.42 156.37 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.25 125.12 19.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.51 140.31 50.08 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 170.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 p -161.87 149.59 14.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.496 1.518 . . . . 0.0 107.696 166.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.35 -118.49 4.13 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -169.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -135.61 62.54 1.63 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 123.101 1.429 . . . . 0.0 111.291 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -59.39 -28.44 66.9 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.86 -1.15 . . . . 0.0 112.245 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -69.21 -24.43 64.03 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.493 0.588 . . . . 0.0 111.128 -173.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.2 m -70.36 -12.18 61.41 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.126 0.97 . . . . 0.0 112.789 175.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -115.93 112.11 21.4 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.4 mm -75.38 92.4 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -100.97 173.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.521 1.128 . . . . 0.0 108.494 175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 p -142.03 174.18 10.83 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.912 1.285 . . . . 0.0 107.545 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 t -138.13 93.48 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.1 t -90.83 87.04 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.627 HG11 HG11 ' A' ' 15' ' ' VAL . 63.9 t -141.6 88.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' PRO . 7.1 p -157.08 154.3 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.964 0.887 . . . . 0.0 111.345 172.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -75.99 127.58 33.28 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.86 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.25 25.89 0.22 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.182 1.393 . . . . 0.0 111.79 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -166.55 -72.27 0.03 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 125.907 1.718 . . . . 0.0 110.079 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.0 t -68.68 -178.86 1.25 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.318 1.059 . . . . 0.0 111.442 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -100.43 165.7 11.31 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.011 2.124 . . . . 0.0 110.37 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.84 173.16 6.53 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.154 1.382 . . . . 0.0 110.234 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -134.01 134.86 42.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.847 2.059 . . . . 0.0 106.832 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' HD21 ' A' ' 48' ' ' LEU . 6.4 t70 -91.69 152.97 19.97 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 124.144 0.902 . . . . 0.0 111.295 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.78 12.22 67.51 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.468 1.985 . . . . 0.0 113.542 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.12 -46.4 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.363 1.581 . . . . 0.0 109.959 166.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -143.12 -27.05 0.58 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.528 1.131 . . . . 0.0 112.588 -166.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.57 31.18 7.23 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.854 1.216 . . . . 0.0 111.709 -172.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -74.0 156.6 37.37 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.05 0.925 . . . . 0.0 109.461 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 p -88.31 135.6 33.38 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.515 1.526 . . . . 0.0 110.403 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD21 ' HB2' ' A' ' 41' ' ' ASP . 2.0 mm? -121.92 131.47 54.04 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 109.943 -177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.54 146.85 52.73 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.272 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.7 p -106.37 157.41 35.05 Favored Pre-proline 0 N--CA 1.467 0.381 0 C-N-CA 123.703 0.801 . . . . 0.0 111.316 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HA ' HG21 ' A' ' 33' ' ' VAL . 72.5 Cg_endo -71.06 173.92 47.21 Favored 'Cis proline' 0 CA--C 1.547 1.151 0 CA-C-N 119.323 0.794 . . . . 0.0 112.093 -10.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.437 ' H ' HG11 ' A' ' 33' ' ' VAL . 59.8 t -147.07 90.11 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 128.698 2.799 . . . . 0.0 104.006 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -116.7 115.49 49.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.5 mt -109.11 160.26 16.21 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.675 0.79 . . . . 0.0 109.731 -168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.37 -175.52 2.95 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.787 1.235 . . . . 0.0 110.128 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -51.54 -39.76 58.37 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.575 1.95 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -48.98 79.42 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.486 0.715 . . . . 0.0 110.596 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -77.38 10.33 2.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.823 2.849 . . . . 0.0 111.84 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.59 19.41 18.72 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.009 2.123 . . . . 0.0 111.466 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.82 -11.69 56.31 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.046 -1.034 . . . . 0.0 111.794 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.81 151.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 124.717 1.207 . . . . 0.0 111.572 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -76.16 -65.91 0.86 Allowed 'General case' 0 C--O 1.218 -0.577 0 C-N-CA 124.224 1.01 . . . . 0.0 110.3 171.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.28 154.95 35.64 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.622 -0.674 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 m -141.42 178.8 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 C-N-CA 127.228 2.211 . . . . 0.0 108.715 -174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -147.2 115.83 6.74 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 164.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 67.2 mt -126.13 144.56 50.7 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 117.854 0.297 . . . . 0.0 110.659 -167.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.09 132.82 12.24 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.155 -158.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.5 p -63.17 138.24 58.48 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.251 1.021 . . . . 0.0 110.414 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.4 p -76.95 -47.53 20.67 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.291 0.95 . . . . 0.0 109.319 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -119.6 -140.8 6.27 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.174 1.845 . . . . 0.0 110.814 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -89.53 116.16 27.48 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.997 -1.296 . . . . 0.0 112.594 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.13 116.65 15.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.6 mm -60.69 -49.99 82.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 125.387 1.475 . . . . 0.0 108.684 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -132.66 139.23 47.61 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -143.69 140.27 29.95 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.215 1.806 . . . . 0.0 108.951 173.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -132.39 154.01 50.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.519 HG11 ' CG2' ' A' ' 99' ' ' VAL . 51.9 t -129.96 79.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.15 -166.35 1.28 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -164.17 -70.35 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 106.59 -2.604 . . . . 0.0 106.59 163.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.0 -167.83 20.88 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.43 178.8 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.126 1.37 . . . . 0.0 107.61 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 p -142.38 161.42 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 148.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.26 83.18 7.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.814 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.63 -46.49 92.08 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 171.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.99 -25.66 0.09 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 117.262 -1.351 . . . . 0.0 113.964 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.79 -83.11 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.16 1.784 . . . . 0.0 111.555 -160.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.0 -95.01 0.47 Allowed Glycine 0 C--N 1.333 0.363 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.8 m -146.75 -173.09 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.339 1.856 . . . . 0.0 107.048 167.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.71 104.03 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 111.209 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -81.63 -169.03 2.12 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.817 1.647 . . . . 0.0 111.358 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 162.52 43.6 Favored Pre-proline 0 CA--C 1.538 0.481 0 O-C-N 121.231 -0.918 . . . . 0.0 110.682 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.68 89.6 0.23 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.751 2.301 . . . . 0.0 111.184 168.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 8.0 ttm -52.36 114.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 157.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -79.06 148.22 32.54 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 161.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.51 121.28 28.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 163.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.12 144.22 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 172.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.48 133.31 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.0 m -136.94 129.91 30.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 169.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.519 ' CG2' HG11 ' A' ' 77' ' ' VAL . 4.5 t -108.22 138.97 32.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 124.689 1.196 . . . . 0.0 108.864 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -121.07 155.3 34.71 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.02 0.928 . . . . 0.0 109.235 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -94.49 -161.19 0.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 108.13 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 89.85 0.03 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 155.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.76 29.87 41.4 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 117.837 -1.535 . . . . 0.0 115.551 160.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -161.48 161.05 29.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.979 1.889 . . . . 0.0 110.038 170.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.73 144.08 32.46 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.377 1.071 . . . . 0.0 108.476 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.51 -15.36 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -133.97 152.66 51.94 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 121.046 1.748 . . . . 0.0 108.769 167.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -157.67 123.23 4.59 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 124.682 1.239 . . . . 0.0 110.446 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -145.61 169.92 17.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.847 0.832 . . . . 0.0 111.517 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 p -147.17 158.55 43.99 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 127.274 2.229 . . . . 0.0 107.73 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 tt -148.77 143.55 26.45 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 126.792 2.037 . . . . 0.0 107.452 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.9 t -144.51 121.5 4.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 166.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.2 156.97 47.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.039 1.336 . . . . 0.0 108.385 170.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -165.77 155.72 12.63 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.259 1.823 . . . . 0.0 107.692 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.92 108.76 4.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.18 -4.0 7.28 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.58 1.562 . . . . 0.0 112.839 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -122.17 47.19 1.95 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.877 1.838 . . . . 0.0 108.121 160.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.306 6.4 pm0 48.03 -163.57 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.61 1.564 . . . . 0.0 111.906 -173.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.46 136.91 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.0 1.32 . . . . 0.0 108.137 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.1 t -147.14 138.19 23.84 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 161.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.95 163.8 25.25 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 122.232 1.015 . . . . 0.0 108.906 160.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -156.04 139.45 15.79 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 167.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -148.88 167.83 24.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.08 144.72 48.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.61 83.79 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.87 127.19 47.66 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 -174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -144.06 127.1 16.47 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -173.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -130.62 126.11 35.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.306 1.443 . . . . 0.0 109.237 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 123.744 0.818 . . . . 0.0 109.217 165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.653 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -63.4 169.1 3.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 123.218 0.607 . . . . 0.0 110.164 141.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -158.11 -179.62 8.29 Favored 'General case' 0 CA--C 1.548 0.891 1 C-N-CA 132.076 4.151 . . . . 0.0 104.238 167.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.6 103.22 5.37 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 120.228 -1.545 . . . . 0.0 109.075 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -130.08 85.0 58.61 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 125.636 1.574 . . . . 0.0 107.842 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -68.2 110.48 2.23 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.462 2.108 . . . . 0.0 110.936 175.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.75 -109.53 2.24 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.169 1.366 . . . . 0.0 112.122 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.14 141.8 3.3 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 125.125 1.345 . . . . 0.0 111.424 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 -169.99 2.44 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.565 1.546 . . . . 0.0 110.314 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.21 -179.37 18.12 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.007 1.289 . . . . 0.0 114.237 170.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.7 167.61 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 126.741 2.016 . . . . 0.0 110.792 166.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.5 mtm -88.82 149.92 23.17 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 156.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -152.29 161.83 42.04 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 124.181 0.926 . . . . 0.0 109.48 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -129.62 151.07 50.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.933 2.493 . . . . 0.0 104.564 168.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.531 HG21 HG23 ' A' ' 77' ' ' VAL 0.252 1.6 p -134.57 164.42 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 m -151.07 124.8 9.08 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 97' ' ' VAL . 3.1 tp -116.19 125.58 73.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -108.09 96.22 6.22 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.935 0.894 . . . . 0.0 108.768 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -89.65 152.76 21.2 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -172.25 172.22 4.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.909 1.684 . . . . 0.0 108.382 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.22 -157.75 53.0 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -94.63 40.81 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 123.938 1.827 . . . . 0.0 110.44 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -69.1 -0.03 5.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 127.884 2.474 . . . . 0.0 115.477 -163.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -107.85 -0.26 21.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.1 0.96 . . . . 0.0 110.954 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -69.54 -24.59 63.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.504 1.047 . . . . 0.0 111.812 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.94 162.26 13.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.003 1.721 . . . . 0.0 110.484 176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.08 143.9 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 120.931 -1.105 . . . . 0.0 108.569 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -154.4 134.91 13.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.354 0.661 . . . . 0.0 110.774 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.4 m -132.3 172.07 12.91 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.048 0.939 . . . . 0.0 109.889 175.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.7 t -143.8 155.26 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.268 1.427 . . . . 0.0 107.365 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.98 103.16 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 128.977 2.911 . . . . 0.0 104.407 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.93 114.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 124.962 1.305 . . . . 0.0 107.637 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 34' ' ' ALA . 5.6 p -156.92 -166.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 165.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -117.86 139.58 50.91 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 125.902 1.681 . . . . 0.0 106.777 162.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.51 12.6 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.15 -69.25 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.412 HG22 ' HB1' ' A' ' 34' ' ' ALA . 5.9 t -68.13 174.29 3.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.814 0.846 . . . . 0.0 110.202 176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -89.72 163.5 15.07 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.6 1.56 . . . . 0.0 110.016 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.24 172.38 8.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.652 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -127.33 137.61 52.84 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.692 1.197 . . . . 0.0 109.886 -171.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' HA ' HD23 ' A' ' 66' ' ' LEU . 32.6 t0 -93.39 147.2 23.16 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.253 1.421 . . . . 0.0 110.719 173.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.6 -4.89 82.07 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-O 116.24 -2.422 . . . . 0.0 114.689 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.35 77.89 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-N 121.964 2.882 . . . . 0.0 109.731 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.52 HG22 ' CG ' ' A' ' 46' ' ' GLU . 1.5 t -155.64 12.08 0.32 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 168.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.01 34.06 34.75 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 120.374 -1.454 . . . . 0.0 110.478 -170.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' CG ' HG22 ' A' ' 44' ' ' THR . 19.8 mt-10 -74.78 145.67 42.74 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.781 174.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.4 m -106.07 148.37 27.86 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 119.701 1.137 . . . . 0.0 110.468 174.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -132.06 157.88 43.02 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.617 1.967 . . . . 0.0 108.425 -166.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.48 168.83 19.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.501 0.72 . . . . 0.0 110.689 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.6 p -129.48 166.63 24.36 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.819 1.248 . . . . 0.0 110.405 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.1 170.56 66.54 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.38 1.171 . . . . 0.0 111.048 -13.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 81.5 t -149.41 123.68 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -134.13 103.28 4.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.14 170.08 7.54 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.539 1.535 . . . . 0.0 111.685 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -140.63 176.63 8.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.098 1.359 . . . . 0.0 109.518 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.87 -37.34 51.85 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.654 1.582 . . . . 0.0 112.395 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.19 -43.02 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 123.387 0.43 . . . . 0.0 112.007 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -70.97 -28.55 64.53 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.685 0.394 . . . . 0.0 110.506 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.31 54.56 0.72 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.106 1.763 . . . . 0.0 110.354 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.91 10.27 30.58 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.844 -1.16 . . . . 0.0 112.794 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.23 -179.98 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 120.213 1.369 . . . . 0.0 111.428 -172.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -114.18 -58.79 2.1 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 111.418 -169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.64 137.9 26.99 Favored 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 121.664 -0.647 . . . . 0.0 111.55 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -162.34 151.71 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 125.146 1.529 . . . . 0.0 108.181 -164.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -146.4 100.53 3.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 41' ' ' ASP . 1.3 mp -111.45 158.57 18.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.946 1.698 . . . . 0.0 109.188 -174.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 t -164.06 162.2 22.93 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.261 0.624 . . . . 0.0 110.041 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.4 p -74.85 161.14 29.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.944 0.898 . . . . 0.0 112.242 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 79.6 p -99.49 -32.08 11.3 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 119.363 -0.351 . . . . 0.0 111.553 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.25 -83.91 0.28 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.02 0.827 . . . . 0.0 112.533 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.57 106.74 2.75 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.042 1.737 . . . . 0.0 107.641 -177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.428 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -70.0 136.28 50.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.117 0.871 . . . . 0.0 108.975 172.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -74.41 -62.99 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -127.08 145.18 50.82 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 127.952 2.501 . . . . 0.0 105.931 -172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.1 173.59 15.84 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 126.808 2.043 . . . . 0.0 108.786 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -158.62 175.49 13.59 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 120.577 -1.327 . . . . 0.0 110.228 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.822 ' CG1' HD22 ' A' ' 126' ' ' LEU . 3.2 p -153.42 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 124.365 2.031 . . . . 0.0 111.752 171.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 p -62.27 172.65 1.4 Allowed 'General case' 0 C--N 1.319 -0.744 0 O-C-N 120.222 -1.549 . . . . 0.0 110.693 174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.32 73.98 0.3 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.27 134.43 50.72 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.061 1.315 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.3 t -141.34 147.96 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 126.513 1.925 . . . . 0.0 108.406 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -146.92 165.58 6.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.56 99.21 6.42 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.17 -75.84 0.51 Allowed Glycine 0 C--O 1.227 -0.343 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 165.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -139.53 104.55 4.97 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.599 1.16 . . . . 0.0 108.441 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 60.12 -31.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 130.439 3.495 . . . . 0.0 118.021 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.49 -24.9 0.47 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 127.192 2.33 . . . . 0.0 114.052 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.8 m 44.75 22.98 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 130.844 3.658 . . . . 0.0 115.069 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.93 120.11 3.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 118.787 0.721 . . . . 0.0 110.256 -165.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -100.32 -85.28 0.41 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -76.41 161.61 74.04 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.26 157.26 57.53 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.553 2.835 . . . . 0.0 110.642 164.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.79 150.21 42.2 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.489 1.916 . . . . 0.0 106.956 164.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -77.91 164.76 24.85 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.497 0.719 . . . . 0.0 109.398 157.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.443 ' CZ3' HD11 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -155.49 93.76 1.52 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 170.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 t -95.87 144.33 10.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 17' ' ' ILE . 5.4 t -143.65 127.81 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.3 m -132.0 109.28 9.92 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -88.88 144.33 9.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 O-C-N 121.307 -0.87 . . . . 0.0 110.027 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.82 125.46 45.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.31 1.844 . . . . 0.0 106.521 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -76.66 -171.99 2.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 166.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.461 ' ND2' ' H ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -55.68 91.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 157.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.85 -78.0 0.26 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.382 1.944 . . . . 0.0 111.65 165.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -142.54 -176.33 4.81 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.367 1.467 . . . . 0.0 109.027 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -65.2 149.53 49.77 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.5 pt -127.55 -11.96 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 119.113 -0.47 . . . . 0.0 111.086 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' HG2' HD21 ' A' ' 126' ' ' LEU . 2.5 tp10 -144.64 147.18 32.78 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -146.88 131.63 17.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 165.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -130.09 151.78 50.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.69 96.64 3.27 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -79.65 143.33 34.76 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.779 -1.564 . . . . 0.0 106.779 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 114' ' ' ARG . 7.2 p -155.58 132.48 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -98.41 27.53 4.68 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.201 1.001 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 112' ' ' VAL . 1.3 tpt180 -153.4 -163.97 1.8 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 126.515 1.926 . . . . 0.0 107.909 172.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 65.63 70.88 0.44 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.872 1.269 . . . . 0.0 110.906 169.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.6 56.78 9.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.22 115.26 1.98 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.392 1.077 . . . . 0.0 112.198 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.16 160.33 27.08 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.58 0.752 . . . . 0.0 110.914 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.1 pp -91.32 4.8 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 113.263 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.6 t -147.07 62.38 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.638 -1.289 . . . . 0.0 108.958 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.5 p -139.86 154.56 47.33 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.093 0.957 . . . . 0.0 110.595 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -155.61 -169.36 3.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 161.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.78 168.79 10.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.062 1.345 . . . . 0.0 113.23 -169.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.97 128.97 38.57 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.894 2.078 . . . . 0.0 111.375 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -149.42 46.37 0.97 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.281 0.633 . . . . 0.0 111.858 -177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.822 HD22 ' CG1' ' A' ' 77' ' ' VAL . 6.6 mp -76.14 155.84 34.28 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.476 1.11 . . . . 0.0 110.807 173.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -156.44 151.8 26.67 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.527 1.531 . . . . 0.0 107.87 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -140.24 131.83 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.137 -0.977 . . . . 0.0 108.576 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.255 1.361 0 C-N-CA 125.779 1.632 . . . . 0.0 108.012 176.507 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.63 121.15 4.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 101.691 -3.448 . . . . 0.0 101.691 -148.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -160.0 170.97 20.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.636 1.574 . . . . 0.0 107.263 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -145.49 118.12 8.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.538 1.063 . . . . 0.0 110.564 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -110.66 76.79 1.2 Allowed Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 124.825 1.25 . . . . 0.0 108.807 175.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.17 81.37 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.593 2.862 . . . . 0.0 111.363 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.34 -66.43 1.79 Allowed Glycine 0 CA--C 1.523 0.535 0 O-C-N 121.605 -0.684 . . . . 0.0 112.615 -176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.03 147.96 18.8 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -147.44 163.77 35.47 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.791 1.636 . . . . 0.0 109.407 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.47 179.91 28.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.26 1.409 . . . . 0.0 114.299 -173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.93 162.59 34.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.206 1.802 . . . . 0.0 110.21 173.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 78.5 mtp -77.65 150.43 34.59 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -148.59 164.52 34.01 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 108.442 163.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -136.9 151.82 49.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 129.051 2.94 . . . . 0.0 105.755 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 99' ' ' VAL . 13.0 p -139.01 147.7 24.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.523 -1.36 . . . . 0.0 108.392 174.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.11 140.34 49.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 tp -135.76 143.46 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -137.62 104.74 5.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.29 148.85 22.71 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.4 p -152.69 -175.01 5.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.111 1.764 . . . . 0.0 107.593 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.65 -151.79 48.62 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 119.694 1.134 . . . . 0.0 111.226 -174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -87.04 58.07 4.86 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 123.534 1.635 . . . . 0.0 110.376 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.466 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 13.2 p90 -61.06 -9.97 5.32 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.845 2.058 . . . . 0.0 114.111 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 23' ' ' PHE . 55.9 mtp180 -104.56 -8.48 18.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 121.352 1.887 . . . . 0.0 114.129 173.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.0 m -70.71 -22.03 62.49 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 120.084 1.311 . . . . 0.0 112.174 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -73.33 -178.81 3.12 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.251 1.02 . . . . 0.0 113.663 -173.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.98 93.02 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.362 1.465 . . . . 0.0 107.615 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -158.68 159.36 35.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 123.191 1.472 . . . . 0.0 112.985 160.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.5 p -68.7 163.81 23.08 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 112.739 -2.028 . . . . 0.0 110.488 157.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.9 t -132.87 148.87 31.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 156.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 21.5 t -123.97 79.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.17 80.38 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 ' H ' ' A' ' 52' ' ' VAL . 1.4 p -145.87 -168.01 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 166.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.46 169.51 17.56 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 121.545 -0.722 . . . . 0.0 110.643 157.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -89.43 19.8 4.26 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -164.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.21 -80.51 0.03 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 CA-C-O 121.697 0.609 . . . . 0.0 112.461 -158.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -69.76 -170.44 0.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.953 2.101 . . . . 0.0 110.973 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -106.08 145.01 31.99 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.233 1.013 . . . . 0.0 108.924 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.38 168.2 16.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.204 1.002 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -130.87 132.14 44.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.037 1.335 . . . . 0.0 109.475 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.6 144.98 26.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.5 1.12 . . . . 0.0 109.973 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -9.32 59.65 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-O 117.696 -1.614 . . . . 0.0 114.345 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.92 24.22 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 120.306 2.053 . . . . 0.0 109.738 -168.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.508 HG22 ' HG2' ' A' ' 46' ' ' GLU . 1.3 t -150.74 19.01 0.8 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.924 -0.485 . . . . 0.0 111.895 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.51 30.1 57.02 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 44' ' ' THR . 1.1 mt-10 -63.67 141.09 58.89 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 t -99.96 149.48 23.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 173.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -128.34 153.75 46.7 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.346 1.458 . . . . 0.0 108.906 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.38 174.41 3.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.89 0.852 . . . . 0.0 109.855 172.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.7 m -151.06 155.56 34.99 Favored Pre-proline 0 CA--C 1.536 0.437 0 O-C-N 120.708 -1.245 . . . . 0.0 109.295 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.02 168.61 73.48 Favored 'Cis proline' 0 CA--C 1.536 0.622 0 CA-C-N 119.48 0.85 . . . . 0.0 112.516 -4.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' H ' HG11 ' A' ' 33' ' ' VAL . 97.1 t -146.17 110.03 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.67 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.2 mt -83.48 157.22 22.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.768 0.794 . . . . 0.0 108.907 -176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.2 m -134.11 177.69 7.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.323 1.449 . . . . 0.0 108.599 170.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -52.59 -45.69 66.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.545 1.538 . . . . 0.0 111.685 -163.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -76.6 -18.09 58.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.719 1.608 . . . . 0.0 113.068 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.7 -3.59 58.74 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.941 1.696 . . . . 0.0 112.337 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.598 HD13 ' CE1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -89.86 29.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.365 1.439 . . . . 0.0 111.67 -178.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -79.92 43.02 0.57 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.261 1.824 . . . . 0.0 112.044 -172.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.49 166.82 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 126.581 1.952 . . . . 0.0 110.128 -170.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.71 -43.2 1.73 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.9 123.5 3.19 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.094 -1.431 . . . . 0.0 111.629 -170.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.71 169.05 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 119.748 1.158 . . . . 0.0 110.594 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -122.17 86.48 2.59 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.585 1.554 . . . . 0.0 109.074 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.62 143.83 31.66 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.036 -1.04 . . . . 0.0 110.863 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 t -155.46 160.93 40.99 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.722 0.692 . . . . 0.0 112.723 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -85.8 144.74 27.57 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.777 -0.577 . . . . 0.0 111.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 66.5 p -80.7 -55.14 5.03 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.327 1.451 . . . . 0.0 110.299 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -97.35 -104.53 2.29 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 126.301 1.905 . . . . 0.0 109.204 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -134.55 132.82 39.59 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.498 1.519 . . . . 0.0 108.964 -175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.85 144.68 29.92 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 118.537 0.608 . . . . 0.0 109.835 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.68 -59.56 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 171.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 35' ' ' ASN . 2.0 pp20? -118.43 166.91 12.1 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.797 1.239 . . . . 0.0 110.859 -176.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.0 t80 177.11 156.16 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.326 3.05 . . . . 0.0 106.765 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -131.36 154.18 48.86 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.233 1.379 . . . . 0.0 111.608 171.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 99' ' ' VAL . 21.7 t -143.03 61.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.6 p -91.87 155.55 18.12 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.089 -1.007 . . . . 0.0 108.393 165.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.13 1.6 6.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 126.4 1.952 . . . . 0.0 111.235 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.57 123.61 33.35 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.0 t -135.3 174.91 12.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 127.292 2.237 . . . . 0.0 108.006 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.47 140.95 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 C-N-CA 126.114 1.765 . . . . 0.0 106.278 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.87 109.99 21.43 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.63 -31.72 5.08 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-O 118.803 -0.998 . . . . 0.0 113.634 -170.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -170.99 162.96 7.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.707 2.403 . . . . 0.0 104.579 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -144.9 179.87 7.05 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.196 -0.94 . . . . 0.0 109.994 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -168.54 -91.48 0.08 OUTLIER Glycine 0 C--N 1.335 0.478 0 CA-C-N 119.214 0.916 . . . . 0.0 112.268 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 98.2 t -78.8 127.32 38.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.966 0.889 . . . . 0.0 109.674 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.2 m -102.83 8.84 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 125.861 1.664 . . . . 0.0 112.508 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -70.15 -49.16 53.39 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.875 -1.141 . . . . 0.0 112.521 -174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -135.37 146.49 58.1 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 126.21 1.804 . . . . 0.0 107.412 -171.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.69 145.2 36.57 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.24 1.96 . . . . 0.0 111.237 175.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.8 ptm -73.19 74.02 1.27 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-O 123.464 1.602 . . . . 0.0 110.343 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -62.15 148.36 44.72 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.135 171.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -128.87 151.11 49.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 166.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.6 t -139.11 91.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.41 142.26 14.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 167.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.41 102.14 3.03 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.623 HG21 HG21 ' A' ' 77' ' ' VAL . 58.1 t -87.8 134.42 27.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 124.261 1.024 . . . . 0.0 109.203 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.68 125.78 54.67 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.429 1.092 . . . . 0.0 108.102 170.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -70.47 175.83 4.49 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 157.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -43.9 94.45 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 128.117 2.567 . . . . 0.0 109.676 165.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.08 17.77 78.84 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 117.328 -1.818 . . . . 0.0 115.802 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.1 ptpm? -150.6 162.18 41.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.859 2.329 . . . . 0.0 111.204 173.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -80.13 149.52 30.55 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.497 1.519 . . . . 0.0 107.68 166.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.44 -13.13 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -148.25 155.69 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.321 1.049 . . . . 0.0 108.554 -176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 94.75 0.6 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.133 1.373 . . . . 0.0 110.632 177.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -120.42 130.62 54.42 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.819 1.247 . . . . 0.0 110.463 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.28 115.43 30.25 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.2 tp -88.14 139.93 30.0 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 168.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 114' ' ' ARG . 13.3 p -142.29 141.01 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 171.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -99.02 1.6 45.53 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.271 1.028 . . . . 0.0 111.554 -176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.447 ' H ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -138.56 -175.09 4.01 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.709 2.003 . . . . 0.0 110.351 175.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.7 t0 73.42 114.15 0.06 Allowed 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.231 2.612 . . . . 0.0 110.792 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 57.8 30.83 63.41 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.376 0.512 . . . . 0.0 113.608 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.65 60.89 3.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 123.714 1.721 . . . . 0.0 109.825 -166.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -101.56 -12.71 18.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.341 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 pt -80.36 167.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 126.6 1.96 . . . . 0.0 111.845 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -178.51 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.667 1.587 . . . . 0.0 112.096 161.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.68 171.93 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.614 1.166 . . . . 0.0 108.499 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.58 169.39 24.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.149 0.58 . . . . 0.0 109.739 171.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.0 154.45 34.99 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.879 0.872 . . . . 0.0 111.838 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.82 150.13 36.15 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 125.857 1.663 . . . . 0.0 111.452 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -150.29 85.93 1.4 Allowed 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mt -128.28 146.62 50.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.91 1.684 . . . . 0.0 107.385 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 1.9 t80 -147.82 133.58 18.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.68 93.37 3.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.817 0.818 . . . . 0.0 109.334 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.787 0 C-N-CA 125.57 1.548 . . . . 0.0 109.661 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.005 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -144.76 162.58 36.4 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -153.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -152.38 178.33 9.64 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 160.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -165.36 176.74 8.05 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.212 2.205 . . . . 0.0 107.304 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -109.43 54.17 0.26 Allowed Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.632 1.173 . . . . 0.0 112.784 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.26 108.76 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.799 2.333 . . . . 0.0 111.51 -170.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.6 -57.76 18.13 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.463 1.506 . . . . 0.0 112.269 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.81 84.7 1.51 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.949 1.262 . . . . 0.0 110.399 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -70.28 120.39 15.88 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.349 1.06 . . . . 0.0 108.188 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.32 175.98 52.32 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.646 1.137 . . . . 0.0 113.775 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.96 164.22 30.29 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 153.99 20.53 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 166.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -149.88 168.12 24.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.707 1.603 . . . . 0.0 107.761 168.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -130.87 151.41 51.32 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 104.023 -2.584 . . . . 0.0 104.023 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.16 149.54 23.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 127.77 38.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -169.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 tp -128.78 147.88 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -135.13 109.3 8.28 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -96.72 144.32 26.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 161.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 t -152.47 174.64 13.64 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.966 2.107 . . . . 0.0 106.273 157.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.0 -160.41 52.48 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.43 73.28 4.01 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.687 1.195 . . . . 0.0 111.518 -166.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -77.91 -27.98 49.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 119.975 -1.703 . . . . 0.0 114.017 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -81.58 50.24 1.46 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.331 1.452 . . . . 0.0 110.518 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 m -158.49 6.53 0.12 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.036 1.734 . . . . 0.0 111.198 -160.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -135.03 123.48 23.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 111.23 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mm -97.52 88.49 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.92 1.288 . . . . 0.0 108.799 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -147.28 168.41 21.82 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.594 -1.316 . . . . 0.0 110.407 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.68 154.01 32.38 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.561 0.744 . . . . 0.0 110.365 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.78 87.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.71 121.46 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.539 147.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -145.08 93.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 113.898 -1.501 . . . . 0.0 110.342 149.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 51' ' ' PRO . 5.0 p -153.44 156.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.575 1.08 . . . . 0.0 113.832 174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -80.86 142.3 33.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.54 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 8.05 39.19 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.05 -76.15 0.04 OUTLIER Glycine 0 CA--C 1.518 0.266 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -70.0 -179.53 1.93 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.217 0.532 . . . . 0.0 111.173 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -94.3 175.25 6.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.161 1.785 . . . . 0.0 110.75 172.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 167.66 12.41 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.608 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -124.16 129.35 50.67 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.541 1.536 . . . . 0.0 108.026 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HB2' HD21 ' A' ' 48' ' ' LEU . 18.1 t70 -72.63 156.15 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 109.72 175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.67 -9.21 66.71 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 117.208 -1.885 . . . . 0.0 114.914 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.32 5.77 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 121.184 2.492 . . . . 0.0 110.641 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.0 p -136.54 6.88 3.02 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -170.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.33 22.6 64.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.405 1.002 . . . . 0.0 112.129 -174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.33 149.48 48.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 118.727 1.264 . . . . 0.0 109.204 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.4 p -92.42 146.34 23.76 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.409 1.084 . . . . 0.0 109.411 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.2 mm? -113.3 165.17 12.68 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.157 1.383 . . . . 0.0 108.438 170.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.75 158.78 29.45 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 p -121.35 151.99 56.98 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.772 1.229 . . . . 0.0 110.28 172.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HA ' HG21 ' A' ' 33' ' ' VAL . 48.2 Cg_endo -72.84 170.41 69.23 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 CA-C-O 122.427 0.928 . . . . 0.0 111.302 -11.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 p -157.38 123.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 102.31 -3.218 . . . . 0.0 102.31 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.9 mt -131.44 115.37 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 -173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.13 152.67 32.67 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.0 m -128.84 -168.72 1.96 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.046 1.338 . . . . 0.0 108.46 168.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -51.5 -40.69 60.05 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 126.796 2.038 . . . . 0.0 112.423 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -70.27 -38.46 75.08 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.318 0.386 . . . . 0.0 111.581 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.58 -13.46 60.66 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.984 0.914 . . . . 0.0 112.024 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.46 8.06 1.56 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.351 -1.468 . . . . 0.0 113.976 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.77 -0.48 1.48 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.584 1.553 . . . . 0.0 113.399 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.7 m -69.74 149.29 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 119.861 -1.774 . . . . 0.0 110.952 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -88.62 -63.32 1.31 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.74 -1.225 . . . . 0.0 108.438 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -138.26 150.47 46.71 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.835 -1.165 . . . . 0.0 108.548 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.6 p -160.88 159.65 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 124.583 1.177 . . . . 0.0 108.548 158.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.0 m -115.99 126.07 53.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 167.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.58 152.02 35.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.534 0.734 . . . . 0.0 109.613 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.9 t -150.5 155.69 39.99 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 72' ' ' ALA . 6.8 p -65.25 159.37 23.91 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.746 1.619 . . . . 0.0 111.417 170.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -96.39 -19.62 19.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.306 0.642 . . . . 0.0 112.004 172.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -145.21 -96.98 0.21 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.303 0.954 . . . . 0.0 112.18 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -141.49 119.64 12.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.539 1.67 . . . . 0.0 110.205 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -82.08 146.52 29.59 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.513 1.125 . . . . 0.0 109.772 174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.25 -49.42 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.42 1.075 . . . . 0.0 108.928 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -127.66 150.11 49.9 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.982 1.313 . . . . 0.0 108.339 -169.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -159.32 160.24 34.88 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.905 1.282 . . . . 0.0 110.464 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' TYR . . . -150.68 153.1 34.98 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.552 1.523 . . . . 0.0 113.884 174.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.9 t -149.04 61.88 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.02 1.328 . . . . 0.0 109.97 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 p -88.28 171.58 10.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.265 -1.522 . . . . 0.0 110.902 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.11 10.32 24.78 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.396 0.998 . . . . 0.0 114.89 -170.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -63.77 156.43 43.52 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.518 1.159 . . . . 0.0 112.385 -172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 p -162.55 168.04 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 128.309 2.644 . . . . 0.0 108.149 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.7 p -133.22 158.72 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 164.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -83.92 119.91 25.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.02 1.728 . . . . 0.0 107.554 170.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -102.36 -72.63 0.95 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -126.46 159.73 32.51 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.282 1.833 . . . . 0.0 107.249 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -147.41 125.51 12.13 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.157 -0.964 . . . . 0.0 110.337 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.88 0.9 87.98 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.265 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.0 t 59.37 71.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.914 1.686 . . . . 0.0 110.483 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -105.44 -22.94 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.84 0.856 . . . . 0.0 111.574 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.52 28.25 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.71 2.004 . . . . 0.0 113.758 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -106.63 87.18 2.6 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.61 1.964 . . . . 0.0 110.306 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 114' ' ' ARG . 97.6 Cg_endo -63.12 94.91 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 1 C-N-CA 126.745 4.963 . . . . 0.0 111.922 -179.166 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.2 ttp -51.53 118.92 3.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.024 0.93 . . . . 0.0 109.702 170.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.66 148.7 30.1 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -127.8 155.27 44.34 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.345 1.458 . . . . 0.0 107.579 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.63 135.2 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 167.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG23 ' HG3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -125.9 131.77 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -135.03 100.12 4.48 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -171.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.71 140.04 16.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.213 1.005 . . . . 0.0 109.373 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -117.7 155.34 30.13 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.801 1.241 . . . . 0.0 108.223 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -85.28 -177.78 6.58 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.1 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.935 1.294 . . . . 0.0 109.535 160.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.59 48.34 63.12 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 126.034 1.778 . . . . 0.0 111.891 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -159.56 167.46 28.48 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.621 2.368 . . . . 0.0 106.603 166.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.45 139.08 40.62 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 169.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.3 pt -129.31 -14.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.761 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -144.75 151.34 38.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 119.628 1.104 . . . . 0.0 110.344 -170.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -162.82 125.08 2.66 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.531 1.132 . . . . 0.0 108.853 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.5 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -159.19 170.86 21.01 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 122.985 0.514 . . . . 0.0 110.41 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.85 152.83 45.43 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.432 1.493 . . . . 0.0 109.35 -171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -137.15 93.73 2.86 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -165.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.445 ' O ' ' HE3' ' A' ' 117' ' ' LYS . 7.3 p -151.42 138.64 13.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -169.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -150.06 134.69 17.52 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -168.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 92' ' ' PRO . 1.3 ptm180 -169.84 -167.61 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.503 1.521 . . . . 0.0 108.838 -168.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.58 -161.87 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.853 1.661 . . . . 0.0 111.676 156.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -47.94 108.07 0.31 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.979 1.752 . . . . 0.0 113.741 -171.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 112' ' ' VAL . 7.6 mtpm? -93.88 134.63 36.05 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 123.877 0.871 . . . . 0.0 109.391 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -69.35 17.06 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.948 1.299 . . . . 0.0 112.641 163.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.43 138.21 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 120.851 1.659 . . . . 0.0 110.266 177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 m -70.64 107.97 4.16 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.977 1.711 . . . . 0.0 112.095 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.63 150.83 6.61 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.457 1.903 . . . . 0.0 110.102 170.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -150.98 176.23 11.31 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 164.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -90.08 154.53 19.72 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.446 2.298 . . . . 0.0 110.16 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.5 mt -141.8 92.44 2.45 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.929 0.891 . . . . 0.0 110.854 -163.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -126.1 118.27 24.91 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 163.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -134.55 147.05 50.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 3.1 t80 -141.96 154.03 44.75 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.06 2.144 . . . . 0.0 105.777 175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -142.94 94.2 2.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 119.459 1.027 . . . . 0.0 109.11 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 p30 . . . . . 0 C--O 1.251 1.136 0 C-N-CA 126.305 1.842 . . . . 0.0 108.133 169.622 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.453 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.21 154.18 41.17 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 160.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -140.23 169.36 17.82 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.305 1.042 . . . . 0.0 108.66 -175.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.59 158.92 28.35 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.222 1.009 . . . . 0.0 110.12 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -140.56 148.37 53.01 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 157.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.41 75.17 4.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.51 2.807 . . . . 0.0 109.857 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.84 -32.42 4.43 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 123.837 0.732 . . . . 0.0 112.746 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.28 162.5 14.42 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 125.724 1.631 . . . . 0.0 110.857 -174.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -133.26 100.02 4.72 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 172.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.77 167.3 0.32 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 128.551 2.976 . . . . 0.0 112.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.34 166.9 20.23 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.407 1.083 . . . . 0.0 110.3 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtm -85.12 155.87 21.29 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.047 1.339 . . . . 0.0 107.907 171.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -162.59 170.06 19.17 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -142.16 111.33 6.42 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.812 2.045 . . . . 0.0 106.729 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG11 HG21 ' A' ' 32' ' ' VAL . 5.6 p -89.13 158.24 2.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.45 133.16 40.15 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tp -133.42 131.39 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -130.11 112.85 13.82 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -108.18 164.16 12.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.02 1.328 . . . . 0.0 107.929 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -163.12 172.54 14.73 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.53 -160.19 53.68 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-O 122.273 0.929 . . . . 0.0 111.59 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 82.12 2.71 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -86.06 -27.71 24.55 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.339 167.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.2 mtm-85 -65.49 -37.44 86.81 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.692 1.133 . . . . 0.0 111.894 -166.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.0 m -74.22 -0.01 15.51 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.11 135.34 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.29 115.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -115.19 154.45 28.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.7 m -146.74 160.81 41.78 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 119.55 -1.969 . . . . 0.0 108.936 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.464 ' CG1' HG12 ' A' ' 32' ' ' VAL . 46.2 t -143.01 146.07 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.662 0.665 . . . . 0.0 109.601 -173.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.87 23.79 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 125.003 1.321 . . . . 0.0 110.702 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.569 HG21 HG11 ' A' ' 15' ' ' VAL . 10.5 p -83.15 96.5 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 34' ' ' ALA 0.266 3.5 p -142.42 -174.09 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 170.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -109.94 150.41 28.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 160.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.71 14.48 4.66 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -151.62 -71.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.411 0 O-C-N 121.508 -0.745 . . . . 0.0 112.26 -170.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -87.87 171.7 10.17 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -172.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -80.44 151.33 29.38 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.861 0.864 . . . . 0.0 108.957 -175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -95.19 179.22 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.102 -0.374 . . . . 0.0 111.001 170.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -135.84 143.6 45.19 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.862 2.065 . . . . 0.0 108.43 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -102.79 160.58 14.47 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 127.174 2.19 . . . . 0.0 111.227 -170.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.04 2.5 66.1 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 117.84 -1.533 . . . . 0.0 113.965 -173.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.51 -57.9 3.26 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 120.792 2.296 . . . . 0.0 111.241 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.7 p -133.11 -3.58 3.12 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.634 1.574 . . . . 0.0 112.718 -163.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.16 62.81 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.64 1.114 . . . . 0.0 110.778 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.29 172.51 13.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.124 0.962 . . . . 0.0 109.674 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.0 p -113.76 121.22 43.41 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.557 1.143 . . . . 0.0 108.645 178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 144.34 48.07 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.528 1.131 . . . . 0.0 111.221 -163.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.13 109.91 4.27 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.413 1.085 . . . . 0.0 110.977 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.3 m -73.17 165.68 50.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.823 161.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.07 158.78 81.67 Favored 'Cis proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.474 -1.469 . . . . 0.0 108.5 -24.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.51 111.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 103.538 -2.764 . . . . 0.0 103.538 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.4 mt -129.45 101.35 6.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -163.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -79.65 159.1 26.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.86 1.314 . . . . 0.0 111.199 -160.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 p -122.61 175.06 6.7 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.366 2.266 . . . . 0.0 107.788 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -35.92 63.67 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.225 0.61 . . . . 0.0 111.812 -175.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -59.77 -48.79 80.27 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 127.826 2.45 . . . . 0.0 112.67 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -71.99 -18.18 62.0 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.05 1.34 . . . . 0.0 110.815 175.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.85 25.85 1.68 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.673 1.589 . . . . 0.0 111.064 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.41 41.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.756 1.623 . . . . 0.0 111.447 170.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.06 154.28 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.023 2.129 . . . . 0.0 111.117 -171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -87.94 -64.12 1.2 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.853 1.261 . . . . 0.0 110.774 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -144.44 159.6 42.47 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.887 -1.133 . . . . 0.0 111.333 -175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.0 p -162.92 170.3 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.045 0.938 . . . . 0.0 109.187 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 m -122.15 137.16 54.92 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 165.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -134.83 134.42 40.79 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.3 t -150.8 155.23 38.82 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.404 1.002 . . . . 0.0 110.697 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.7 p -78.59 139.87 38.53 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.142 1.377 . . . . 0.0 111.068 -173.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.8 p -80.66 -13.6 58.88 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.756 -1.215 . . . . 0.0 111.236 170.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -154.18 -128.87 1.25 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 120.994 -1.066 . . . . 0.0 110.972 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -89.82 121.91 32.4 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.749 -0.853 . . . . 0.0 111.316 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.37 130.74 35.73 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 164.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.93 -63.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 125.151 1.532 . . . . 0.0 108.002 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -127.59 151.86 48.37 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 104.151 -2.536 . . . . 0.0 104.151 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.68 171.55 16.51 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.011 1.324 . . . . 0.0 108.433 -170.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -168.39 171.27 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.748 1.219 . . . . 0.0 110.563 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.0 t -158.21 101.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.328 1 C-N-CA 132.65 4.38 . . . . 0.0 102.98 -169.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.7 p -129.87 146.93 51.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.17 0.896 . . . . 0.0 109.077 164.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.44 -35.52 87.24 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.92 171.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 47.5 79.25 0.07 OUTLIER Glycine 0 C--N 1.338 0.659 0 C-N-CA 126.787 2.136 . . . . 0.0 112.913 173.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.8 t -128.19 144.45 37.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 123.799 0.84 . . . . 0.0 109.397 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.1 155.01 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -72.85 92.2 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 127.36 2.264 . . . . 0.0 107.653 168.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.56 -82.6 0.7 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -134.63 61.92 1.66 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.866 1.266 . . . . 0.0 107.771 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -151.23 -172.89 4.33 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.765 -1.209 . . . . 0.0 108.368 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.35 1.54 0.03 OUTLIER Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.141 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.32 -169.02 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 119.845 1.822 . . . . 0.0 110.692 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.96 157.15 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.728 2.011 . . . . 0.0 108.47 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -147.37 170.83 16.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.168 0.894 . . . . 0.0 112.708 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.66 161.53 20.23 Favored Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 121.94 -0.475 . . . . 0.0 111.495 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -67.92 92.59 0.38 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.804 2.336 . . . . 0.0 110.833 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -60.18 107.28 0.62 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 168.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 141.45 53.32 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.83 137.85 45.3 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.8 t -140.09 138.82 37.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.2 130.17 38.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' OE1' ' A' ' 105' ' ' GLU . 1.2 m -141.29 96.89 3.06 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 t -88.98 77.7 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.627 1.971 . . . . 0.0 111.133 -171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -65.25 125.67 25.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 120.553 -1.342 . . . . 0.0 108.288 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -169.6 0.17 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.29 1.436 . . . . 0.0 108.534 168.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -60.11 79.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 110.573 162.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.82 25.17 53.86 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 118.482 -1.177 . . . . 0.0 114.495 168.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -148.84 171.91 15.52 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.711 1.604 . . . . 0.0 108.835 166.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.451 ' OE1' HG22 ' A' ' 98' ' ' THR . 13.2 tp10 -103.28 153.45 20.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.85 -12.72 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.258 2.223 . . . . 0.0 113.231 -176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -147.62 168.97 20.66 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.005 1.722 . . . . 0.0 108.182 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.26 64.97 0.06 Allowed 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.923 -1.736 . . . . 0.0 110.345 168.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -76.63 130.42 37.79 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 108.788 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 t -123.73 153.51 40.78 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 159.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.2 mp -124.87 135.54 52.98 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 127.095 2.158 . . . . 0.0 105.567 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 81.2 t -142.42 102.55 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -143.07 149.23 37.9 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.715 0.806 . . . . 0.0 110.319 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -175.73 -175.6 0.78 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.489 1.916 . . . . 0.0 109.08 -168.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -45.95 -59.29 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.541 2.336 . . . . 0.0 113.135 166.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.76 55.92 4.9 Favored Glycine 0 CA--C 1.523 0.566 0 O-C-N 120.571 -1.331 . . . . 0.0 110.83 -178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -153.03 16.85 0.56 Allowed 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -170.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 75.13 -43.6 0.51 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 120.787 1.631 . . . . 0.0 112.128 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.9 tp -147.11 164.17 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 126.663 1.985 . . . . 0.0 108.758 164.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.4 m -115.9 9.13 14.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.028 1.731 . . . . 0.0 113.341 -168.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.2 p -125.57 155.6 40.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.194 0.998 . . . . 0.0 110.387 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -165.92 143.33 5.5 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.978 1.311 . . . . 0.0 108.288 165.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -139.71 143.92 37.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.917 2.087 . . . . 0.0 106.663 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 pp -118.37 144.52 45.84 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.778 1.631 . . . . 0.0 109.727 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -139.27 134.66 32.94 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 mt -143.5 166.68 24.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -144.05 158.1 43.92 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.963 -1.711 . . . . 0.0 108.9 162.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.49 132.9 16.58 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.866 2.066 . . . . 0.0 109.274 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 . . . . . 0 C--O 1.254 1.306 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 156.906 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.98 152.32 34.75 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -138.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -137.71 -169.4 2.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.01 1.324 . . . . 0.0 110.123 -173.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.66 131.36 5.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.249 1.02 . . . . 0.0 108.671 -163.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.5 72.2 66.76 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 124.418 1.087 . . . . 0.0 109.234 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.27 68.22 8.35 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.628 2.885 . . . . 0.0 113.197 -167.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.36 102.83 0.38 Allowed Glycine 0 C--N 1.336 0.538 0 O-C-N 120.716 -1.24 . . . . 0.0 113.608 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.32 -103.52 0.17 Allowed Glycine 0 C--N 1.333 0.397 0 O-C-N 121.522 -0.987 . . . . 0.0 113.632 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -55.92 146.28 22.58 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.922 1.289 . . . . 0.0 110.387 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.32 -176.92 47.1 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 122.334 0.963 . . . . 0.0 112.382 -170.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.28 168.71 19.8 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 127.425 2.29 . . . . 0.0 107.657 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 29.8 mtp -85.3 144.22 28.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -150.55 172.04 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.411 0.684 . . . . 0.0 109.609 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -141.11 139.84 34.05 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.16 2.584 . . . . 0.0 105.913 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.08 144.39 31.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 m -123.47 98.96 6.09 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.3 134.96 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -136.36 85.23 2.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -86.95 154.2 20.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.4 t -165.32 158.18 15.98 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.22 -116.17 5.14 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.35 97.21 6.19 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.044 1.337 . . . . 0.0 108.078 -169.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -120.26 -13.17 8.93 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -103.62 21.49 16.04 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.852 1.205 . . . . 0.0 112.436 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.3 m -143.98 62.31 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.169 0.988 . . . . 0.0 110.81 166.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -144.81 132.52 21.09 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.697 1.599 . . . . 0.0 110.211 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.0 mm -75.94 89.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 119.419 1.009 . . . . 0.0 111.392 -174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.54 172.16 17.0 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.01 -1.056 . . . . 0.0 111.358 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -140.37 169.68 17.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.878 1.671 . . . . 0.0 109.926 -171.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -136.15 100.69 2.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.726 1.251 . . . . 0.0 108.167 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 62.1 t -85.46 82.28 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 p -129.72 75.43 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.45 0.643 . . . . 0.0 110.478 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 52' ' ' VAL . 5.0 p -148.17 161.58 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 O-C-N 120.862 -1.149 . . . . 0.0 109.449 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.07 145.05 26.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.13 21.75 0.7 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.897 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.05 -83.37 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 t -66.74 172.69 4.05 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 125.119 1.129 . . . . 0.0 111.018 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -92.2 158.9 15.91 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.9 1.28 . . . . 0.0 110.742 178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 163.24 13.61 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.768 1.227 . . . . 0.0 110.953 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.13 131.86 54.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.51 1.924 . . . . 0.0 109.135 173.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HB2' HD21 ' A' ' 48' ' ' LEU . 2.3 m-20 -84.17 133.91 34.59 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -178.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.31 9.1 7.85 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.545 0.593 . . . . 0.0 112.787 169.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.86 -63.69 1.14 Allowed 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 120.911 -1.347 . . . . 0.0 108.525 166.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.6 p -154.26 3.31 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.144 1.378 . . . . 0.0 112.281 -157.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.47 23.61 62.41 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.775 1.171 . . . . 0.0 112.737 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.73 169.53 4.96 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.133 . . . . 0.0 110.478 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -116.13 127.15 54.59 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.769 1.228 . . . . 0.0 110.478 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.7 mm? -123.18 161.41 24.53 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.497 1.519 . . . . 0.0 107.541 -167.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.42 177.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.511 1.124 . . . . 0.0 112.179 -173.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 p -144.25 156.15 57.75 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.208 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.53 167.53 70.04 Favored 'Cis proline' 0 CA--C 1.543 0.926 0 CA-C-N 119.433 0.833 . . . . 0.0 111.107 -14.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.449 ' H ' HG11 ' A' ' 33' ' ' VAL . 38.6 t -151.74 116.89 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 128.47 2.708 . . . . 0.0 104.52 173.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.97 103.37 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -171.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -77.83 130.12 36.26 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.4 m -99.86 -173.06 2.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.642 1.177 . . . . 0.0 109.929 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -60.51 -41.91 95.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.208 0.603 . . . . 0.0 111.691 -174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -73.63 -37.5 65.34 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 123.216 0.322 . . . . 0.0 110.268 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.15 4.29 4.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.364 1.465 . . . . 0.0 112.758 175.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.46 11.77 25.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 120.939 -1.101 . . . . 0.0 111.91 176.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -73.69 44.32 0.17 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.761 1.625 . . . . 0.0 111.394 176.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -117.61 175.61 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 129.583 3.153 . . . . 0.0 108.205 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -132.13 -51.73 0.96 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.041 1.291 . . . . 0.0 111.462 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.64 29.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.264 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.5 p -164.33 162.52 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.024 0.93 . . . . 0.0 108.733 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.5 m -116.15 109.06 16.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 159.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.14 135.05 48.3 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.4 t -142.29 156.63 45.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.721 0.772 . . . . 0.0 109.777 -174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 72' ' ' ALA . 42.6 p -94.63 131.61 40.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 p -58.95 -41.88 88.51 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.634 0.374 . . . . 0.0 110.36 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.62 -145.96 5.67 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.114 1.816 . . . . 0.0 111.779 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -73.99 113.43 11.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.817 0.847 . . . . 0.0 110.09 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -75.97 125.43 29.1 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 168.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.6 mm -67.27 -59.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 O-C-N 124.742 1.276 . . . . 0.0 108.492 174.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.2 162.18 16.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.887 2.075 . . . . 0.0 109.783 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -163.54 154.57 16.4 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.237 2.215 . . . . 0.0 107.86 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 31' ' ' VAL . . . -130.51 150.69 51.61 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.576 1.535 . . . . 0.0 112.789 170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 99' ' ' VAL . 4.0 t -142.84 50.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.605 1.562 . . . . 0.0 108.793 -171.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -75.74 173.11 11.54 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.725 -1.234 . . . . 0.0 110.323 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.57 -0.18 2.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.749 1.166 . . . . 0.0 111.912 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.42 160.05 47.13 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.76 1.28 . . . . 0.0 112.347 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 t -140.19 169.89 15.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 129.425 3.09 . . . . 0.0 106.127 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.88 154.62 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.69 84.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.93 1.692 . . . . 0.0 110.589 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.58 -69.79 1.35 Allowed Glycine 0 CA--C 1.523 0.589 0 O-C-N 121.769 -0.582 . . . . 0.0 112.301 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.97 155.2 11.75 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.368 1.067 . . . . 0.0 108.806 -165.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -57.92 152.39 16.25 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.041 1.736 . . . . 0.0 112.767 -165.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.22 178.64 25.67 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.909 1.719 . . . . 0.0 112.059 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.5 m -136.48 -13.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.0 t 44.32 59.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.872 1.669 . . . . 0.0 114.229 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -60.2 -42.19 94.57 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.928 -1.107 . . . . 0.0 111.962 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.74 158.28 68.22 Favored Pre-proline 0 C--O 1.233 0.221 0 C-N-CA 124.056 0.942 . . . . 0.0 111.373 -176.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.4 112.51 3.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.978 3.119 . . . . 0.0 112.047 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.25 154.75 34.08 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.861 1.264 . . . . 0.0 110.222 167.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -142.46 104.22 4.37 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -100.61 122.45 43.3 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 126.291 1.837 . . . . 0.0 107.152 171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.53 138.19 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.9 t -140.15 112.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -129.98 125.81 36.28 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 77' ' ' VAL . 13.3 t -109.94 132.36 58.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -117.56 110.28 17.74 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -67.07 170.86 6.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.96 83.13 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.93 2.092 . . . . 0.0 111.663 167.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.44 17.28 53.27 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.995 1.283 . . . . 0.0 115.615 172.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.07 175.96 13.29 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 120.437 2.118 . . . . 0.0 110.73 164.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -89.04 144.25 26.28 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 108.065 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.82 -0.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.538 0.735 . . . . 0.0 112.272 165.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.04 154.51 41.29 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 119.589 1.086 . . . . 0.0 110.841 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -162.23 91.48 0.78 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.313 1.045 . . . . 0.0 108.519 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 mmpp? -122.04 154.0 37.86 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.428 1.091 . . . . 0.0 109.583 -176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 t -152.43 116.44 4.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.687 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 tp -72.25 31.55 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.721 2.009 . . . . 0.0 112.154 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.06 120.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 120.671 -1.268 . . . . 0.0 108.614 -169.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -142.91 130.86 21.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 126.737 2.015 . . . . 0.0 109.034 175.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.61 158.33 23.15 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 167.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 44.5 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.817 2.847 . . . . 0.0 113.802 -173.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.87 126.95 1.38 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 106.76 -2.536 . . . . 0.0 106.76 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -143.92 26.47 1.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.208 1.003 . . . . 0.0 110.307 -170.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.254 7.9 pm0 50.71 26.19 2.41 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.004 2.122 . . . . 0.0 115.977 173.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.09 176.86 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.223 -1.548 . . . . 0.0 114.085 -175.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.8 t -153.81 59.07 0.74 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.107 1.363 . . . . 0.0 110.323 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.62 162.09 35.16 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.245 -1.534 . . . . 0.0 110.97 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.87 -11.9 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -128.66 152.83 47.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.058 1.753 . . . . 0.0 108.712 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -134.77 142.95 46.86 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.1 1.36 . . . . 0.0 107.602 175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -134.17 91.74 2.85 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.945 1.298 . . . . 0.0 109.245 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -130.6 132.81 45.71 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.706 0.802 . . . . 0.0 109.068 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.412 ' HD1' ' HB2' ' A' ' 76' ' ' ALA . 32.0 t80 -146.59 129.39 16.22 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.862 1.665 . . . . 0.0 107.27 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -126.43 94.35 4.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.963 1.705 . . . . 0.0 108.373 -172.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 117.362 -1.304 . . . . 0.0 110.853 -176.127 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.65 160.76 38.29 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.142 0.977 . . . . 0.0 109.241 -168.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.72 153.32 18.33 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.52 1.528 . . . . 0.0 106.994 156.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -165.08 145.54 7.22 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.807 0.843 . . . . 0.0 108.733 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -118.19 78.69 13.93 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.514 1.526 . . . . 0.0 109.462 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -85.22 89.23 0.83 Allowed 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.165 3.243 . . . . 0.0 112.369 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.12 -66.38 2.11 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 122.012 -0.43 . . . . 0.0 112.087 175.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.51 155.14 19.51 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 124.722 1.153 . . . . 0.0 112.351 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -142.04 117.5 10.25 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.1 -175.1 4.75 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 128.335 2.874 . . . . 0.0 112.004 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.37 160.74 36.46 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.989 -0.713 . . . . 0.0 110.837 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.8 mtm -76.31 148.8 37.26 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.1 167.38 22.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.692 0.797 . . . . 0.0 110.114 166.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -143.18 121.23 12.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.28 142.92 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.0 m -134.73 118.86 17.56 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 tp -125.75 127.5 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 17.5 mt-10 -113.65 103.51 11.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 168.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -81.32 176.27 9.88 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 150.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 p -173.26 166.09 4.83 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 170.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.93 -150.01 46.39 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.81 113.8 16.04 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -118.06 -28.32 5.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.095 1.358 . . . . 0.0 110.984 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -77.33 51.02 0.82 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.071 1.748 . . . . 0.0 111.79 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 54.3 m -149.0 19.52 0.99 Allowed 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 127.979 2.512 . . . . 0.0 109.449 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -151.09 113.51 4.62 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.537 2.335 . . . . 0.0 107.125 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.26 108.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -142.21 159.39 42.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.679 1.228 . . . . 0.0 114.129 171.318 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -83.88 154.59 23.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 112.7 -2.045 . . . . 0.0 109.319 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.439 HG23 HD21 ' A' ' 59' ' ' LEU . 24.7 t -134.11 110.88 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 161.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.1 124.27 29.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.976 -1.077 . . . . 0.0 109.348 150.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -151.76 111.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 O-C-N 124.146 0.904 . . . . 0.0 109.815 141.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 34' ' ' ALA . 9.3 p -157.92 -173.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 158.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.614 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -111.14 153.47 25.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.511 1.524 . . . . 0.0 109.212 165.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.29 12.55 19.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.06 -77.41 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 107.936 -2.066 . . . . 0.0 107.936 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -69.55 171.33 9.06 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.299 0.647 . . . . 0.0 110.901 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -84.16 166.17 17.82 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 123.223 1.487 . . . . 0.0 110.855 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -103.1 154.95 18.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.058 175.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -122.66 133.16 54.52 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.903 1.281 . . . . 0.0 109.121 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HB2' HD21 ' A' ' 48' ' ' LEU . 23.6 t0 -75.39 126.49 31.11 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.584 1.154 . . . . 0.0 108.964 171.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -13.45 60.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.547 -1.141 . . . . 0.0 113.654 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.26 4.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.756 1.778 . . . . 0.0 110.768 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.4 p -137.4 -1.61 2.08 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.643 1.177 . . . . 0.0 111.74 -163.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.33 21.19 76.01 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.666 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -65.14 147.29 53.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.857 1.329 . . . . 0.0 109.074 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.3 p -92.08 116.49 28.98 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.844 1.657 . . . . 0.0 107.304 173.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 41' ' ' ASP . 1.3 mm? -85.38 163.09 18.75 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.95 177.32 6.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.958 0.885 . . . . 0.0 109.216 172.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -144.63 162.37 39.25 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 0.0 109.367 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HA ' HG21 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -70.19 176.26 34.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 119.94 1.014 . . . . 0.0 110.847 -13.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 t -150.79 115.76 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -124.92 138.21 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.97 156.85 21.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.983 0.913 . . . . 0.0 110.342 -170.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.2 m -141.35 -172.01 3.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.888 2.075 . . . . 0.0 108.05 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.95 -36.55 67.91 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -161.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -66.78 -26.22 66.86 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.746 -1.221 . . . . 0.0 111.672 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -100.94 4.42 42.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.872 2.469 . . . . 0.0 110.877 -178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.449 HD12 ' HE3' ' A' ' 28' ' ' LYS . 2.4 mm? -79.42 -0.34 32.49 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.366 -1.459 . . . . 0.0 112.254 167.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.96 26.43 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.178 2.991 . . . . 0.0 114.824 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.64 134.57 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.643 1.577 . . . . 0.0 108.628 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -74.75 -43.87 52.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.565 0.697 . . . . 0.0 109.838 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -143.88 141.17 30.15 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -161.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -157.88 138.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 O-C-N 124.513 1.133 . . . . 0.0 108.13 -173.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.2 m -129.54 99.5 5.19 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.224 1.41 . . . . 0.0 107.221 165.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.71 153.43 24.3 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.2 t -151.79 163.39 39.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.579 0.704 . . . . 0.0 109.206 -171.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -86.9 161.71 18.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.603 -0.686 . . . . 0.0 111.016 -175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.8 p -97.24 -20.27 18.02 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.667 -0.645 . . . . 0.0 111.851 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.28 -97.8 0.19 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.517 1.532 . . . . 0.0 110.09 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -133.92 132.95 40.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.011 1.905 . . . . 0.0 111.797 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -85.92 142.04 29.12 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 169.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 mt -99.06 -55.79 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 O-C-N 125.34 1.65 . . . . 0.0 107.078 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -123.89 137.58 54.62 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.397 1.879 . . . . 0.0 106.577 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -159.46 143.99 15.24 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.754 2.022 . . . . 0.0 106.663 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.24 161.68 37.31 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.947 0.899 . . . . 0.0 110.486 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.73 90.56 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 128.357 2.663 . . . . 0.0 105.621 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 89.2 p -137.66 171.49 14.37 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 119.741 -1.849 . . . . 0.0 109.664 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.89 -94.27 0.98 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.46 72.47 0.62 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.356 0.979 . . . . 0.0 111.786 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.9 t -82.66 155.27 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 163.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.41 162.04 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 158.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -84.02 131.3 34.83 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.14 -158.95 11.08 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.957 1.741 . . . . 0.0 109.736 177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -120.75 92.07 3.68 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.382 1.073 . . . . 0.0 109.254 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.15 -86.04 0.65 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.249 1.82 . . . . 0.0 106.431 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.98 -152.62 6.97 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 127.712 2.577 . . . . 0.0 109.995 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.7 t -133.97 -8.68 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.031 1.332 . . . . 0.0 111.102 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 90' ' ' ASN 0.341 7.7 p 46.51 -166.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 127.26 2.224 . . . . 0.0 111.709 -175.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.518 ' H ' HG22 ' A' ' 89' ' ' VAL . 55.0 t30 -162.0 -75.42 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.159 -1.588 . . . . 0.0 110.385 162.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 163.77 25.8 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.177 1.791 . . . . 0.0 111.514 -171.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.67 155.05 71.61 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.099 1.866 . . . . 0.0 113.959 -169.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.82 99.21 5.04 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 -178.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -67.76 157.14 35.39 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.403 164.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.09 150.16 39.14 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 128.875 2.87 . . . . 0.0 106.314 168.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.6 24.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 171.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.71 146.24 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 99.6 m -159.3 100.77 1.53 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.514 ' H ' ' HB3' ' A' ' 107' ' ' GLU . 17.6 t -76.01 143.48 13.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -116.88 142.98 46.24 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.485 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 71.9 tttt -106.24 -165.41 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 34.6 p30 -44.79 73.75 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.308 3.043 . . . . 0.0 113.632 165.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.76 -14.39 9.8 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 117.343 -1.81 . . . . 0.0 114.538 157.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -164.2 171.59 14.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.863 1.832 . . . . 0.0 111.407 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -52.38 140.03 23.12 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 128.77 2.828 . . . . 0.0 110.609 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.95 -8.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.514 ' HB3' ' H ' ' A' ' 99' ' ' VAL . 13.5 tm-20 -139.13 172.43 12.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -171.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -174.93 110.5 0.12 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.814 1.646 . . . . 0.0 111.694 168.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -131.19 142.5 50.21 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.922 -1.111 . . . . 0.0 112.981 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.56 128.14 36.59 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.872 2.069 . . . . 0.0 108.665 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.2 mt -125.31 160.3 29.63 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.853 1.261 . . . . 0.0 109.804 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.1 p -163.81 81.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.078 0.942 . . . . 0.0 109.5 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -91.0 174.3 7.49 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.127 -0.983 . . . . 0.0 110.733 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -158.19 159.73 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.33 2.652 . . . . 0.0 106.113 165.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.31 144.91 37.74 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 161.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.66 47.28 69.29 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -170.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -98.92 171.78 7.84 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 150.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.05 -58.47 7.17 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.249 0.547 . . . . 0.0 110.437 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 tp -148.24 99.16 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.976 -168.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -44.63 120.7 2.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 127.286 2.234 . . . . 0.0 111.167 166.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.17 151.02 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.58 1.952 . . . . 0.0 108.475 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -147.0 156.39 43.0 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 168.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.07 51.9 0.26 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.868 1.267 . . . . 0.0 111.588 -162.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mp -138.29 146.9 43.03 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.486 -1.384 . . . . 0.0 112.56 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.46 56.43 0.09 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 148.7 27.66 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 120.736 -1.228 . . . . 0.0 110.79 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.83 158.02 44.31 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.625 1.57 . . . . 0.0 108.408 170.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.08 103.27 4.28 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.587 1.555 . . . . 0.0 107.606 171.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 p30 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 168.8 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.774 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -139.96 163.6 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -155.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -77.62 77.97 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.404 1.481 . . . . 0.0 110.446 -170.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -123.2 109.1 13.57 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.901 2.08 . . . . 0.0 107.734 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -130.66 62.2 63.63 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.72 1.608 . . . . 0.0 110.565 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.66 102.56 1.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.97 2.446 . . . . 0.0 110.446 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.21 -77.32 0.18 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.116 0.865 . . . . 0.0 113.177 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 51.65 54.35 25.15 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.091 0.853 . . . . 0.0 112.118 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -95.76 143.11 27.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 164.43 54.92 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.648 1.118 . . . . 0.0 112.651 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 -179.2 6.3 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.745 2.018 . . . . 0.0 109.49 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 53.2 mtm -78.95 154.51 29.54 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -149.18 163.43 37.64 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.389 0.614 . . . . 0.0 110.716 164.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -139.63 151.89 46.34 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -156.03 150.58 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -142.54 147.49 36.04 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 171.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.4 tt -130.69 138.79 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 C-N-CA 127.238 2.215 . . . . 0.0 106.971 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -127.27 86.48 2.5 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.004 1.721 . . . . 0.0 106.538 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -88.67 165.79 14.53 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.443 2.297 . . . . 0.0 108.752 172.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t 174.65 171.91 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 129.326 3.05 . . . . 0.0 106.834 172.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.15 -153.84 43.8 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -165.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -86.93 51.14 2.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.969 1.366 . . . . 0.0 112.152 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -55.47 -40.43 71.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.707 1.603 . . . . 0.0 114.663 -171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -86.79 28.23 0.91 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.038 1.29 . . . . 0.0 112.364 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 m -126.35 21.9 7.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.484 1.914 . . . . 0.0 110.781 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.67 120.48 29.57 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.252 1.421 . . . . 0.0 111.314 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.7 mt -72.8 98.45 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 125.398 1.479 . . . . 0.0 108.049 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 80' ' ' GLY . 8.0 tptt -148.45 -166.99 2.69 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.7 m -155.49 173.74 16.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 127.144 2.177 . . . . 0.0 106.335 -170.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 32' ' ' VAL . 1.3 p -144.2 177.11 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 170.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.37 32.58 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.42 1.088 . . . . 0.0 109.562 171.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG23 HG22 ' A' ' 30' ' ' VAL . 39.3 t -78.49 87.14 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 O-C-N 120.219 -1.551 . . . . 0.0 107.988 177.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 34' ' ' ALA . 10.0 p -151.05 -176.18 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 163.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 33' ' ' VAL . . . -108.25 152.83 24.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 159.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.36 11.14 31.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.432 1.093 . . . . 0.0 113.636 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.54 -4.07 0.08 OUTLIER Glycine 0 CA--C 1.533 1.217 0 CA-C-O 118.222 -1.321 . . . . 0.0 115.89 -171.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 t -143.49 178.51 7.72 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 120.206 2.003 . . . . 0.0 108.724 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.53 157.52 19.15 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.175 1.39 . . . . 0.0 110.067 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.98 179.64 3.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.782 0.833 . . . . 0.0 112.22 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -134.64 119.33 18.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.786 1.234 . . . . 0.0 110.62 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -75.58 144.83 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.007 1.723 . . . . 0.0 109.315 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.92 13.73 55.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.732 1.158 . . . . 0.0 112.893 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.23 -64.12 1.13 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 119.625 1.712 . . . . 0.0 108.968 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 p -133.57 -14.03 2.55 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 127.066 2.146 . . . . 0.0 111.53 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.24 35.69 29.33 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.133 -0.98 . . . . 0.0 111.818 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -67.79 169.9 8.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.997 1.319 . . . . 0.0 108.853 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.59 117.03 29.76 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.771 1.228 . . . . 0.0 110.59 -174.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -118.01 146.09 44.29 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.141 0.577 . . . . 0.0 110.23 -166.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.09 -172.44 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.427 1.491 . . . . 0.0 111.833 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 p -153.55 162.13 27.41 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.205 -0.935 . . . . 0.0 112.884 -172.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.84 172.98 25.9 Favored 'Cis proline' 0 CA--C 1.54 0.804 0 CA-C-N 118.897 0.642 . . . . 0.0 111.181 -17.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' H ' HG11 ' A' ' 33' ' ' VAL . 65.7 t -144.89 94.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.9 mm -93.64 145.94 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 166.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB2' HG12 ' A' ' 30' ' ' VAL . 31.5 mt -114.14 131.69 56.33 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.5 m -97.76 -175.81 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 124.219 0.949 . . . . 0.0 109.027 165.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.96 -49.16 8.61 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 129.801 3.241 . . . . 0.0 113.427 -176.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -80.07 -17.93 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -88.57 -17.49 30.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.129 1.372 . . . . 0.0 111.866 169.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.36 22.98 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 128.78 2.832 . . . . 0.0 112.792 -178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.96 26.92 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.602 1.561 . . . . 0.0 111.398 -165.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.9 m -96.15 172.17 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 119.447 1.021 . . . . 0.0 111.693 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -121.95 -63.98 1.25 Allowed 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 126.78 23.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.121 173.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 66' ' ' LEU . 2.9 p -156.91 151.2 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 123.804 0.69 . . . . 0.0 109.28 169.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 27.9 m -117.13 123.82 47.67 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -109.49 150.73 27.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 125.082 1.353 . . . . 0.0 110.018 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.9 t -157.64 152.43 25.35 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 119.198 0.908 . . . . 0.0 109.991 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -76.24 146.74 38.81 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.107 0.963 . . . . 0.0 111.245 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.4 p -83.1 -47.37 11.71 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -98.19 -137.71 9.85 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 124.821 1.2 . . . . 0.0 110.311 170.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -100.27 147.72 25.45 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.085 1.754 . . . . 0.0 107.323 172.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.404 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -79.1 175.76 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.86 1.209 . . . . 0.0 110.199 164.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.28 -51.48 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 165.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -129.97 152.02 49.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.037 1.735 . . . . 0.0 106.981 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -165.42 146.76 7.34 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.786 2.435 . . . . 0.0 105.174 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.68 147.78 30.33 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.937 0.789 . . . . 0.0 109.489 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.29 110.39 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 -169.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.99 154.69 42.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -163.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.16 -158.9 9.07 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -160.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' C ' ' HE2' ' A' ' 28' ' ' LYS . . . 74.11 -161.5 53.86 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -167.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.9 p -164.57 175.35 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.756 1.622 . . . . 0.0 107.617 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.13 162.51 3.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 166.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -80.77 79.75 7.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -55.28 -47.73 73.24 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.279 0.466 . . . . 0.0 112.273 -167.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -140.93 32.66 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.097 1.359 . . . . 0.0 109.188 172.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 49.57 -87.04 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.384 2.274 . . . . 0.0 109.737 -156.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.52 170.21 16.62 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.293 1.901 . . . . 0.0 110.613 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.06 157.99 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.28 1.032 . . . . 0.0 108.239 170.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t 58.09 85.67 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.863 2.065 . . . . 0.0 112.215 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -153.03 175.81 12.57 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.145 -0.972 . . . . 0.0 111.027 169.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -85.61 165.87 33.1 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 125.555 1.542 . . . . 0.0 111.21 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.54 101.94 1.44 Allowed 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.963 3.109 . . . . 0.0 112.96 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -69.15 97.09 0.87 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.617 1.967 . . . . 0.0 109.131 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -72.23 140.02 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -124.56 138.3 54.34 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.805 1.242 . . . . 0.0 108.347 172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 t -145.7 128.76 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -133.57 137.29 53.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.9 m -127.93 111.56 13.71 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.65 124.58 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 129.326 3.05 . . . . 0.0 112.218 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 105' ' ' GLU . 4.6 m-85 -114.14 164.38 13.94 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.537 1.535 . . . . 0.0 108.977 174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -132.87 -162.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 165.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -62.24 27.18 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 127.424 2.29 . . . . 0.0 115.791 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -144.97 -66.83 0.02 OUTLIER Glycine 0 CA--C 1.526 0.726 0 O-C-N 120.427 -1.42 . . . . 0.0 110.656 164.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -154.67 -171.66 3.92 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.676 1.59 . . . . 0.0 109.475 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 100' ' ' TYR . 7.5 pm0 -67.91 131.24 45.14 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.096 0.958 . . . . 0.0 109.423 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.1 pt -116.78 -13.41 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.147 0.579 . . . . 0.0 111.704 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.94 165.22 30.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -160.41 147.66 15.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 171.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -142.7 149.56 38.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.076 0.55 . . . . 0.0 109.545 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.58 157.22 45.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.945 1.298 . . . . 0.0 109.599 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 tt -145.28 142.23 29.29 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.287 1.835 . . . . 0.0 107.625 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.8 p -167.66 139.08 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.936 1.694 . . . . 0.0 107.111 164.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.429 ' HA ' ' HD2' ' A' ' 117' ' ' LYS . 69.1 m-85 -135.48 164.98 26.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.091 0.956 . . . . 0.0 108.431 166.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.23 165.12 13.2 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.889 1.676 . . . . 0.0 107.617 171.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -49.12 -44.11 42.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.136 1.774 . . . . 0.0 112.794 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.5 47.48 3.62 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 123.799 0.714 . . . . 0.0 112.615 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -160.38 -177.87 6.53 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.137 1.375 . . . . 0.0 107.959 165.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -63.73 137.12 57.94 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.7 tp -96.7 136.67 26.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 161.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.0 t -154.75 130.9 10.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.64 174.15 11.86 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.998 0.817 . . . . 0.0 111.605 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -152.33 -175.44 5.27 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.528 1.131 . . . . 0.0 109.889 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -164.37 140.06 5.99 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.013 1.725 . . . . 0.0 109.295 173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -130.94 159.57 37.04 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.391 1.876 . . . . 0.0 109.466 -169.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -164.42 68.98 0.17 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.967 0.907 . . . . 0.0 110.671 172.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.6 mt -84.04 137.2 33.71 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 119.961 -1.712 . . . . 0.0 109.412 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -138.87 132.15 30.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.892 0.877 . . . . 0.0 109.725 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -132.4 95.67 3.69 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.557 1.543 . . . . 0.0 110.312 -169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.246 0.912 0 C-N-CA 125.906 1.682 . . . . 0.0 108.631 176.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.73 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -50.82 123.69 9.59 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 122.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -143.96 170.34 16.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.943 2.497 . . . . 0.0 105.555 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.29 176.65 8.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.308 0.958 . . . . 0.0 111.518 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -125.46 73.33 67.97 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.037 1.335 . . . . 0.0 111.085 -174.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.23 64.33 7.08 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.025 3.15 . . . . 0.0 112.061 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 -71.53 1.13 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.222 1.391 . . . . 0.0 110.416 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.47 76.95 0.17 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.479 1.038 . . . . 0.0 113.477 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.9 mmtt -133.65 176.22 8.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.693 1.197 . . . . 0.0 112.908 -166.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.42 171.99 42.28 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 122.624 1.125 . . . . 0.0 113.985 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.84 155.09 42.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.669 1.987 . . . . 0.0 110.3 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.4 mtt -82.38 150.77 26.96 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 165.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.28 170.95 19.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.378 1.085 . . . . 0.0 109.387 162.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -142.08 153.01 43.85 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 128.66 2.784 . . . . 0.0 104.866 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.02 157.49 5.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 65' ' ' THR . 4.7 t -140.83 150.63 43.53 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.79 -0.569 . . . . 0.0 109.584 166.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 tt -128.48 140.72 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 126.881 2.073 . . . . 0.0 108.327 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 63' ' ' LYS . 2.8 mt-10 -133.27 97.73 4.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -82.32 164.79 20.87 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 170.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.3 p -153.82 -177.76 6.61 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.755 1.222 . . . . 0.0 108.908 168.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.41 -142.93 47.71 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.32 58.38 0.75 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 124.965 2.317 . . . . 0.0 110.486 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -62.75 -19.13 63.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.86 -1.973 . . . . 0.0 114.753 -176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.87 10.68 15.38 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.444 1.02 . . . . 0.0 112.595 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.9 m -112.65 47.12 1.12 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.907 0.883 . . . . 0.0 110.635 173.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -138.98 110.84 7.19 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.752 1.621 . . . . 0.0 109.138 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.4 mm -78.33 94.58 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.034 0.934 . . . . 0.0 110.594 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -148.65 169.86 19.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.693 -1.255 . . . . 0.0 113.559 164.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.0 m -96.6 149.98 21.17 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.217 1.407 . . . . 0.0 110.286 171.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.2 t -129.04 98.2 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.17 124.9 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.257 149.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -145.71 83.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.316 144.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 52' ' ' VAL . 3.0 m -144.73 144.98 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 120.607 -1.308 . . . . 0.0 110.027 -166.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.16 124.53 30.6 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 118.472 0.578 . . . . 0.0 111.299 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.07 9.28 0.59 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 171.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.04 -18.8 0.03 OUTLIER Glycine 0 N--CA 1.467 0.766 0 N-CA-C 117.281 1.673 . . . . 0.0 117.281 -175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -125.59 -164.81 1.34 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.917 1.859 . . . . 0.0 108.163 178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.05 170.0 8.53 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.988 1.715 . . . . 0.0 110.59 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -129.95 172.85 11.27 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.227 -173.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.559 ' H ' HD23 ' A' ' 39' ' ' LEU . 15.1 ttmt -132.0 132.64 43.62 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 126.908 2.083 . . . . 0.0 108.184 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -71.58 159.46 34.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.089 0.956 . . . . 0.0 110.214 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -4.47 88.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.442 1.02 . . . . 0.0 111.993 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.38 -64.96 1.08 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.587 1.155 . . . . 0.0 110.909 -169.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.9 p -134.0 -6.67 2.72 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.584 0.754 . . . . 0.0 112.916 -157.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.31 20.99 79.52 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 119.481 1.037 . . . . 0.0 112.852 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -65.7 165.88 11.82 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.969 1.708 . . . . 0.0 109.404 159.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.7 m -124.83 143.95 50.55 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.974 1.31 . . . . 0.0 109.952 174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -133.04 158.05 43.7 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.932 1.693 . . . . 0.0 109.514 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.21 172.62 1.39 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.139 1.776 . . . . 0.0 112.842 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -152.62 151.5 27.0 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.693 1.197 . . . . 0.0 108.764 163.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.99 157.14 99.25 Favored 'Cis proline' 0 CA--C 1.536 0.595 0 CA-C-N 120.47 1.204 . . . . 0.0 113.979 6.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' H ' HG11 ' A' ' 33' ' ' VAL . 2.7 p -155.15 72.96 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.736 2.014 . . . . 0.0 108.126 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.19 102.43 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 -161.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.2 mt -66.02 154.15 40.26 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.444 0.698 . . . . 0.0 109.868 -170.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.77 179.8 5.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.999 2.119 . . . . 0.0 107.828 178.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -44.47 -40.89 5.9 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 127.494 2.317 . . . . 0.0 112.283 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -57.04 -43.37 81.89 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.598 1.159 . . . . 0.0 112.054 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.12 4.74 53.47 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.105 1.762 . . . . 0.0 111.439 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.14 -3.1 51.0 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.591 -1.318 . . . . 0.0 112.307 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.15 19.17 0.24 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -170.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 1.8 m -111.34 151.18 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 120.149 1.341 . . . . 0.0 111.429 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.73 -62.74 1.39 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.727 0.775 . . . . 0.0 109.77 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 18' ' ' GLU . 2.6 mptm? -130.9 142.4 50.36 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 124.259 1.024 . . . . 0.0 111.005 -167.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 t -156.04 123.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.547 0 O-C-N 126.266 2.229 . . . . 0.0 109.798 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 16' ' ' THR . 27.6 m -118.54 115.25 24.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.59 1.156 . . . . 0.0 109.116 174.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.7 mt -128.71 139.0 52.43 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -167.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.8 t -151.21 151.63 32.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 122.085 0.945 . . . . 0.0 112.189 -169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 72' ' ' ALA . 7.2 p -80.58 147.12 30.9 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.106 0.962 . . . . 0.0 112.679 -170.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.8 p -90.86 -2.66 57.74 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 111.914 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.87 -161.94 23.26 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.726 2.107 . . . . 0.0 108.396 -166.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -80.99 113.52 19.26 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.915 1.357 . . . . 0.0 111.397 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -70.2 141.78 52.5 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 163.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.31 -61.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -133.55 138.62 46.14 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.257 1.423 . . . . 0.0 107.44 -166.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.23 171.76 13.71 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.168 1.387 . . . . 0.0 109.92 -176.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -159.62 160.0 33.81 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.596 1.159 . . . . 0.0 109.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.8 t -140.2 39.88 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 123.462 1.601 . . . . 0.0 108.56 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.2 p -84.18 152.37 24.3 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 120.412 -1.43 . . . . 0.0 109.133 -178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.56 -115.87 1.59 Allowed Glycine 0 C--N 1.33 0.198 0 N-CA-C 107.199 -2.36 . . . . 0.0 107.199 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.77 -175.49 44.34 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -172.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.97 -172.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.529 0 O-C-N 122.386 -0.479 . . . . 0.0 110.514 -176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.22 165.95 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 149.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -72.67 95.37 1.86 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.216 1.406 . . . . 0.0 109.42 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.73 -52.66 5.78 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.887 -0.508 . . . . 0.0 112.282 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -163.44 148.52 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.42 1.888 . . . . 0.0 107.162 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -44.57 -53.11 7.44 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.266 2.627 . . . . 0.0 113.594 -163.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.82 2.79 47.53 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.693 -1.615 . . . . 0.0 115.821 170.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.253 32.6 m 49.55 -177.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.43 1.892 . . . . 0.0 112.312 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.1 t -71.23 139.82 19.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -120.43 -177.07 3.36 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -78.6 156.44 78.02 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 120.685 -1.259 . . . . 0.0 109.992 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.06 85.76 1.78 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.209 2.606 . . . . 0.0 112.593 -166.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.57 127.22 15.14 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.964 1.705 . . . . 0.0 110.948 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -90.45 146.03 24.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -122.22 146.02 47.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 162.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.73 131.22 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 163.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.22 112.42 8.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 85.1 m -109.25 120.32 42.16 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.393 1.077 . . . . 0.0 108.85 -176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.61 135.97 34.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 126.43 1.892 . . . . 0.0 109.458 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -115.01 176.68 4.95 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.62 1.568 . . . . 0.0 107.566 169.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -144.28 -166.22 2.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -55.55 14.54 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.084 2.554 . . . . 0.0 116.766 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.88 -64.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 120.22 1.373 . . . . 0.0 110.246 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -157.14 -179.73 8.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 109.144 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -53.41 132.73 40.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 128.138 2.575 . . . . 0.0 110.1 170.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 12.3 pt -128.2 -19.16 2.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 117.789 -1.101 . . . . 0.0 113.175 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -145.49 149.99 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 120.132 1.333 . . . . 0.0 108.315 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 113.26 3.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.18 143.34 43.4 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 123.626 0.771 . . . . 0.0 109.279 178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.38 95.61 2.82 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.65 1.18 . . . . 0.0 109.629 -165.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 tp -78.65 127.95 32.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 127.494 2.317 . . . . 0.0 107.82 -172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 t -155.08 117.98 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -148.48 123.12 9.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.589 1.54 . . . . 0.0 109.695 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.38 71.23 0.13 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.43 1.892 . . . . 0.0 110.558 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 54.62 -172.03 0.05 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.096 0.959 . . . . 0.0 110.029 -169.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.28 23.8 60.42 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.535 -1.353 . . . . 0.0 114.288 167.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -142.84 119.49 11.1 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -67.69 97.5 0.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.9 tp -170.97 165.45 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.004 2.122 . . . . 0.0 107.173 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.4 t -152.88 58.29 0.79 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 169.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -161.83 153.39 18.71 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.907 1.683 . . . . 0.0 107.1 174.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -146.9 12.47 1.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 168.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.88 171.95 13.53 Favored 'General case' 0 C--O 1.242 0.679 0 O-C-N 120.607 -1.308 . . . . 0.0 110.607 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 tp -143.83 151.4 39.86 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.674 -0.641 . . . . 0.0 112.065 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -147.42 105.41 3.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.524 1.529 . . . . 0.0 108.047 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.57 141.37 51.76 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 166.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.92 149.7 52.42 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -145.47 121.02 10.4 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.794 1.638 . . . . 0.0 108.171 177.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.892 0 N-CA-C 107.001 -2.44 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.2 t0 56.53 101.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -112.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.24 177.41 7.7 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.607 1.563 . . . . 0.0 108.865 -160.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -105.81 75.8 1.15 Allowed 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.677 0.751 . . . . 0.0 112.311 -159.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.98 59.31 10.52 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.151 1.38 . . . . 0.0 113.588 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -64.21 109.49 1.16 Allowed 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 112.07 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.03 50.3 3.9 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 126.548 2.023 . . . . 0.0 112.345 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.49 123.49 0.83 Allowed Glycine 0 N--CA 1.451 -0.312 0 N-CA-C 107.394 -2.282 . . . . 0.0 107.394 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -141.19 146.05 36.43 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.442 1.121 . . . . 0.0 110.399 178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.08 161.06 44.86 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 124.491 1.119 . . . . 0.0 112.999 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.0 171.03 15.89 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.925 1.69 . . . . 0.0 109.726 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mtt -74.74 150.65 39.34 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.093 0.557 . . . . 0.0 111.502 -177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -146.59 171.28 15.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.48 1.112 . . . . 0.0 108.942 166.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -142.11 154.31 44.8 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 127.446 2.298 . . . . 0.0 104.926 167.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 p -142.33 143.54 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 120.165 1.348 . . . . 0.0 108.79 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -134.88 136.92 42.76 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.8 tt -132.59 141.9 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.506 1.522 . . . . 0.0 108.451 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.1 110.19 19.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -97.41 152.62 18.77 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -162.9 169.09 20.29 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 120.788 -1.195 . . . . 0.0 109.611 -174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 51.33 -122.03 13.83 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -112.13 78.45 1.13 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 123.604 1.669 . . . . 0.0 108.679 -172.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HG3' ' A' ' 24' ' ' ARG . 31.5 p90 -70.46 -37.83 74.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.522 167.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 72.5 mtm-85 -79.54 72.66 6.21 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.603 1.161 . . . . 0.0 108.107 176.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 m -157.79 1.98 0.11 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.033 1.733 . . . . 0.0 112.818 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -146.02 169.97 17.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.739 1.154 . . . . 0.0 111.186 -166.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.1 mm -112.26 103.29 15.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.038 1.335 . . . . 0.0 108.662 -175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.68 118.02 10.23 Favored 'General case' 0 CA--C 1.52 -0.201 0 O-C-N 121.573 -0.705 . . . . 0.0 109.856 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.22 159.99 17.9 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.876 1.67 . . . . 0.0 110.048 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.6 t -139.7 110.36 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 121.882 0.849 . . . . 0.0 108.859 175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.54 100.61 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 164.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -135.68 100.94 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG21 ' HA ' ' A' ' 51' ' ' PRO . 11.5 p -154.0 -178.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 160.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 33' ' ' VAL . . . -103.65 135.43 45.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.47 1.108 . . . . 0.0 108.854 160.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.29 31.75 0.34 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.14 -64.45 0.02 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.542 1.068 . . . . 0.0 111.171 -175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 34' ' ' ALA . 2.6 t -77.74 176.14 9.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.653 0.727 . . . . 0.0 111.671 -177.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -92.76 151.28 20.13 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 127.346 2.258 . . . . 0.0 108.546 170.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.52 168.51 9.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.619 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -126.93 130.96 51.13 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 127.333 2.253 . . . . 0.0 107.942 -174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' HB2' HD21 ' A' ' 48' ' ' LEU . 22.7 t0 -67.84 169.98 8.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.005 2.122 . . . . 0.0 111.356 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.56 9.08 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.422 1.963 . . . . 0.0 114.323 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 41' ' ' ASP . . . -75.0 -53.26 9.24 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 120.455 2.128 . . . . 0.0 108.528 164.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -130.5 -15.35 3.59 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.068 1.747 . . . . 0.0 112.385 -168.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.11 24.48 73.54 Favored Glycine 0 CA--C 1.524 0.637 0 O-C-N 120.835 -1.166 . . . . 0.0 111.463 -173.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.45 154.09 21.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 162.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.0 m -113.42 124.48 52.53 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -106.62 175.39 5.51 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.34 1.456 . . . . 0.0 109.083 -170.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.76 167.07 19.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.468 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -149.84 160.05 34.6 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 126.233 1.813 . . . . 0.0 107.863 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.79 ' HA ' HG21 ' A' ' 33' ' ' VAL . 86.8 Cg_endo -70.05 169.76 62.99 Favored 'Cis proline' 0 CA--C 1.537 0.673 0 CA-C-N 120.836 1.334 . . . . 0.0 112.332 -0.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -147.1 132.96 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.09 110.88 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.97 141.9 28.22 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.328 0.651 . . . . 0.0 109.983 -171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.21 -179.79 3.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.003 1.721 . . . . 0.0 110.467 176.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -54.58 -39.31 67.68 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.834 1.254 . . . . 0.0 112.926 -167.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.75 -44.2 74.25 Favored 'General case' 0 N--CA 1.436 -1.129 0 C-N-CA 125.988 1.715 . . . . 0.0 110.427 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -66.81 -19.29 65.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.332 1.053 . . . . 0.0 111.025 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.29 6.09 35.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.855 1.662 . . . . 0.0 112.369 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -75.19 51.83 0.56 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.008 1.723 . . . . 0.0 110.251 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.74 178.47 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.398 1.879 . . . . 0.0 111.369 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -110.56 -64.95 1.21 Allowed 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 120.785 -1.197 . . . . 0.0 111.632 -160.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.01 126.19 5.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 -170.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.71 154.09 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 119.767 1.167 . . . . 0.0 109.634 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -113.57 115.74 28.42 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 161.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.24 142.54 34.83 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.7 t -150.5 153.1 35.24 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 122.084 0.945 . . . . 0.0 110.526 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 p -79.28 149.31 31.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 124.143 0.977 . . . . 0.0 110.704 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.0 p -78.75 -53.74 6.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -112.39 -123.5 4.2 Favored Glycine 0 C--N 1.342 0.866 0 C-N-CA 125.435 1.493 . . . . 0.0 111.596 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -113.82 138.39 50.34 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.598 1.699 . . . . 0.0 112.143 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -101.36 114.23 28.02 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.119 1.367 . . . . 0.0 108.878 -174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.82 -46.12 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 O-C-N 124.353 1.033 . . . . 0.0 108.306 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -137.78 153.46 49.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.204 2.602 . . . . 0.0 106.961 -176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -165.86 156.62 13.29 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.205 2.202 . . . . 0.0 108.628 164.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 149.13 42.73 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 124.17 0.988 . . . . 0.0 110.376 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.6 74.12 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 -176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.7 p -107.51 158.38 17.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.229 1.012 . . . . 0.0 109.492 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -178.08 68.57 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 106.903 -2.479 . . . . 0.0 106.903 -169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.14 -175.87 33.22 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 164.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.6 t -131.6 173.25 14.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.04 162.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 122.303 1.049 . . . . 0.0 110.477 161.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -58.85 105.62 0.33 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.796 2.039 . . . . 0.0 107.049 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.17 -95.34 2.39 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -135.84 170.74 15.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.954 1.702 . . . . 0.0 107.928 171.202 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 2.9 t70 70.47 -179.59 0.23 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.096 2.158 . . . . 0.0 110.816 174.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.64 -176.46 28.33 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.385 6.4 p 61.83 -0.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 127.602 2.361 . . . . 0.0 113.569 -173.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 89' ' ' VAL . 1.9 t -59.56 -9.89 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 127.827 2.451 . . . . 0.0 113.877 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 44.4 t30 64.99 11.3 6.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.449 1.499 . . . . 0.0 112.967 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -100.8 89.48 1.25 Allowed Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 128.092 2.557 . . . . 0.0 112.207 -159.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.38 64.59 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.985 1 C-N-CA 126.012 4.475 . . . . 0.0 112.814 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 28.5 mmt -69.63 99.47 1.31 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.973 1.309 . . . . 0.0 108.919 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.77 163.51 13.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.126 0.965 . . . . 0.0 110.055 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -134.11 153.03 52.07 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 152.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.7 t -134.49 144.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 105.002 -2.222 . . . . 0.0 105.002 166.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.9 143.65 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 C-N-CA 126.172 1.789 . . . . 0.0 106.623 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.5 m -125.5 136.23 53.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 107' ' ' GLU . 0.8 OUTLIER -87.96 162.69 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 173.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -141.01 138.28 33.58 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 160.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 102' ' ' ASN . 28.0 tttt -88.27 -170.89 3.14 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 101' ' ' LYS . 57.6 p30 -58.02 28.49 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 128.135 2.574 . . . . 0.0 114.768 160.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.67 -79.89 0.03 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.56 -169.86 3.26 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.337 2.255 . . . . 0.0 107.582 -176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -57.67 138.36 55.47 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.569 1.148 . . . . 0.0 110.352 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.45 -11.49 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.995 0.918 . . . . 0.0 111.348 167.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.49 ' H ' HG12 ' A' ' 99' ' ' VAL . 2.0 tp10 -153.72 148.63 26.61 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.2 1.8 . . . . 0.0 108.985 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.01 121.81 4.07 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -177.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -125.18 164.19 20.82 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.496 1.118 . . . . 0.0 111.027 -172.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.14 171.66 13.75 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.882 1.673 . . . . 0.0 108.298 -175.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.91 138.75 25.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.624 1.57 . . . . 0.0 108.257 172.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -146.62 97.77 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -132.6 161.76 33.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.716 0.806 . . . . 0.0 109.087 170.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -154.99 30.45 0.41 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.022 1.329 . . . . 0.0 111.504 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 63.1 30.41 16.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.2 1.8 . . . . 0.0 111.469 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 159.63 115.76 0.41 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -141.91 -177.78 5.37 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.345 1.072 . . . . 0.0 108.753 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.7 mp0 -71.6 -15.96 62.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.548 1.539 . . . . 0.0 112.579 -170.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.4 tp -164.99 170.48 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 130.992 3.717 . . . . 0.0 106.135 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.08 143.29 33.0 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.652 1.181 . . . . 0.0 108.433 169.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.17 168.45 9.71 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.876 1.27 . . . . 0.0 109.702 -174.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.5 98.09 1.93 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.446 -0.784 . . . . 0.0 110.22 166.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.7 94.79 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.093 -1.818 . . . . 0.0 106.093 165.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.2 mt -144.3 100.07 3.48 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.211 1.005 . . . . 0.0 109.043 171.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.38 115.46 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.57 138.05 53.41 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.551 1.14 . . . . 0.0 108.066 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -145.44 132.62 20.46 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.085 0.954 . . . . 0.0 108.515 -166.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -129.58 94.44 3.76 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 122.261 1.029 . . . . 0.0 108.816 -169.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.229 -1.843 . . . . 0.0 108.934 176.788 . . . . . . . . 0 0 . 1 stop_ save_